Site|Patient_Name|Folder|Record_position|Page_repeatnumber|AESPID|AETERM|AESTDAT|AESTTIM|AESTTIMUNK|AEONGO|AEENDAT|AEENTIM|AEENTIMUNK|AEOUT|AESEV|AESCALE|AETOXGR|AEREL|AEACN|AECONTRT|AEACNOTH|AEACNOTHSP|AESER|AESI|AEDLT|AEMED
001|001-1001|AE|1|0|0001|GENERALIZED WEAKNESS|30 NOV 2020|13:45|0|N|08 DEC 2020|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
001|001-1002|AE|1|0|0001|PROSTATIC OBSTRUCTION|07 FEB 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
001|001-1002|AE|2|0|0002|CYTOKINE RELEASE SYNDROME|11 FEB 2023|09:00|0|N|02 MAR 2023|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
001|001-1002|AE|3|0|0003|INFECTIONS AND INFESTATIONS - OTHER: C. DIFFICILE|22 DEC 2020|20:00|0|N|27 DEC 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
001|001-1002|AE|4|0|0004|CHRONIC KIDNEY DISEASE|27 MAY 2023|14:30|0|N|14 JUN 2023|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
001|001-1003|AE|1|0|0001|NEOPLASM PAIN|07 JUL 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
001|001-1004|AE|1|0|0001|IV CATHETER OCCLUSION|06 AUG 2023|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
001|001-1004|AE|2|0|0002|INTERMITTENT HIP PAIN|01 NOV 2021|08:15|0|N|28 NOV 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
001|001-1004|AE|3|0|0003|ODEMA, LOWER LIMBS|22 FEB 2023|08:15|0|N|06 MAR 2023|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
001|001-1004|AE|4|0|0004|DIARRHEA INTERMITTENT|02 MAY 2022|16:00|0|N|29 MAY 2022|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
001|001-1005|AE|1|0|0001|BENIGN PAROXYSMAL POSITIONAL VERTIGO|10 NOV 2020|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
001|001-1005|AE|2|0|0002|NON CARDIAC CHEST PAIN|01 JUL 2020|15:00|0|N|27 JUL 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
001|001-1005|AE|3|0|0003|BLOOD LACTATEDEHYDROGENASE INCREASED|28 AUG 2020|09:30|0|N|05 SEP 2020|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
001|001-1005|AE|4|0|0004|ARTHRALGIA|12 DEC 2020|15:00|0|N|31 DEC 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
001|001-1005|AE|5|0|0005|AST INCREASED (INTERMITTENT)|05 FEB 2021|13:45|0|N|11 FEB 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
001|001-1006|AE|1|0|0001|B12 DEFICIENCY|03 JUN 2022|12:00|0|N|03 JUL 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
001|001-1006|AE|2|0|0002|BONE MARROW HYPOCELLULAR|29 SEP 2022|20:00|0|N|21 OCT 2022|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
001|001-1007|AE|1|0|0001|SMALL UMBILICAL HERNIA|23 NOV 2023|11:00|0|N|08 DEC 2023|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
001|001-1007|AE|2|0|0002|EDEMA EXTREMITIES (LEG)|25 AUG 2023|11:00|0|N|12 SEP 2023|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
001|001-1007|AE|3|0|0003|INVESTIGATIONS OTHER: MONOCYTES ELEVATED|15 AUG 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
001|001-1007|AE|4|0|0004|RESTLESS LEGS|28 OCT 2020|10:30|0|N|16 NOV 2020|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
001|001-1007|AE|5|0|0005|PETECHIAL RASH ON LOWER EXTREMITIES|13 DEC 2022|07:30|0|N|24 DEC 2022|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
001|001-1007|AE|6|0|0006|CYTOKINE RELEASE SYNDROME|01 MAR 2021|17:00|0|N|02 MAR 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
001|001-1008|AE|1|0|0001|CEREBRAL INFARCTION|20 JAN 2023|11:00|0|N|29 JAN 2023|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
001|001-1008|AE|2|0|0002|CONFUSION|19 JUN 2021|09:30|0|N|14 JUL 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
001|001-1008|AE|3|0|0003|HEPATIC INFECTION|17 MAY 2021|15:00|0|N|30 MAY 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
001|001-1008|AE|4|0|0004|CANCER-RELATED PAIN|23 FEB 2022|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
001|001-1008|AE|5|0|0005|TINNITUS|19 JUL 2022|15:00|0|N|05 AUG 2022|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
001|001-1008|AE|6|0|0006|THRUSH|21 DEC 2020|14:00|0|N|02 JAN 2021|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
001|001-1008|AE|7|0|0007|HYPERGLYCEMIA|08 OCT 2021|12:00|0|N|10 OCT 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
002|002-1001|AE|1|0|0001|SWELLING OF EYELID|31 OCT 2020|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
002|002-1001|AE|2|0|0002|ERECTILE DYSFUNCTION|05 SEP 2020|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
002|002-1002|AE|1|0|0001|OSTEOARTHRITIS OF LEFT HIP|29 DEC 2020|09:00|0|N|10 JAN 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
002|002-1002|AE|2|0|0002|ASPARTATE AMINOTRANSFERASE INCREASED|13 NOV 2020|14:00|0|N|28 NOV 2020|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
002|002-1002|AE|3|0|0003|PLATELETS COUNT DECREASED|24 AUG 2021|11:00|0|N|24 AUG 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
002|002-1002|AE|4|0|0004|HAEMATOMA RIGHT OUTER THIGH|04 NOV 2021|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
002|002-1002|AE|5|0|0005|CHOLELITHIASIS|10 JAN 2021|08:30|0|N|04 FEB 2021|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
002|002-1002|AE|6|0|0006|AGITATION|14 JUN 2021|08:00|0|N|17 JUN 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
002|002-1002|AE|7|0|0007|NEUTROPHIL COUNT DECREASED|10 FEB 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
002|002-1002|AE|8|0|0008|RIGHT LEG SKIN RASH|13 MAR 2022|12:00|0|N|26 MAR 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
002|002-1002|AE|9|0|0009|CONSTIPATION|15 JUL 2021|15:00|0|N|30 JUL 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
002|002-1003|AE|1|0|0001|ORTHOSTATIC HYPOTENSION|10 MAY 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
002|002-1004|AE|1|0|0001|HEADACHE (INTERMITTENT)|04 SEP 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
002|002-1004|AE|10|0|0010|ENDOMETRIAL CARCINOMA|28 MAR 2022|15:00|0|N|31 MAR 2022|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
002|002-1004|AE|2|0|0002|BLAST CELL COUNT INCREASED|20 MAR 2021|08:00|0|N|29 MAR 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
002|002-1004|AE|3|0|0003|PRURITUS|07 FEB 2023|15:00|0|N|24 FEB 2023|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
002|002-1004|AE|4|0|0004|SMALL UMBILICAL HERNIA|22 APR 2022|16:00|0|N|15 MAY 2022|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
002|002-1004|AE|5|0|0005|ALANINE AMINOTRANSFERASE INCREASED|14 SEP 2020|08:30|0|N|26 SEP 2020|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
002|002-1004|AE|6|0|0006|OSTEOARTHRITIS OF LEFT HIP|09 MAR 2023|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
002|002-1004|AE|7|0|0007|ABODOMINAL PAIN|06 SEP 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
002|002-1004|AE|8|0|0008|TYPE II DIABETES|10 MAY 2022|12:00|0|N|22 MAY 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
002|002-1004|AE|9|0|0009|SKIN HYPERPIGMENTATION|01 SEP 2021|11:00|0|N|05 SEP 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
002|002-1005|AE|1|0|0001|HYPOMAGNESAEMIA|18 AUG 2022|15:00|0|N|07 SEP 2022|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
002|002-1005|AE|2|0|0002|SKIN AND SUBCUTANEOUS TISSUE DISORDERS -LACERATION - THUMB|11 OCT 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
002|002-1005|AE|3|0|0003|DIZZINESS|03 DEC 2021|11:00|0|N|16 DEC 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
002|002-1005|AE|4|0|0004|TYPE II DIABETES|22 AUG 2020|09:00|0|N|17 SEP 2020|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
002|002-1005|AE|5|0|0005|DEGENERATIVE DISEASE OF THE CERVICAL SPINE|09 OCT 2020|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
002|002-1005|AE|6|0|0006|MEMBRANOUS NEPHROPATHY|16 JUL 2020|08:00|0|N|13 AUG 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
002|002-1005|AE|7|0|0007|LEFT AXILLARY ABSCESS|09 JAN 2022|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
002|002-1005|AE|8|0|0008|PAROTID MASS|15 JUL 2021|09:00|0|N|29 JUL 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
002|002-1006|AE|1|0|0001|PRURITUS|23 FEB 2021|09:30|0|N|20 MAR 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
002|002-1006|AE|10|0|0010|NON CARDIAC CHEST PAIN|03 APR 2021|08:15|0|N|24 APR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
002|002-1006|AE|2|0|0002|RASH ON SKIN NEAR PICC SITE|04 APR 2021|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
002|002-1006|AE|3|0|0003|INVESTIGATIONS OTHER: MONOCYTES ELEVATED|10 APR 2021|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
002|002-1006|AE|4|0|0004|MELANOMA INSITU|02 APR 2021|11:00|0|N|23 APR 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
002|002-1006|AE|5|0|0005|OSTEOARTHRITIS|07 MAR 2021|15:00|0|N|22 MAR 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
002|002-1006|AE|6|0|0006|WORSENED ANEMIA|09 MAR 2021|22:30|0|N|31 MAR 2021|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
002|002-1006|AE|7|0|0007|AGE-RELATED CATARACTS|31 MAR 2021|12:00|0|N|28 APR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
002|002-1006|AE|8|0|0008|ALLERGY TO PENICILLIN G BENZATHINE|14 MAR 2021|15:00|0|N|13 APR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
002|002-1006|AE|9|0|0009|BILATERAL SUBDURAL HEMATOMA|11 APR 2021|12:00|0|N|06 MAY 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
002|002-1007|AE|1|0|0001|COAGULOPATHY|18 FEB 2021|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
002|002-1007|AE|2|0|0002|NEUROPATHY – BILATERAL LEGS AND TOES|13 JAN 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
002|002-1007|AE|3|0|0003|MELANOMA INSITU|30 MAR 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
002|002-1007|AE|4|0|0004|HYPERCHOLESTEROLAEMIA|23 MAR 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
002|002-1007|AE|5|0|0005|VASCULITIS|29 JAN 2021|10:00|0|N|31 JAN 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
002|002-1007|AE|6|0|0006|ALANINE AMINOTRANSFERASE INCREASED|24 FEB 2021|13:45|0|N|22 MAR 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
002|002-1007|AE|7|0|0007|SMALL UMBILICAL HERNIA|08 FEB 2021|12:00|0|N|14 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
002|002-1008|AE|1|0|0001|NEUROPATHIC PAIN|21 FEB 2021|15:00|0|N|16 MAR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
002|002-1009|AE|1|0|0001|ANEMIA|22 APR 2022|08:00|0|N|22 APR 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
002|002-1009|AE|10|0|0010|DENTAL ABSCESS|16 NOV 2021|11:00|0|N|26 NOV 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
002|002-1009|AE|2|0|0002|LOWER EXTREMITY EDEMA|01 MAY 2022|15:00|0|N|07 MAY 2022|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
002|002-1009|AE|3|0|0003|MACROCRYTIC ANEMIA|09 FEB 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
002|002-1009|AE|4|0|0004|PROLONGED PR INTERVAL|06 APR 2022|15:00|0|N|20 APR 2022|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
002|002-1009|AE|5|0|0005|SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, RED SWOLLEN AREA ON HAND|30 MAR 2021|08:15|0|N|23 APR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
002|002-1009|AE|6|0|0006|POST-MENOPAUSAL|02 FEB 2022|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
002|002-1009|AE|7|0|0007|LEFT BUNDLE BRANCH BLOCK|21 SEP 2021|15:00|0|N|10 OCT 2021|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
002|002-1009|AE|8|0|0008|DYSPNOEA|16 DEC 2020|22:30|0|N|03 JAN 2021|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
002|002-1009|AE|9|0|0009|PANCREATIC INSUFFICIENCY|23 JUL 2021|15:00|0|N|15 AUG 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
003|003-1001|AE|1|0|0001|BLOOD LACTATEDEHYDROGENASE INCREASED|10 MAR 2021|17:00|0|N|25 MAR 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
003|003-1001|AE|2|0|0002|HYPERURICAEMIA|29 MAY 2021|08:30|0|N|10 JUN 2021|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
003|003-1001|AE|3|0|0003|CARDIAC TROPONIN T INCREASED|16 APR 2021|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
003|003-1001|AE|4|0|0004|MELANOMA INSITU|18 DEC 2020|09:00|0|N|31 DEC 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
003|003-1001|AE|5|0|0005|NEUTROPENIC FEVER|05 DEC 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
003|003-1001|AE|6|0|0006|WEIGHT LOSS|13 APR 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
003|003-1002|AE|1|0|0001|WORSENING NEUTROPENIA|27 MAY 2021|08:00|0|N|01 JUN 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
003|003-1002|AE|2|0|0002|CHRONIC COUGH|04 MAY 2021|09:00|0|N|18 MAY 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
003|003-1003|AE|1|0|0001|PAIN IN EXTREMITY L ANKLE|08 NOV 2020|20:00|0|N|01 DEC 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
003|003-1003|AE|2|0|0002|ASTHMA|26 SEP 2021|20:00|0|N|27 SEP 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
003|003-1003|AE|3|0|0003|INTERMITTENT NEUTROPENIA|05 JUL 2020|11:00|0|N|17 JUL 2020|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
003|003-1003|AE|4|0|0004|HYPERTENSION|10 JAN 2021|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
003|003-1003|AE|5|0|0005|UMBILICAL HERNIA|02 DEC 2021|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
003|003-1003|AE|6|0|0006|NOVEL CORONAVIRUS INFECTION|05 JAN 2021|23:00|0|N|19 JAN 2021|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
003|003-1004|AE|1|0|0001|FLATULENCE|13 MAR 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
003|003-1005|AE|1|0|0001|MILD AORTIC REGURGITATION|08 AUG 2021|15:00|0|N|01 SEP 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
003|003-1005|AE|10|0|0010|DYSLIPIDEMIA|23 JUN 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
003|003-1005|AE|11|0|0011|EDEMA EXTREMITIES (LEG)|03 JUL 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
003|003-1005|AE|2|0|0002|NON-CARDIAC CHEST PAIN|22 JUL 2021|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
003|003-1005|AE|3|0|0003|APPENDICITIS|26 DEC 2020|17:00|0|N|07 JAN 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
003|003-1005|AE|4|0|0004|HYPERNATREMIA|05 JUL 2021|10:00|0|N|10 JUL 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
003|003-1005|AE|5|0|0005|DIARRHEA INTERMITTENT|18 JUN 2021|10:00|0|N|05 JUL 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
003|003-1005|AE|6|0|0006|NODULAR GOITER|24 MAY 2021|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
003|003-1005|AE|7|0|0007|UMBILICAL HERNIA|07 JUN 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
003|003-1005|AE|8|0|0008|VESICULITIS|29 MAR 2021|10:00|0|N|21 APR 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
003|003-1005|AE|9|0|0009|VITAMIN B12 DEFICIENCY|02 SEP 2021|10:00|0|N|02 SEP 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
003|003-1006|AE|1|0|0001|SCIATICA|26 APR 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
003|003-1006|AE|2|0|0002|LEFT LOWER EXTREMITY DEEP VEIN THROMBOSIS|24 JAN 2021|12:00|0|N|13 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
003|003-1006|AE|3|0|0003|GASRITIS|28 APR 2021|09:00|0|N|08 MAY 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
003|003-1006|AE|4|0|0004|LEG PAIN|02 APR 2021|09:15|0|N|21 APR 2021|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
003|003-1006|AE|5|0|0005|PROTEINURIA|10 JUL 2021|17:00|0|N|11 JUL 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
003|003-1006|AE|6|0|0006|GLAUCOMA|08 FEB 2021|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
003|003-1006|AE|7|0|0007|INTRAMEDULLARY LUCENCY AT L3|16 MAR 2021|12:00|0|N|21 MAR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
003|003-1006|AE|8|0|0008|LOWER BACK PAIN|02 FEB 2021|14:00|0|N|09 FEB 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
003|003-1007|AE|1|0|0001|INJECTION SITE REACTION - INTERMITTENT|29 DEC 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
003|003-1007|AE|10|0|0010|CONSTIPATION|22 MAR 2021|20:00|0|N|29 MAR 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
003|003-1007|AE|2|0|0002|MALIGNANT NEOPLASM RELATED FATIGUE|11 FEB 2021|15:00|0|N|16 FEB 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
003|003-1007|AE|3|0|0003|CONGESTIVE HEART FAILURE|18 NOV 2021|08:00|0|N|25 NOV 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
003|003-1007|AE|4|0|0004|OSTEOPENIA|20 DEC 2020|11:00|0|N|27 DEC 2020|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
003|003-1007|AE|5|0|0005|OEDEMA - LEFT ARM|10 JUL 2021|08:00|0|N|10 JUL 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
003|003-1007|AE|6|0|0006|SEASONAL ALLERGIC RHINITIS|01 MAR 2021|08:00|0|N|08 MAR 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
003|003-1007|AE|7|0|0007|ACUTE MEDIAL MENISCUS TEAR OF RIGHT KNEE|30 AUG 2020|13:45|0|N|10 SEP 2020|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
003|003-1007|AE|8|0|0008|FIBRINOGEN DECREASED|10 MAR 2021|09:00|0|N|13 MAR 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
003|003-1007|AE|9|0|0009|FUNGAL PNEUMONIA|08 MAY 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
003|003-1008|AE|1|0|0001|ALANINE AMINOTRANSFERASE INCREASED|02 AUG 2021|08:15|0|N|18 AUG 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
003|003-1008|AE|10|0|0010|ELEVATED CARDIAC TROPONIN T|04 JAN 2021|17:00|0|N|14 JAN 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
003|003-1008|AE|11|0|0011|PAIN IN RIGHT FOOT|13 JAN 2021|12:00|0|N|06 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
003|003-1008|AE|2|0|0002|ADHESIVE TAPE ALLERGY|12 SEP 2021|09:00|0|N|30 SEP 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
003|003-1008|AE|3|0|0003|INTERMITTENT HYPOKALEMIA|26 JAN 2021|08:15|0|N|17 FEB 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
003|003-1008|AE|4|0|0004|DIABETES MELLITUS, TYPE 2|22 OCT 2020|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
003|003-1008|AE|5|0|0005|SKIN HYPERPIGMENTATION|05 AUG 2021|08:00|0|N|13 AUG 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
003|003-1008|AE|6|0|0006|HYPERPHOSPHATEMIA|25 DEC 2020|10:00|0|N|19 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
003|003-1008|AE|7|0|0007|CHOLELITHIASIS|05 NOV 2021|08:30|0|N|07 NOV 2021|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
003|003-1008|AE|8|0|0008|CHRONIC BACK PAIN|18 JUL 2020|17:00|0|N|27 JUL 2020|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
003|003-1008|AE|9|0|0009|THROMBOCYTOPENIA|20 MAR 2021|15:00|0|N|25 MAR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
003|003-1009|AE|1|0|0001|PROLONGED PR INTERVAL|19 SEP 2021|18:00|0|N|02 OCT 2021|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
003|003-1009|AE|2|0|0002|HYPOXIA|18 OCT 2020|13:00|0|N|16 NOV 2020|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
003|003-1009|AE|3|0|0003|MUCOSITIS|26 AUG 2022|12:00|0|N|16 SEP 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
004|004-1001|AE|1|0|0001|DYSPHAGIA|21 FEB 2021|08:00|0|N|03 MAR 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
004|004-1001|AE|2|0|0002|ELEVATED TRANSAMINASE|06 MAR 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
004|004-1001|AE|3|0|0003|CHRONIC HIP PAIN|18 JAN 2021|16:00|0|N|22 JAN 2021|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
004|004-1001|AE|4|0|0004|ANAEMIA|22 FEB 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
004|004-1001|AE|5|0|0005|CHILLS|23 DEC 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
004|004-1001|AE|6|0|0006|HAND TREMORS|01 FEB 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
004|004-1001|AE|7|0|0007|BLOOD LACTATE DEHYDROGENASE INCREASED|31 JAN 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
004|004-1001|AE|8|0|0008|HYPOALBUMINAEMIA|20 JAN 2021|17:00|0|N|22 JAN 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
004|004-1001|AE|9|0|0009|MALIGNANT PLEURAL EFFUSION|22 JAN 2021|08:00|0|N|20 FEB 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
004|004-1002|AE|1|0|0001|SEASONAL ALLERGIES|15 JUN 2022|12:15|0|N|07 JUL 2022|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
004|004-1002|AE|10|0|0010|PAIN OF SKIN - AZACITIDINE SITE|16 APR 2021|10:00|0|N|21 APR 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
004|004-1002|AE|2|0|0002|INTERMITTENT HIP PAIN|26 MAR 2021|09:00|0|N|10 APR 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
004|004-1002|AE|3|0|0003|HEPATIC CYST|31 MAY 2022|09:15|0|N|27 JUN 2022|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
004|004-1002|AE|4|0|0004|EMPYEMA|29 JUL 2020|20:00|0|N|25 AUG 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
004|004-1002|AE|5|0|0005|DEHYDRATION|29 OCT 2020|15:00|0|N|13 NOV 2020|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
004|004-1002|AE|6|0|0006|OEDEMA LIMBS - LEFT LEG|19 JUL 2020|17:00|0|N|14 AUG 2020|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
004|004-1002|AE|7|0|0007|ABNORMAL GAIT|22 OCT 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
004|004-1002|AE|8|0|0008|FLUID OVERLOAD|04 SEP 2021|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
004|004-1002|AE|9|0|0009|SENSORY NEURAL DEAFNESS ON RIGHT|12 SEP 2020|10:00|0|N|22 SEP 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
004|004-1003|AE|1|0|0001|GASTRIC ULCER|19 MAR 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
004|004-1003|AE|2|0|0002|THROMBOCYTOPAENIA|04 APR 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
004|004-1003|AE|3|0|0003|BLOOD AND LYMPHATIC SYSTEM OTHER: POST TRANSPLANT BLOOD MISMATCH CAUSING INCREASED TRANSFUSION REACTIONS|04 MAR 2021|15:00|0|N|31 MAR 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
004|004-1004|AE|1|0|0001|CYSTOCELE|18 MAR 2022|14:00|0|N|12 APR 2022|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
004|004-1004|AE|2|0|0002|NAUSEA INTERMITTENT|08 MAY 2022|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
004|004-1005|AE|1|0|0001|INTERNAL HEMORRHOIDS|02 JAN 2021|20:00|0|N|30 JAN 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
004|004-1006|AE|1|0|0001|CANCER-RELATED PAIN|26 OCT 2020|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
004|004-1006|AE|2|0|0002|HYPERTENSION R/T CKD|08 SEP 2021|12:00|0|N|08 SEP 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
004|004-1006|AE|3|0|0003|GASRITIS|06 APR 2021|09:00|0|N|16 APR 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
004|004-1007|AE|1|0|0001|PRODUCTIVE COUGH|03 MAY 2021|09:00|0|N|06 MAY 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
004|004-1007|AE|2|0|0002|CHRONIC CYSTITIS|19 AUG 2021|09:00|0|N|19 AUG 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
004|004-1007|AE|3|0|0003|HEARING IMPAIRMENT|13 JUL 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
004|004-1007|AE|4|0|0004|PAROTID MASS|13 APR 2021|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
004|004-1007|AE|5|0|0005|SKIN AND SUBCUTANEOUS TISSUE DISORDER - SUPERFICIAL BURN RIGHT FOREARM|17 JUL 2021|22:30|0|N|26 JUL 2021|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
004|004-1007|AE|6|0|0006|FLUID OVERLOAD|23 AUG 2021|10:30|0|N|31 AUG 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
004|004-1007|AE|7|0|0007|FIBRINOGEN DECREASED|07 SEP 2021|13:45|0|N|15 SEP 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
004|004-1008|AE|1|0|0001|HEADACHE|13 AUG 2023|10:00|0|N|12 SEP 2023|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
004|004-1009|AE|1|0|0001|CHILLS|27 JUL 2020|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
004|004-1009|AE|2|0|0002|OSTEOARTHRITIS HIPS|30 JUN 2022|11:00|0|N|01 JUL 2022|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
004|004-1009|AE|3|0|0003|SEPSIS|28 APR 2021|08:00|0|N|14 MAY 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
004|004-1009|AE|4|0|0004|INTERMITTENT NAUSEA|18 NOV 2021|15:00|0|N|12 DEC 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
004|004-1009|AE|5|0|0005|MALIGNANT NEOPLASM RELATED FATIGUE|21 AUG 2021|08:00|0|N|17 SEP 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
004|004-1009|AE|6|0|0006|STROKE|22 DEC 2020|08:00|0|N|22 DEC 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
004|004-1010|AE|1|0|0001|HYPERCHOLESTEROLEMIA|05 JUL 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
004|004-1010|AE|2|0|0002|PAIN INTERMITTENT (BMAT PROCEDURE)|04 AUG 2022|10:00|0|N|01 SEP 2022|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
004|004-1010|AE|3|0|0003|CANCER PAIN|15 OCT 2020|15:00|0|N|07 NOV 2020|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
004|004-1010|AE|4|0|0004|OEDEMA L EYE|05 SEP 2022|09:00|0|N|05 OCT 2022|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
004|004-1010|AE|5|0|0005|WEAKNESS|11 MAY 2022|12:00|0|N|01 JUN 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
005|005-1001|AE|1|0|0001|ATYPICAL PNEUMONIA|15 JUN 2022|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
005|005-1001|AE|10|0|0010|BILATERAL CATARACT|07 JAN 2021|08:15|0|N|27 JAN 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
005|005-1001|AE|2|0|0002|INTERMITTENT CONSTIPATION|14 NOV 2021|08:00|0|N|05 DEC 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
005|005-1001|AE|3|0|0003|CPK INCREASED|21 APR 2021|11:00|0|N|25 APR 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
005|005-1001|AE|4|0|0004|GASTROESOPHAGEAL REFLUX DISEASE|16 AUG 2022|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
005|005-1001|AE|5|0|0005|INSOMNIA - INTERMITTENT|25 DEC 2022|15:00|0|N|31 DEC 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
005|005-1001|AE|6|0|0006|PAIN IN EXTREMITY L ANKLE|07 JUL 2021|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
005|005-1001|AE|7|0|0007|DIABETES MELLITUS, TYPE 2|25 NOV 2021|15:00|0|N|19 DEC 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
005|005-1001|AE|8|0|0008|TOOTH DISORDER|18 JAN 2022|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
005|005-1001|AE|9|0|0009|ALOPECIA|11 JUN 2022|15:00|0|N|09 JUL 2022|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
005|005-1002|AE|1|0|0001|TUBERCULOSIS EXPOSURE|16 MAY 2022|09:30|0|N|19 MAY 2022|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
005|005-1002|AE|2|0|0002|MINI CEREBROVASCULAR ACCIDENT|07 MAR 2021|08:15|0|N|16 MAR 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
005|005-1002|AE|3|0|0003|NEUTROPENIC FEVER|26 FEB 2022|15:00|0|N|26 MAR 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
005|005-1002|AE|4|0|0004|DIABETES TYPE 2|19 OCT 2021|23:00|0|N|26 OCT 2021|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
005|005-1002|AE|5|0|0005|LYMPHOCYTOPENIA|30 MAR 2021|09:30|0|N|07 APR 2021|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
005|005-1002|AE|6|0|0006|CREATININE INCREASED|29 MAY 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
005|005-1002|AE|7|0|0007|FIBRINOGEN DECREASED|06 AUG 2021|10:00|0|N|19 AUG 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
005|005-1003|AE|1|0|0001|TUBERCULOSIS EXPOSURE|12 JUN 2021|09:00|0|N|25 JUN 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
005|005-1003|AE|2|0|0002|POSTMENOPAUSAL|19 DEC 2022|12:00|0|N|08 JAN 2023|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
005|005-1003|AE|3|0|0003|MARANTIC ENDOCARDITIS|02 OCT 2022|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
005|005-1003|AE|4|0|0004|PULMONARY EMBOLISM|16 MAY 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
005|005-1003|AE|5|0|0005|RASH ON SKIN NEAR PICC SITE|12 APR 2022|09:15|0|N|14 APR 2022|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
005|005-1004|AE|1|0|0001|DEGENERATIVE CHANGES LUMBAR SPINE|06 APR 2023|23:00|0|N|17 APR 2023|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
005|005-1004|AE|2|0|0002|SCAPHOID FRACTURE RIGHT WRIST|11 NOV 2022|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
005|005-1005|AE|1|0|0001|LYMPHOCYTE COUNT DECREASED|28 DEC 2020|12:00|0|N|16 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
005|005-1005|AE|2|0|0002|DEGENERATIVE DISEASE OF THE CERVICAL SPINE|16 JAN 2021|09:30|0|N|18 JAN 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
005|005-1005|AE|3|0|0003|BACK PAIN (INTERMITTENT)|25 MAY 2021|15:00|0|N|18 JUN 2021|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
005|005-1006|AE|1|0|0001|MUSCLE SPASM OF BACK|12 DEC 2020|12:00|0|N|05 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
005|005-1006|AE|2|0|0002|LEFT BUNDLE BRANCH BLOCK|13 JAN 2021|10:30|0|N|29 JAN 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
005|005-1007|AE|1|0|0001|RASH MACULO-PAPULAR|07 MAR 2021|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
005|005-1007|AE|2|0|0002|BONE PAIN|04 MAR 2022|17:00|0|N|12 MAR 2022|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
005|005-1007|AE|3|0|0003|LOCALIZED PRURITIS|22 AUG 2022|09:15|0|N|14 SEP 2022|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
005|005-1007|AE|4|0|0004|LARGE HIATAL HERNIA|18 AUG 2022|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
005|005-1007|AE|5|0|0005|PAROXYSMAL SHORTNESS OF BREATH|09 JUL 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
005|005-1007|AE|6|0|0006|PAROXYSMAL ARTERIAL FIBRILLATION|24 NOV 2022|09:00|0|N|01 DEC 2022|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
005|005-1007|AE|7|0|0007|NOVEL CORONAVIRUS INFECTION|19 APR 2022|10:00|0|N|05 MAY 2022|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
006|006-1001|AE|1|0|0001|DYSARTHRIA|05 DEC 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
006|006-1001|AE|10|0|0010|IMPACTED CERUMEN OF RIGHT EAR|30 MAY 2020|15:00|0|N|10 JUN 2020|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1001|AE|2|0|0002|BILATERAL ABSENCE OF THYROID|08 FEB 2021|08:45|0|N|15 FEB 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1001|AE|3|0|0003|OTHER PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE|14 AUG 2020|15:00|0|N|24 AUG 2020|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
006|006-1001|AE|4|0|0004|NASAL CONGESTION|26 AUG 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
006|006-1001|AE|5|0|0005|NEUTROPENIC FEVERS|24 AUG 2021|12:00|0|N|05 SEP 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1001|AE|6|0|0006|LOW BACK PAIN|11 JUL 2020|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
006|006-1001|AE|7|0|0007|VITAMIN D DEFICIENCY|12 MAY 2020|10:30|0|N|24 MAY 2020|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
006|006-1001|AE|8|0|0008|TUBERCULOSIS EXPOSURE|27 FEB 2021|08:30|0|N|22 MAR 2021|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
006|006-1001|AE|9|0|0009|PAIN INTERMITTENT (BMAT PROCEDURE)|07 AUG 2021|11:00|0|N|01 SEP 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1002|AE|1|0|0001|METASTASES TO BONE|11 OCT 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
006|006-1003|AE|1|0|0001|SUBCLINICAL SEIZURES|04 AUG 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
006|006-1003|AE|10|0|0010|ACTIVATED PARTIAL THROMBOPLASTIN TIME|06 OCT 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
006|006-1003|AE|2|0|0002|OTHER PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE|30 JUN 2021|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
006|006-1003|AE|3|0|0003|SINUS TACHYCARDIA (INTERMITTENT)|11 JAN 2021|09:00|0|N|30 JAN 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
006|006-1003|AE|4|0|0004|VITAMIN B DEFICIENCY|16 AUG 2021|14:00|0|N|04 SEP 2021|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
006|006-1003|AE|5|0|0005|INFECTIONS AND INFESTATIONS - OTHER: C. DIFFICILE|13 MAY 2021|15:00|0|N|26 MAY 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
006|006-1003|AE|6|0|0006|GASTRO OESOPHAGEAL REFLUX DISEASE|03 AUG 2021|11:00|0|N|18 AUG 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1003|AE|7|0|0007|ANAEMIA|03 JUN 2021|09:00|0|N|15 JUN 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
006|006-1003|AE|8|0|0008|ALKALINE PHOSPHATASE INCREASED|19 MAR 2021|23:00|0|N|25 MAR 2021|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1003|AE|9|0|0009|INJECTION SITE REACTION - INTERMITTENT|18 APR 2021|08:00|0|N|18 APR 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
006|006-1004|AE|1|0|0001|ALLERGY TO LATEX|08 SEP 2022|08:15|0|N|16 SEP 2022|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
006|006-1004|AE|2|0|0002|SECONDARY MALIGNANT NEOPLASM OF THE BONE|02 NOV 2020|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
006|006-1004|AE|3|0|0003|BUTTOCK PAIN|23 JUL 2023|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
006|006-1004|AE|4|0|0004|WHEEZING|22 APR 2023|10:30|0|N|23 APR 2023|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
006|006-1004|AE|5|0|0005|HYPERPHOSTATAEMIA|14 JAN 2021|12:00|0|N|11 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1004|AE|6|0|0006|NEOPLASM PAIN|17 MAY 2021|15:00|0|N|20 MAY 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
006|006-1005|AE|1|0|0001|SLOW TRANSIT CONSTIPATION|24 MAR 2021|09:00|0|N|13 APR 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
006|006-1005|AE|10|0|0010|INTERMITTENT VOMITING|23 MAR 2021|08:00|0|N|26 MAR 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
006|006-1005|AE|11|0|0011|INTERMITTENT CONSTIPATION|07 FEB 2021|10:30|0|N|09 FEB 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
006|006-1005|AE|2|0|0002|SKIN INFECTION (RIGHT LOWER LEG CELLULITIS)|28 JUL 2020|15:00|0|N|27 AUG 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
006|006-1005|AE|3|0|0003|HYPOMAGNESMIA|10 SEP 2021|09:30|0|N|22 SEP 2021|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
006|006-1005|AE|4|0|0004|NOVEL CORONAVIRUS INFECTION|12 JUN 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
006|006-1005|AE|5|0|0005|UMBILICAL HERNIA|05 MAY 2021|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
006|006-1005|AE|6|0|0006|GLUCOSURIA|09 JUL 2022|20:00|0|N|07 AUG 2022|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1005|AE|7|0|0007|HEMORRHOID PAIN|11 AUG 2022|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
006|006-1005|AE|8|0|0008|VASCULITIS|25 JAN 2021|08:00|0|N|29 JAN 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
006|006-1005|AE|9|0|0009|AORTIC ARTERIOSCLEROSIS|01 DEC 2021|08:00|0|N|01 DEC 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
006|006-1006|AE|1|0|0001|DIARRHEA|20 MAY 2020|15:00|0|N|21 MAY 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
006|006-1006|AE|10|0|0010|LOW BACK PAIN|06 OCT 2020|17:00|0|N|14 OCT 2020|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
006|006-1006|AE|11|0|0011|HEPATIC CYST|28 JUL 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
006|006-1006|AE|2|0|0002|ORAL MUCOSITIS|19 SEP 2020|15:00|0|N|08 OCT 2020|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
006|006-1006|AE|3|0|0003|PROLONGED PR INTERVAL|01 AUG 2021|09:00|0|N|10 AUG 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
006|006-1006|AE|4|0|0004|POST-MENOPAUSE|10 OCT 2020|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
006|006-1006|AE|5|0|0005|INCREASED GLUTAMYLTRANSFERASE|25 OCT 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
006|006-1006|AE|6|0|0006|OTHER PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE|23 APR 2021|12:00|0|N|23 APR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1006|AE|7|0|0007|TRANSFUSION IRON OVERLOAD|27 SEP 2021|09:30|0|N|27 SEP 2021|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
006|006-1006|AE|8|0|0008|POSTMENOPAUSAL|19 JAN 2022|09:30|0|N|08 FEB 2022|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
006|006-1006|AE|9|0|0009|LARGE HIATAL HERNIA|12 FEB 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
006|006-1007|AE|1|0|0001|CORONARY ARTERY DISEASE|15 APR 2021|12:15|0|N|26 APR 2021|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
006|006-1007|AE|2|0|0002|LUNG INFECTION (COMMUNITY ACQUIRED)|22 FEB 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
006|006-1008|AE|1|0|0001|INTESTINAL FLORA DYSREGULATION|12 OCT 2020|12:00|0|N|24 OCT 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1009|AE|1|0|0001|VESICULITIS|04 APR 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
006|006-1009|AE|2|0|0002|INSOMNIA - INTERMITTENT|08 NOV 2020|15:00|0|N|21 NOV 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
006|006-1009|AE|3|0|0003|INR INCREASE|10 AUG 2022|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
006|006-1009|AE|4|0|0004|HYPERTENSION (INTERMITTENT)|15 AUG 2022|13:00|0|N|16 AUG 2022|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
006|006-1009|AE|5|0|0005|PULMONARY EMBOLISM|12 OCT 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
006|006-1009|AE|6|0|0006|PROTEINURIA|02 APR 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
006|006-1010|AE|1|0|0001|NEUTROPENIA|20 SEP 2020|12:00|0|N|27 SEP 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1010|AE|10|0|0010|HYPERPHOSPHATEMIA|14 DEC 2020|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
006|006-1010|AE|11|0|0011|DOUBLE RENAL CYST|03 JAN 2021|10:00|0|N|28 JAN 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
006|006-1010|AE|2|0|0002|DENTAL ABSCESS|04 OCT 2020|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
006|006-1010|AE|3|0|0003|PNEUMONIA|13 DEC 2020|15:00|0|N|28 DEC 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
006|006-1010|AE|4|0|0004|DENTAL ABSCESS|13 OCT 2020|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
006|006-1010|AE|5|0|0005|SCAPHOID FRACTURE RIGHT WRIST|17 SEP 2020|09:00|0|N|22 SEP 2020|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
006|006-1010|AE|6|0|0006|SKIN AND SUBCUTANEOUS TISSUE DISORDER - SUPERFICIAL BURN RIGHT FOREARM|16 JAN 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
006|006-1010|AE|7|0|0007|NON-PRURITIC RASH (LEFT CUBICAL FOSSA)|08 DEC 2020|11:00|0|N|07 JAN 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1010|AE|8|0|0008|DIPLOPIA|21 DEC 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
006|006-1010|AE|9|0|0009|RIGHT SHOULDER SOFT TISSUE INFECTION|05 NOV 2020|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
006|006-1011|AE|1|0|0001|PAIN IN EXTREMITY|12 APR 2021|09:00|0|N|23 APR 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
006|006-1011|AE|10|0|0010|OVERWEIGHT|17 MAY 2021|10:00|0|N|15 JUN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1011|AE|11|0|0011|GASRITIS|14 MAR 2021|14:00|0|N|14 MAR 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
006|006-1011|AE|2|0|0002|WOUND INFECTION|22 OCT 2020|15:00|0|N|23 OCT 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
006|006-1011|AE|3|0|0003|HEPATIC STEATOSIS|30 JAN 2021|15:00|0|N|11 FEB 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
006|006-1011|AE|4|0|0004|SPLENOMEGALY|12 NOV 2020|20:00|0|N|13 NOV 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
006|006-1011|AE|5|0|0005|SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, RED SWOLLEN AREA ON HAND|18 DEC 2020|15:00|0|N|23 DEC 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
006|006-1011|AE|6|0|0006|SKIN AND SUBCUTANEOUS TISSUE DISORDER - SUPERFICIAL BURN RIGHT FOREARM|05 MAR 2021|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
006|006-1011|AE|7|0|0007|ASPARTATE AMINOTRANSFERASE INCREASED|09 JAN 2021|16:00|0|N|05 FEB 2021|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
006|006-1011|AE|8|0|0008|HYPOMAGNESMIA|01 FEB 2021|23:00|0|N|01 FEB 2021|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1011|AE|9|0|0009|ELEVATED URIC ACID|22 MAY 2021|14:00|0|N|09 JUN 2021|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
006|006-1012|AE|1|0|0001|SPLENOMEGALY|20 DEC 2021|09:30|0|N|14 JAN 2022|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
006|006-1012|AE|2|0|0002|GASTRO OESOPHAGEAL REFLUX DISEASE|05 JUN 2021|16:00|0|N|29 JUN 2021|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
006|006-1012|AE|3|0|0003|ABODOMINAL PAIN|15 NOV 2020|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
006|006-1012|AE|4|0|0004|CHRONIC COUGH|11 MAY 2022|09:30|0|N|09 JUN 2022|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
006|006-1012|AE|5|0|0005|ALT INCREASED (INTERMITTENT)|27 SEP 2021|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
006|006-1012|AE|6|0|0006|BLAST CELL COUNT INCREASED|10 DEC 2022|08:00|0|N|03 JAN 2023|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
006|006-1012|AE|7|0|0007|MINI CEREBROVASCULAR ACCIDENT|08 OCT 2021|12:00|0|N|20 OCT 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
006|006-1013|AE|1|0|0001|COUGH|30 JAN 2021|22:30|0|N|17 FEB 2021|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
006|006-1013|AE|2|0|0002|LEFT BUNDLE BRANCH BLOCK|05 NOV 2020|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
006|006-1013|AE|3|0|0003|SECONDARY MALIGNANT NEOPLASM OF RIGHT LUNG|10 OCT 2020|10:30|0|N|27 OCT 2020|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
006|006-1013|AE|4|0|0004|POSTURAL DIZZINESS|23 OCT 2020|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
006|006-1013|AE|5|0|0005|NAUSEA - INTERMITTENT|23 NOV 2020|15:00|0|N|16 DEC 2020|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
006|006-1013|AE|6|0|0006|PAROXYSMAL ARTERIAL FIBRILLATION|25 NOV 2020|08:00|0|N|25 NOV 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
006|006-1013|AE|7|0|0007|SINUS TACHYCARDIA INTERMITTENT|25 NOV 2020|15:00|0|N|16 DEC 2020|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
007|007-1001|AE|1|0|0001|HISTORY OF STROKE|15 MAY 2021|14:00|0|N|14 JUN 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
007|007-1001|AE|2|0|0002|PNEUMONIA|31 MAR 2021|09:00|0|N|17 APR 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
007|007-1001|AE|3|0|0003|TROPONIN T INCREASED|03 MAY 2020|20:00|0|N|15 MAY 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1001|AE|4|0|0004|GASTRIC ULCER|12 DEC 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
007|007-1001|AE|5|0|0005|GERD|08 DEC 2021|08:00|0|N|04 JAN 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
007|007-1001|AE|6|0|0006|CERVICAL STENOSIS|16 MAR 2020|12:00|0|N|28 MAR 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1001|AE|7|0|0007|CHRONIC HIP PAIN|29 AUG 2021|09:30|0|N|02 SEP 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
007|007-1001|AE|8|0|0008|DYSPNOEA|28 FEB 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
007|007-1002|AE|1|0|0001|NERVE ROOT INJURY – DUE TO LAMINECTOMY WITH BILATERAL MEDIAL FACETECTOMY|23 DEC 2022|08:45|0|N|21 JAN 2023|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1002|AE|2|0|0002|HYPERCHOLESTEROEMIA|14 MAY 2021|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
007|007-1002|AE|3|0|0003|LABORATORY TUMOR LYSIS SYNDROME|09 JUL 2022|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
007|007-1002|AE|4|0|0004|BLOOD LACTATEDEHYDROGENASE INCREASED|19 OCT 2022|12:00|0|N|28 OCT 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1002|AE|5|0|0005|HYDRONEPHROSIS|28 MAR 2023|20:00|0|N|31 MAR 2023|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1002|AE|6|0|0006|DIARRHEA INTERMITTENT|03 APR 2022|09:30|0|N|13 APR 2022|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
007|007-1002|AE|7|0|0007|LAMINECTOMY|02 MAR 2023|18:00|0|N|24 MAR 2023|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
007|007-1002|AE|8|0|0008|HYPO MAGNESIA|03 JAN 2022|09:00|0|N|10 JAN 2022|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
007|007-1002|AE|9|0|0009|WHEEZING|26 MAY 2022|12:00|0|N|01 JUN 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1003|AE|1|0|0001|DEHYDRATION|20 NOV 2021|09:30|0|N|15 DEC 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
007|007-1003|AE|2|0|0002|FALL|19 MAY 2021|09:00|0|N|21 MAY 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
007|007-1003|AE|3|0|0003|CHRONIC PAIN: KNEE AND HIP|14 MAY 2021|12:00|0|N|03 JUN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1003|AE|4|0|0004|RASH|25 JUL 2021|12:00|0|N|26 JUL 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1003|AE|5|0|0005|ORAL THRUSH|10 JUN 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
007|007-1004|AE|1|0|0001|MUCOSITIS|09 SEP 2020|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
007|007-1005|AE|1|0|0001|LYMPHOCYTOPENIA|12 JUL 2021|12:00|0|N|14 JUL 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1005|AE|2|0|0002|B12 DEFICIENCY|02 APR 2023|14:00|0|N|08 APR 2023|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
007|007-1005|AE|3|0|0003|TINNITUS|08 APR 2022|11:00|0|N|15 APR 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1006|AE|1|0|0001|NUMBNESS OF LIMBS|26 APR 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
007|007-1006|AE|2|0|0002|HYPERKALAEMIA|31 JUL 2021|17:00|0|N|04 AUG 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
007|007-1006|AE|3|0|0003|THORACIC MUSCULOSKELETAL PAIN|02 JUN 2021|10:00|0|N|06 JUN 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
007|007-1007|AE|1|0|0001|HYPERLIPIDEMIA|30 JUN 2022|15:00|0|N|22 JUL 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
007|007-1007|AE|2|0|0002|STROKE|21 JAN 2022|12:00|0|N|18 FEB 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1007|AE|3|0|0003|NON-CARDIAC CHEST PAIN|11 APR 2022|12:00|0|N|04 MAY 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1007|AE|4|0|0004|INTERMITTENT HIP PAIN|09 DEC 2020|10:00|0|N|15 DEC 2020|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
007|007-1007|AE|5|0|0005|HEPATIC INFECTION|27 DEC 2020|15:00|0|N|22 JAN 2021|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
007|007-1007|AE|6|0|0006|CARDIAC TROPONIN INCREASED|30 OCT 2021|15:00|0|N|24 NOV 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
007|007-1008|AE|1|0|0001|PAIN IN RIGHT FOOT|05 DEC 2020|12:00|0|N|27 DEC 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1008|AE|2|0|0002|FATTY LIVER DISEASE|13 SEP 2022|12:00|0|N|01 OCT 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1008|AE|3|0|0003|FIBROMYALGIA|25 OCT 2021|14:30|0|N|09 NOV 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
007|007-1008|AE|4|0|0004|RHEUMATOID ARTHRITIS|20 OCT 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
007|007-1008|AE|5|0|0005|ADJUSTMENT DISORDER WITH ANXIOUS MOOD|31 AUG 2020|20:00|0|N|20 SEP 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
007|007-1008|AE|6|0|0006|CORONARY ARTERY DISEASE|03 OCT 2021|09:15|0|N|06 OCT 2021|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
007|007-1008|AE|7|0|0007|WORSENING HYPERGLYCEMIA|13 AUG 2022|17:00|0|N|28 AUG 2022|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
008|008-1001|AE|1|0|0001|LABORATORY TUMOR LYSIS SYNDROME|12 SEP 2021|15:00|0|N|01 OCT 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
008|008-1001|AE|10|0|0010|VOMITING|02 AUG 2021|13:00|0|N|24 AUG 2021|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
008|008-1001|AE|2|0|0002|MUSCLE PAIN|22 MAY 2021|08:15|0|N|18 JUN 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
008|008-1001|AE|3|0|0003|LYME DISEASE|03 MAR 2021|15:00|0|N|01 APR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
008|008-1001|AE|4|0|0004|CHILLS|28 JAN 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
008|008-1001|AE|5|0|0005|ALLERGY TO LATEX|07 APR 2021|12:00|0|N|15 APR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
008|008-1001|AE|6|0|0006|SINUS TACHYCARDIA (INTERMITTENT)|19 AUG 2021|08:30|0|N|25 AUG 2021|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
008|008-1001|AE|7|0|0007|GOUT|13 JAN 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
008|008-1001|AE|8|0|0008|RETINAL NERVE FIBER LAYER THINNING (BOTH EYES)|11 JUL 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
008|008-1001|AE|9|0|0009|SKIN ULCERATION: RIGHT LOWER EXTREMITY|07 APR 2021|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
008|008-1002|AE|1|0|0001|POST MENOPAUSE|25 FEB 2021|09:00|0|N|26 MAR 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
008|008-1002|AE|2|0|0002|DIZZINESS|07 MAR 2021|09:00|0|N|15 MAR 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
008|008-1002|AE|3|0|0003|FALL|29 JAN 2021|10:00|0|N|21 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
008|008-1003|AE|1|0|0001|PLATELETS COUNT DECREASED|06 SEP 2020|10:00|0|N|24 SEP 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
008|008-1004|AE|1|0|0001|DELIRIUM|12 OCT 2020|15:00|0|N|02 NOV 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
008|008-1004|AE|2|0|0002|GLAUCOMA|10 AUG 2020|14:00|0|N|13 AUG 2020|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
008|008-1005|AE|1|0|0001|LOWER EXTREMITY EDEMA|28 FEB 2021|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
008|008-1005|AE|2|0|0002|SIADH (SYNDROME OF INAPPROPRIATE ADH PRODUCTION)|07 OCT 2020|17:00|0|N|25 OCT 2020|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
008|008-1005|AE|3|0|0003|VITAMIN D DEFICIENCY|15 DEC 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
008|008-1006|AE|1|0|0001|THROMBOCYTOPAENIA|11 FEB 2022|09:30|0|N|28 FEB 2022|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
008|008-1007|AE|1|0|0001|DRY EYES|03 JUN 2020|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
008|008-1008|AE|1|0|0001|SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, RED SWOLLEN AREA ON HAND|17 DEC 2020|12:00|0|N|30 DEC 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
008|008-1008|AE|2|0|0002|INTERMITTENT DYSURIA|27 OCT 2020|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
008|008-1008|AE|3|0|0003|DYSPHAGIA|20 FEB 2021|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
008|008-1008|AE|4|0|0004|HYPERGLYCEMIA|15 MAR 2021|15:00|0|N|05 APR 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
008|008-1008|AE|5|0|0005|FATIGUE|24 FEB 2021|12:00|0|N|25 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
008|008-1008|AE|6|0|0006|CHRONIC KIDNEY DISEASE (STAGEIII, PROGRESSED TO STAGE IV)|15 JUN 2021|08:45|0|N|27 JUN 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
008|008-1008|AE|7|0|0007|MEMORY LOSS|12 AUG 2021|09:00|0|N|01 SEP 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
008|008-1008|AE|8|0|0008|RESTLESS LEGS|06 JUL 2021|14:00|0|N|27 JUL 2021|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
008|008-1009|AE|1|0|0001|DYSPHAGIA|10 OCT 2020|17:00|0|N|24 OCT 2020|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
008|008-1009|AE|2|0|0002|RIGHT LEG SKIN RASH|18 DEC 2020|09:00|0|N|14 JAN 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
008|008-1009|AE|3|0|0003|MEMBRANOUS NEPHROPATHY|13 FEB 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
008|008-1009|AE|4|0|0004|VOMITING|08 JAN 2021|08:00|0|N|04 FEB 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
008|008-1009|AE|5|0|0005|EPISTAXIS|17 JAN 2021|09:00|0|N|09 FEB 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
008|008-1009|AE|6|0|0006|PERICARDIAL EFFUSION|19 OCT 2020|08:00|0|N|08 NOV 2020|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
008|008-1009|AE|7|0|0007|STRABISMUS|11 JAN 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
008|008-1009|AE|8|0|0008|SORE THROAT|28 FEB 2021|12:15|0|N|20 MAR 2021|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
008|008-1010|AE|1|0|0001|APPENDICITIS|19 FEB 2022|18:00|0|N|06 MAR 2022|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
008|008-1010|AE|2|0|0002|PATHOLOGICAL FRACTURE T6 VERTEBRAL BODY|28 FEB 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
008|008-1010|AE|3|0|0003|EYE DISORDERS OTHER: BLOOD IN CONJUNCTIVA R-OUTER|11 OCT 2021|09:00|0|N|10 NOV 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
009|009-1001|AE|1|0|0001|FEBRILE NEUTROPENIA|30 OCT 2022|09:00|0|N|19 NOV 2022|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
009|009-1001|AE|2|0|0002|HYPERKALEMIA|09 MAR 2023|09:00|0|N|08 APR 2023|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
009|009-1001|AE|3|0|0003|REDNESS OF EYELID|15 SEP 2021|08:15|0|N|27 SEP 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
009|009-1001|AE|4|0|0004|ALLERGY TO LATEX|19 JAN 2023|09:00|0|N|08 FEB 2023|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
009|009-1001|AE|5|0|0005|THORACIC MUSCULOSKELETAL PAIN|07 MAR 2023|14:00|0|N|07 MAR 2023|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
009|009-1001|AE|6|0|0006|CONFUSION|21 JAN 2023|08:00|0|N|13 FEB 2023|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
009|009-1001|AE|7|0|0007|INTERNAL HEMORRHOIDS|25 NOV 2022|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
009|009-1001|AE|8|0|0008|EYE DISORDERS OTHER: BLOOD IN LEFT CONJUNCTIVA|09 APR 2023|08:00|0|N|13 APR 2023|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
009|009-1002|AE|1|0|0001|PROTRUSION OF INTERVERTEBRAL DISC|09 JAN 2022|10:30|0|N|07 FEB 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
009|009-1002|AE|2|0|0002|HISTORY OF PROSTATE CANCER|13 APR 2022|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
009|009-1002|AE|3|0|0003|COUGH (INTERMITTENT)|05 OCT 2021|11:00|0|N|20 OCT 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
009|009-1002|AE|4|0|0004|HYPOTENSION (INTERMITTENT)|11 JUL 2022|12:00|0|N|01 AUG 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
009|009-1002|AE|5|0|0005|LYMPHEDEMA|25 APR 2022|08:00|0|N|06 MAY 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
009|009-1002|AE|6|0|0006|DIABETES TYPE 2|06 JUN 2021|11:00|0|N|05 JUL 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
009|009-1002|AE|7|0|0007|INTERMITTENT NAUSEA|06 AUG 2021|17:00|0|N|04 SEP 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
009|009-1003|AE|1|0|0001|FATIGUE (INTERMITTENT)|07 SEP 2021|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
009|009-1003|AE|2|0|0002|TOOTHACHE|12 OCT 2021|15:00|0|N|03 NOV 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
009|009-1003|AE|3|0|0003|ELEVATED TRANSAMINASE|23 FEB 2021|07:30|0|N|21 MAR 2021|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
009|009-1004|AE|1|0|0001|SMALL UMBILICAL HERNIA|29 JUN 2022|18:00|0|N|13 JUL 2022|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
009|009-1004|AE|2|0|0002|ALT INCREASED|17 OCT 2021|17:00|0|N|08 NOV 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
009|009-1004|AE|3|0|0003|HEART FAILURE|05 JAN 2021|15:00|0|N|09 JAN 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
009|009-1004|AE|4|0|0004|PAIN IN EXTREMITY - BOTH FEET|20 NOV 2022|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
009|009-1004|AE|5|0|0005|CHRONIC BACK PAIN|27 DEC 2020|10:00|0|N|27 DEC 2020|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
009|009-1004|AE|6|0|0006|LOW BACK PAIN|16 AUG 2022|09:30|0|N|29 AUG 2022|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
009|009-1004|AE|7|0|0007|HYPERTENSION|07 DEC 2020|11:00|0|N|18 DEC 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
009|009-1005|AE|1|0|0001|LABORATORY TUMOR LYSIS SYNDROME|29 APR 2021|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
009|009-1005|AE|2|0|0002|INTERMITTENT ARTHRALGIA|22 OCT 2021|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
009|009-1005|AE|3|0|0003|LEUKOCYTOSIS|13 NOV 2020|09:30|0|N|22 NOV 2020|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
009|009-1005|AE|4|0|0004|MELANOMA INSITU|23 APR 2021|10:30|0|N|13 MAY 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
009|009-1005|AE|5|0|0005|BUTTOCK PAIN|03 AUG 2021|12:00|0|N|04 AUG 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
009|009-1005|AE|6|0|0006|FATIGUE|28 AUG 2021|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
009|009-1005|AE|7|0|0007|HYPOPOTASSEMIA|02 MAY 2021|17:00|0|N|22 MAY 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
009|009-1005|AE|8|0|0008|PAPILLARY MUCINOUS NEOPLASM OF PANCREAS|02 DEC 2020|09:30|0|N|04 DEC 2020|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
009|009-1005|AE|9|0|0009|OVARIAN CYST|27 APR 2021|11:00|0|N|26 MAY 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
009|009-1006|AE|1|0|0001|IDIOPATHIC PARKINSON'S DISEASE|29 AUG 2020|13:00|0|N|16 SEP 2020|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
009|009-1006|AE|2|0|0002|PAIN|16 OCT 2020|09:00|0|N|17 OCT 2020|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
009|009-1006|AE|3|0|0003|HEADACHE (INTERMITTENT)|19 OCT 2020|15:00|0|N|31 OCT 2020|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
009|009-1006|AE|4|0|0004|SMALL BILATERAL INGUINAL HERNIA|17 DEC 2020|20:00|1|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
009|009-1006|AE|5|0|0005|CLOSTRIDIUM DIFFICILE INFECTION|17 DEC 2020|15:00|0|N|31 DEC 2020|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
009|009-1006|AE|6|0|0006|CONSTIPATION|18 NOV 2020|10:30|0|N|08 DEC 2020|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
009|009-1006|AE|7|0|0007|HAEMATOMA RIGHT OUTER THIGH|06 JAN 2021|15:00|0|N|11 JAN 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
009|009-1006|AE|8|0|0008|STRABISMUS|31 MAY 2020|23:00|0|N|23 JUN 2020|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
009|009-1006|AE|9|0|0009|ELEVATED LFTS|21 MAR 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
009|009-1007|AE|1|0|0001|OVARIAN CYST|14 DEC 2020|15:00|0|N|31 DEC 2020|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
009|009-1007|AE|2|0|0002|PAROXYSMAL ARTERIAL FIBRILLATION|03 AUG 2022|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
009|009-1007|AE|3|0|0003|EYE DISORDERS OTHER: BLOOD IN LEFT CONJUNCTIVA|04 DEC 2020|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
009|009-1007|AE|4|0|0004|INTERNAL HEMORRHOIDS|16 FEB 2022|15:00|0|N|06 MAR 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
009|009-1007|AE|5|0|0005|CONCUSSION|10 MAR 2021|09:00|0|N|19 MAR 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
009|009-1007|AE|6|0|0006|ISCHEMIC HEART DISEASE|19 OCT 2021|12:00|0|N|26 OCT 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
009|009-1007|AE|7|0|0007|INFECTION: STAPH EPIDERMIS BACTEREMIA|20 MAY 2021|13:00|0|N|22 MAY 2021|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
009|009-1007|AE|8|0|0008|CORONARY DISEASE|18 DEC 2022|17:00|0|N|15 JAN 2023|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
009|009-1007|AE|9|0|0009|NON-CARDIAC CHEST PAIN|06 SEP 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
009|009-1008|AE|1|0|0001|MEMORY IMPAIRMENT|29 DEC 2021|10:00|0|N|13 JAN 2022|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
009|009-1008|AE|10|0|0010|OSTEOARTHRITIS HIPS|31 DEC 2020|09:00|0|N|23 JAN 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
009|009-1008|AE|2|0|0002|OSTEOPENIA|14 AUG 2022|09:30|0|N|19 AUG 2022|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
009|009-1008|AE|3|0|0003|HYPERBILIRUBINEMIA|02 JUN 2022|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
009|009-1008|AE|4|0|0004|ALLERGY TO LATEX|22 DEC 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
009|009-1008|AE|5|0|0005|DEGENERATIVE DISEASE OF THE CERVICAL SPINE|03 SEP 2022|09:15|0|N|21 SEP 2022|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
009|009-1008|AE|6|0|0006|CARDIAC TROPONIN I INCREASED|08 JAN 2021|20:00|1|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
009|009-1008|AE|7|0|0007|HYPERTENSION (INTERMITTENT)|11 NOV 2020|12:15|0|N|04 DEC 2020|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
009|009-1008|AE|8|0|0008|CONGESTIVE HEART FAILURE|16 APR 2021|13:45|0|N|25 APR 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
009|009-1008|AE|9|0|0009|LUNG INFECTION (COMMUNITY ACQUIRED)|18 FEB 2022|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
009|009-1009|AE|1|0|0001|CALCULUS GALLBLADDER|30 NOV 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
009|009-1009|AE|10|0|0010|RECTAL HEMMORHAGE|24 JAN 2022|08:30|0|N|02 FEB 2022|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
009|009-1009|AE|11|0|0011|TOOTHACHE|24 JUN 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
009|009-1009|AE|2|0|0002|PAIN – UPPER RIGHT SHOULDER|09 MAY 2022|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
009|009-1009|AE|3|0|0003|HEMATURIA|02 OCT 2021|09:00|0|N|09 OCT 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
009|009-1009|AE|4|0|0004|LEG TREMORS|18 DEC 2021|10:30|0|N|14 JAN 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
009|009-1009|AE|5|0|0005|WHEEZING|03 AUG 2021|18:00|0|N|09 AUG 2021|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
009|009-1009|AE|6|0|0006|NUMBNESS OF LIMBS|19 JUL 2021|09:00|0|N|01 AUG 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
009|009-1009|AE|7|0|0007|SERUM CREATININE INCREASED|25 MAY 2021|15:00|0|N|03 JUN 2021|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
009|009-1009|AE|8|0|0008|OEDEMA L ANKLE|18 AUG 2020|09:30|0|N|25 AUG 2020|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
009|009-1009|AE|9|0|0009|DENTAL ABSCESS|16 MAR 2021|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
009|009-1010|AE|1|0|0001|LEFT AXILLARY ABSCESS|25 AUG 2022|12:15|0|N|21 SEP 2022|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
009|009-1010|AE|2|0|0002|OSTEO ARTHRITIS|19 DEC 2020|12:00|0|N|31 DEC 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
009|009-1010|AE|3|0|0003|THORACIC MUSCULOSKELETAL PAIN|19 NOV 2021|15:00|0|N|05 DEC 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
009|009-1011|AE|1|0|0001|FOLATE DEFICIENCY|16 DEC 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
010|010-1001|AE|1|0|0001|OSTEOARTHRITIS OF LEFT HIP|02 JUN 2022|17:00|0|N|01 JUL 2022|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
010|010-1001|AE|2|0|0002|CORONARY DISEASE|14 JAN 2023|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
010|010-1001|AE|3|0|0003|LEFT ADRENAL HYPERPLASIA|01 AUG 2022|20:00|1|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
010|010-1001|AE|4|0|0004|BILATERAL PLEURAL EFFUSIONS|24 JUN 2022|08:45|0|N|07 JUL 2022|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
010|010-1001|AE|5|0|0005|ABODOMINAL PAIN|20 NOV 2021|10:00|0|N|07 DEC 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
010|010-1001|AE|6|0|0006|CONGESTIVE HEART FAILURE|13 AUG 2021|12:00|0|N|30 AUG 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
010|010-1002|AE|1|0|0001|DYSPNEA|20 AUG 2021|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
010|010-1002|AE|2|0|0002|HEPATIC STEATOSIS|28 JUN 2021|22:30|0|N|21 JUL 2021|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
010|010-1002|AE|3|0|0003|CANCER ASSOCIATED PAIN|20 JUL 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
010|010-1002|AE|4|0|0004|HYPERKALAEMIA|26 AUG 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
010|010-1002|AE|5|0|0005|ATRIAL FIBRILLATION|03 SEP 2021|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
010|010-1003|AE|1|0|0001|SCIATICA|29 JAN 2022|17:00|0|N|01 FEB 2022|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
010|010-1004|AE|1|0|0001|INTERMITTENT HEADACHES|23 OCT 2020|20:00|0|N|18 NOV 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
010|010-1004|AE|2|0|0002|TINNITUS|13 AUG 2020|10:30|0|N|11 SEP 2020|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
010|010-1004|AE|3|0|0003|ALOPECIA|17 JAN 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
010|010-1005|AE|1|0|0001|GLAUCOMA|01 NOV 2020|12:00|0|N|01 DEC 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
010|010-1005|AE|2|0|0002|ASCITES|26 OCT 2020|09:30|0|N|20 NOV 2020|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
010|010-1006|AE|1|0|0001|GAIT PROBLEM|20 DEC 2020|11:00|0|N|11 JAN 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
010|010-1006|AE|2|0|0002|LABORATORY TUMOR LYSIS SYNDROME|01 JAN 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
010|010-1006|AE|3|0|0003|GENERALIZED MUSCLE WEAKNESS|03 DEC 2020|15:00|0|N|23 DEC 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
010|010-1006|AE|4|0|0004|NEUROPATHY – BILATERAL LEGS AND TOES|10 SEP 2020|22:30|0|N|24 SEP 2020|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
010|010-1007|AE|1|0|0001|NEOPLASM PAIN|02 AUG 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
010|010-1007|AE|2|0|0002|INCREASED GLUTAMYLTRANSFERASE|23 JUN 2022|08:00|0|N|12 JUL 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
010|010-1007|AE|3|0|0003|THORACIC MUSCULOSKELETAL PAIN|23 FEB 2022|15:00|0|N|05 MAR 2022|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
010|010-1007|AE|4|0|0004|VISION DECREASED|11 MAR 2022|08:00|0|N|01 APR 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
010|010-1007|AE|5|0|0005|CARDIAC TROPONIN INCREASED|09 SEP 2021|14:00|0|N|04 OCT 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
010|010-1007|AE|6|0|0006|OVERWEIGHT|16 MAY 2022|13:00|0|N|25 MAY 2022|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
010|010-1007|AE|7|0|0007|SKIN RASHES|13 JUN 2022|08:00|0|N|28 JUN 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
010|010-1007|AE|8|0|0008|ABODOMINAL PAIN|11 JAN 2023|11:00|0|N|17 JAN 2023|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
010|010-1007|AE|9|0|0009|ALANINE AMINOTRANSFERASE INCREASED (ALT)|22 NOV 2020|11:00|0|N|30 NOV 2020|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
010|010-1008|AE|1|0|0001|ARTHRALGIAS (INTERMITTENT)|14 SEP 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
010|010-1008|AE|2|0|0002|EDEMA: BILATERAL LOWER EXTREMITIES|23 OCT 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
010|010-1008|AE|3|0|0003|GOUTY TOPHI|16 JUN 2021|08:45|0|N|10 JUL 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
010|010-1008|AE|4|0|0004|WHEEZING|05 SEP 2021|17:00|0|N|27 SEP 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
010|010-1008|AE|5|0|0005|DEFICIENCY OF VIT. D3|09 OCT 2021|12:00|0|N|05 NOV 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
010|010-1008|AE|6|0|0006|OBSESSIVE COMPULSIVE DISORDER|01 AUG 2022|12:00|0|N|20 AUG 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
010|010-1008|AE|7|0|0007|CARDIAC TROPONIN INCREASED|09 MAY 2021|10:00|0|N|28 MAY 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
010|010-1008|AE|8|0|0008|RECTAL PAIN|07 NOV 2021|12:00|0|N|07 NOV 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
010|010-1008|AE|9|0|0009|SINUS TACHYCARDIA (INTERMITTENT)|19 APR 2022|17:00|0|N|17 MAY 2022|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
011|011-1001|AE|1|0|0001|SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, RED SWOLLEN AREA ON HAND|16 DEC 2021|08:15|0|N|03 JAN 2022|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
011|011-1001|AE|2|0|0002|DEGENERATIVE DISEASE OF THE CERVICAL SPINE|14 MAY 2021|15:00|0|N|30 MAY 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1001|AE|3|0|0003|CIRCULATING BLASTS|03 MAY 2021|15:00|0|N|28 MAY 2021|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
011|011-1001|AE|4|0|0004|BULLOUS DERMATITIS|18 DEC 2020|11:00|0|N|31 DEC 2020|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1001|AE|5|0|0005|SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, RED SWOLLEN AREA ON HAND|11 OCT 2020|11:00|0|N|01 NOV 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
011|011-1002|AE|1|0|0001|APPENDICITIS|18 JUL 2021|15:00|0|N|30 JUL 2021|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
011|011-1002|AE|10|0|0010|THROMBOCYTOSIS|09 SEP 2021|09:30|0|N|16 SEP 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
011|011-1002|AE|2|0|0002|BENIGN  COLON  ADENOMA|11 SEP 2020|20:00|0|N|14 SEP 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1002|AE|3|0|0003|AGITATION|27 OCT 2020|13:45|0|N|01 NOV 2020|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
011|011-1002|AE|4|0|0004|OVARIAN CYST|09 DEC 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
011|011-1002|AE|5|0|0005|SUBCLINICAL SEIZURES|02 JUN 2021|15:00|0|N|05 JUN 2021|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
011|011-1002|AE|6|0|0006|HYPERPIGMENTATION OF THE SKIN|20 JAN 2022|08:15|0|N|13 FEB 2022|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
011|011-1002|AE|7|0|0007|MUCOSITIS ORAL|13 SEP 2020|22:00|0|N|24 SEP 2020|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
011|011-1002|AE|8|0|0008|THROMBOCYTOPAENIA|29 AUG 2021|11:00|0|N|02 SEP 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1002|AE|9|0|0009|SECONDARY MALIGNANT NEOPLASM OF THE BONE|10 FEB 2021|08:00|0|N|24 FEB 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
011|011-1003|AE|1|0|0001|TORN ROTATOR CUFF|20 AUG 2020|07:30|0|N|09 SEP 2020|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
011|011-1004|AE|1|0|0001|NEUTROPENIA|12 NOV 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
011|011-1004|AE|2|0|0002|ASPARTATE AMINOTRANSFERASE INCREASED|04 NOV 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
011|011-1004|AE|3|0|0003|GERD|10 JUL 2020|11:00|0|N|03 AUG 2020|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1004|AE|4|0|0004|BENIGN PAROXYSMAL POSITIONAL VERTIGO|25 SEP 2020|14:30|0|N|11 OCT 2020|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
011|011-1004|AE|5|0|0005|LEG PAIN|05 DEC 2020|12:00|0|N|03 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1004|AE|6|0|0006|VESICULITIS|15 OCT 2020|14:00|0|N|23 OCT 2020|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
011|011-1004|AE|7|0|0007|BOWEL IRREGULARITY|04 SEP 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
011|011-1004|AE|8|0|0008|SMALL UMBILICAL HERNIA|30 JUN 2020|22:30|0|N|03 JUL 2020|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
011|011-1005|AE|1|0|0001|DIABETES TYPE 2|21 JAN 2021|12:00|0|N|26 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1005|AE|2|0|0002|DRY EYES|03 FEB 2021|08:15|0|N|12 FEB 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
011|011-1005|AE|3|0|0003|ALOPECIA|18 JUL 2021|08:00|0|N|23 JUL 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
011|011-1005|AE|4|0|0004|OSTEOARTHRITIS OF LEFT HIP|01 APR 2021|11:00|0|N|21 APR 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
011|011-1005|AE|5|0|0005|INTERMITTENT DIARRHOEA|30 JUL 2021|23:00|0|N|19 AUG 2021|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1006|AE|1|0|0001|NUMBNESS OF LIMBS|11 APR 2021|09:30|0|N|02 MAY 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
011|011-1006|AE|2|0|0002|INTESTINAL FLORA DYSREGULATION|15 FEB 2021|15:00|0|N|05 MAR 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
011|011-1006|AE|3|0|0003|POSTURAL DIZZINESS|18 AUG 2021|08:00|0|N|03 SEP 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
011|011-1006|AE|4|0|0004|SECONDARY MALIGNANT NEOPLASM OF PERITONEUM|19 SEP 2021|08:15|0|N|24 SEP 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
011|011-1006|AE|5|0|0005|ALT INCREASED|24 AUG 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
011|011-1006|AE|6|0|0006|CONFUSION|27 AUG 2021|09:00|0|N|12 SEP 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
011|011-1006|AE|7|0|0007|CHRONIC KNEE PAIN|10 JUL 2021|10:00|0|N|19 JUL 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
011|011-1006|AE|8|0|0008|SINUS TACHYCARDIA (INTERMITTENT)|05 OCT 2021|15:00|0|N|13 OCT 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
011|011-1007|AE|1|0|0001|AST INCREASE|17 MAR 2021|10:00|0|N|25 MAR 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
011|011-1007|AE|10|0|0010|THROMBOCYTOPAENIA|06 APR 2021|10:00|0|N|14 APR 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
011|011-1007|AE|11|0|0011|SECONDARY MALIGNANT NEOPLASM OF THE BONE|02 JUN 2021|15:00|0|N|09 JUN 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
011|011-1007|AE|2|0|0002|DIZZINESS|18 JUN 2021|20:00|0|N|08 JUL 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1007|AE|3|0|0003|ASPARTATE AMINOTRANSFERASE INCREASED|29 JAN 2021|11:00|0|N|11 FEB 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1007|AE|4|0|0004|MUSCLE SPASMS|09 JUN 2021|22:30|0|N|10 JUN 2021|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
011|011-1007|AE|5|0|0005|CORONARY ARTERY DISEASE|09 MAR 2021|10:00|0|N|13 MAR 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
011|011-1007|AE|6|0|0006|ALT INCREASED (INTERMITTENT)|07 MAR 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
011|011-1007|AE|7|0|0007|ALANINE AMINOTRANSFERASE INCREASED (ALT)|10 MAR 2021|10:30|0|N|06 APR 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
011|011-1007|AE|8|0|0008|DIABETES TYPE 2|22 DEC 2020|14:00|0|N|21 JAN 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
011|011-1007|AE|9|0|0009|WOUND INFECTION|25 SEP 2020|08:00|0|N|07 OCT 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
011|011-1008|AE|1|0|0001|ALLERGIC REACTION|23 AUG 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
011|011-1008|AE|2|0|0002|PAIN IN EXTREMITY - BOTH FEET|29 JAN 2021|12:00|0|N|22 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1008|AE|3|0|0003|HYPOALBUMINAEMIA|16 JUL 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
011|011-1008|AE|4|0|0004|WORSENING COLITIS|21 JUN 2021|12:00|0|N|14 JUL 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1008|AE|5|0|0005|OSTEOARTHRITIS HIPS|18 MAR 2021|10:30|0|N|12 APR 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
011|011-1008|AE|6|0|0006|WHEEZING|12 AUG 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
011|011-1008|AE|7|0|0007|APPETITE CHANGE|18 JUN 2022|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
011|011-1008|AE|8|0|0008|NEUROPATHIC PAIN|01 FEB 2022|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
011|011-1008|AE|9|0|0009|THROMBOCYTOSIS|18 MAY 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
011|011-1009|AE|1|0|0001|OVARIAN CYST|24 JUL 2021|08:00|0|N|04 AUG 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
011|011-1009|AE|2|0|0002|C-REACTIVE PROTEIN INCREASED|23 JUN 2021|08:00|0|N|19 JUL 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
011|011-1009|AE|3|0|0003|GERD (GASTROESOPHAGEAL REFLUX DISEASE)|21 OCT 2021|08:00|0|N|09 NOV 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
011|011-1009|AE|4|0|0004|FLATULENCE|19 AUG 2021|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
011|011-1009|AE|5|0|0005|HYPOMAGNESMIA|20 NOV 2021|12:00|0|N|17 DEC 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
011|011-1009|AE|6|0|0006|TYPE 2 DIABETES MELLITUS|12 FEB 2021|09:00|0|N|14 FEB 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
011|011-1009|AE|7|0|0007|CIPROFLOXACIN HYDROCHLORIDE ALLERGY|13 DEC 2021|09:00|0|N|22 DEC 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
012|012-1001|AE|1|0|0001|PERIANAL FISSURE|10 OCT 2020|15:00|0|N|18 OCT 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
012|012-1001|AE|2|0|0002|HYDRONEPHROSIS|08 SEP 2021|12:00|0|N|24 SEP 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
012|012-1001|AE|3|0|0003|PALPITATIONS|25 MAR 2021|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
012|012-1001|AE|4|0|0004|GASTROESOPHAGEAL REFLUX DISEASE|10 OCT 2021|08:00|0|N|18 OCT 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
012|012-1001|AE|5|0|0005|MONOCLONAL B CELL LYMPHOCYTOSIS|15 JAN 2021|08:00|0|N|02 FEB 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
012|012-1001|AE|6|0|0006|ESSENTIAL PRIMARY HYPERTENSION|20 SEP 2021|15:00|0|N|12 OCT 2021|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
012|012-1002|AE|1|0|0001|AST INCREASED|29 JUN 2021|12:00|0|N|26 JUL 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
012|012-1002|AE|2|0|0002|NASAL CONGESTION|21 NOV 2020|16:00|0|N|02 DEC 2020|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
012|012-1002|AE|3|0|0003|DYSPNOEA|11 AUG 2020|10:00|0|N|07 SEP 2020|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
012|012-1002|AE|4|0|0004|EPISTAXIS (INTERMITTENT)|20 JAN 2021|09:00|0|N|13 FEB 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
012|012-1002|AE|5|0|0005|MUSCLE SPASM OF BACK|20 APR 2021|13:45|0|N|05 MAY 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
012|012-1002|AE|6|0|0006|EDEMA: BILATERAL LOWER EXTREMITIES|25 FEB 2021|20:00|1|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
012|012-1002|AE|7|0|0007|BLAST CELL COUNT INCREASED|02 SEP 2020|10:00|0|N|21 SEP 2020|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
012|012-1002|AE|8|0|0008|TRANSAMINITIS|10 JUN 2021|08:00|0|N|25 JUN 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
012|012-1003|AE|1|0|0001|HISTORY OF IRON DEFICIENCY|12 JUN 2020|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
012|012-1003|AE|2|0|0002|DIZZINESS|25 JUN 2022|08:15|0|N|24 JUL 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
012|012-1003|AE|3|0|0003|MUSCLE SPASM OF BACK|21 FEB 2021|08:00|0|N|10 MAR 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
012|012-1003|AE|4|0|0004|INTERMITTENT CONSTIPATION|31 JAN 2021|18:00|0|N|28 FEB 2021|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
012|012-1004|AE|1|0|0001|ANEMIA, UNSPECIFIED|15 MAR 2021|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
012|012-1004|AE|2|0|0002|DIABETES INSIPIDUS|08 APR 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
012|012-1005|AE|1|0|0001|DIABETES MELLITUS, TYPE 2|16 NOV 2020|15:00|0|N|12 DEC 2020|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
012|012-1005|AE|2|0|0002|SCAPHOID FRACTURE RIGHT WRIST|03 JAN 2021|20:00|0|N|04 JAN 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
012|012-1005|AE|3|0|0003|RHEUMATOID ARTHRITIS|28 JAN 2022|11:00|0|N|29 JAN 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
012|012-1005|AE|4|0|0004|HYPERCHOLESTEROLEMIA|01 JUL 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
012|012-1005|AE|5|0|0005|PROTEINURIA|27 AUG 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
012|012-1005|AE|6|0|0006|TONGUE HAEMATOMA|15 JAN 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
012|012-1006|AE|1|0|0001|HYPERPHOSPHATEMIA|16 OCT 2021|09:00|0|N|05 NOV 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
012|012-1006|AE|2|0|0002|BLOOD LACTATEDEHYDROGENASE INCREASED|12 OCT 2021|18:00|0|N|07 NOV 2021|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
012|012-1006|AE|3|0|0003|RECTAL HEMMORHAGE|24 JAN 2022|10:30|0|N|17 FEB 2022|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
012|012-1006|AE|4|0|0004|PANCREATIC INSUFFICIENCY|18 JUL 2022|18:00|0|N|26 JUL 2022|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
012|012-1006|AE|5|0|0005|MILD GENERALIZED PETECHIAL RASH|11 APR 2022|11:00|0|N|26 APR 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
012|012-1006|AE|6|0|0006|UMBILICAL HERNIA|24 SEP 2022|09:00|0|N|29 SEP 2022|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
012|012-1006|AE|7|0|0007|WEIGHT LOSS|09 APR 2021|11:00|0|N|16 APR 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
012|012-1007|AE|1|0|0001|GENERAL ACHES/PAIN|25 JUN 2020|14:00|0|N|28 JUN 2020|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
012|012-1007|AE|2|0|0002|AST INCREASED (INTERMITTENT)|17 JUL 2021|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
012|012-1007|AE|3|0|0003|SCAPHOID FRACTURE RIGHT WRIST|20 APR 2021|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
012|012-1007|AE|4|0|0004|BILATERAL CARPEL TUNNEL SYNDROME|03 DEC 2021|14:00|0|N|24 DEC 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
012|012-1007|AE|5|0|0005|CORONARY DISEASE|08 JUN 2021|10:00|0|N|20 JUN 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
012|012-1007|AE|6|0|0006|BILATERAL CATARACT|07 OCT 2020|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
013|013-1001|AE|1|0|0001|CALCULUS GALLBLADDER|24 JAN 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
013|013-1001|AE|10|0|0010|SINUSITIS|29 DEC 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
013|013-1001|AE|2|0|0002|THROMBOCYTOSIS|12 JAN 2021|12:00|0|N|16 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
013|013-1001|AE|3|0|0003|DYSPHAGIA|25 MAR 2021|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
013|013-1001|AE|4|0|0004|HICCUPS|24 MAR 2021|10:00|0|N|06 APR 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
013|013-1001|AE|5|0|0005|HYPOKALAEMIA|16 JAN 2021|15:00|0|N|11 FEB 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
013|013-1001|AE|6|0|0006|MENOPAUSE|28 DEC 2020|09:30|0|N|20 JAN 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
013|013-1001|AE|7|0|0007|POST-MENOPAUSE|14 FEB 2021|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
013|013-1001|AE|8|0|0008|ADJUSTMENT DISORDER WITH ANXIOUS MOOD|16 JAN 2021|09:00|0|N|25 JAN 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
013|013-1001|AE|9|0|0009|ANEMIA|18 MAR 2021|15:00|0|N|11 APR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
013|013-1002|AE|1|0|0001|ASCITES|15 JUN 2020|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
013|013-1002|AE|2|0|0002|GENERALIZED MUSCLE WEAKNESS|15 JUN 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
013|013-1002|AE|3|0|0003|PERIANAL ABSCESS|15 JUN 2020|09:00|0|N|21 JUN 2020|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
013|013-1002|AE|4|0|0004|CONGESTIVE HEART FAILURE|15 JUN 2020|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
013|013-1003|AE|1|0|0001|SPLENOMEGALY|07 NOV 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
013|013-1003|AE|2|0|0002|DIPLOPIA|07 OCT 2020|15:00|0|N|09 OCT 2020|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
013|013-1003|AE|3|0|0003|STRABISMUS|09 FEB 2021|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
013|013-1003|AE|4|0|0004|MUSCLE WEAKNESS LOWER LIMB|14 MAR 2022|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
013|013-1003|AE|5|0|0005|CALCULUS GALLBLADDER|31 JAN 2021|09:00|0|N|22 FEB 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
013|013-1003|AE|6|0|0006|C-REACTIVE PROTEIN INCREASED|14 FEB 2021|09:30|0|N|08 MAR 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
013|013-1003|AE|7|0|0007|IDIOPATHIC PARKINSON'S DISEASE|06 NOV 2020|16:00|0|N|03 DEC 2020|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
013|013-1004|AE|1|0|0001|DIARRHEA INTERMITTENT|08 SEP 2020|22:00|0|N|08 OCT 2020|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
013|013-1004|AE|2|0|0002|LUNG INFECTION (COMMUNITY ACQUIRED)|18 MAR 2021|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
013|013-1004|AE|3|0|0003|OTHER PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE|10 JUN 2021|15:00|0|N|01 JUL 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
013|013-1004|AE|4|0|0004|CONGESTIVE HEART FAILURE|17 SEP 2020|09:00|0|N|30 SEP 2020|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
013|013-1004|AE|5|0|0005|CARDIAC TROPONIN T INCREASED|11 FEB 2021|20:00|0|N|14 FEB 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
013|013-1004|AE|6|0|0006|ALLERGIC DERMATITIS|21 JUL 2020|15:00|0|N|08 AUG 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
013|013-1004|AE|7|0|0007|ABODOMINAL PAIN|21 OCT 2020|12:00|0|N|14 NOV 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
013|013-1004|AE|8|0|0008|PRODUCTIVE COUGH|29 JAN 2021|20:00|0|N|01 FEB 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
013|013-1004|AE|9|0|0009|BENIGN PROSTATIC HYPERTROPHY|09 JUL 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
013|013-1005|AE|1|0|0001|TUBERCULOSIS EXPOSURE|06 FEB 2021|11:00|0|N|07 MAR 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
013|013-1005|AE|2|0|0002|HYPERTENSION|03 OCT 2020|09:00|0|N|10 OCT 2020|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
013|013-1006|AE|1|0|0001|PICC LINE SITE PAIN|24 JUN 2022|08:00|0|N|29 JUN 2022|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
013|013-1006|AE|2|0|0002|AGGRAVATED ANEMIA|04 OCT 2022|14:00|0|N|23 OCT 2022|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
013|013-1006|AE|3|0|0003|CHILLS|12 NOV 2020|11:00|0|N|12 NOV 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
013|013-1006|AE|4|0|0004|OBSTRUCTIVE SLEEP APNOEA|12 DEC 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
013|013-1006|AE|5|0|0005|MARANTIC ENDOCARDITIS|22 SEP 2022|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
013|013-1006|AE|6|0|0006|DYSPNEA ON EXERTION|18 JAN 2023|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
013|013-1006|AE|7|0|0007|HYPONATREMIA|07 FEB 2023|11:00|0|N|28 FEB 2023|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
013|013-1006|AE|8|0|0008|CANCER ASSOCIATED PAIN|10 NOV 2021|18:00|0|N|08 DEC 2021|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
013|013-1006|AE|9|0|0009|BENIGN PAROXYSMAL POSITIONAL VERTIGO|11 MAY 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
013|013-1007|AE|1|0|0001|DENTAL ABSCESS|25 AUG 2021|23:00|0|N|15 SEP 2021|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
013|013-1007|AE|10|0|0010|WORSENING CREATININE INCREASE|04 MAY 2022|12:00|0|N|21 MAY 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
013|013-1007|AE|2|0|0002|GLAUCOMA|14 APR 2021|13:45|0|N|17 APR 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
013|013-1007|AE|3|0|0003|DYSGEUSIA|09 DEC 2021|09:00|0|N|20 DEC 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
013|013-1007|AE|4|0|0004|NUMBNESS OF LIMBS|15 MAY 2021|09:00|0|N|17 MAY 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
013|013-1007|AE|5|0|0005|DYSARTHRIA|19 MAY 2022|10:00|0|N|09 JUN 2022|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
013|013-1007|AE|6|0|0006|HIPS PAIN (INTERMITTENT)|13 JAN 2022|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
013|013-1007|AE|7|0|0007|MAJOR DEPRESSION|24 MAR 2022|08:00|0|N|02 APR 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
013|013-1007|AE|8|0|0008|HYPERTENSION R/T CKD|18 MAY 2022|08:30|0|N|24 MAY 2022|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
013|013-1007|AE|9|0|0009|HICCUPS|14 SEP 2021|10:00|0|N|29 SEP 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
014|014-1001|AE|1|0|0001|WORSENING COLITIS|23 JAN 2021|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
014|014-1001|AE|10|0|0010|INTERMITTENT HIP PAIN|14 NOV 2021|15:00|0|N|17 NOV 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
014|014-1001|AE|2|0|0002|ABDOMINAL DISTENSTION|13 DEC 2021|15:00|0|N|15 DEC 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
014|014-1001|AE|3|0|0003|DOUBLE RENAL CYST|06 JUL 2021|12:00|0|N|27 JUL 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
014|014-1001|AE|4|0|0004|CREATININE INCREASE|07 NOV 2021|10:00|0|N|06 DEC 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
014|014-1001|AE|5|0|0005|OSTEOARTHRITIS HIPS|17 NOV 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
014|014-1001|AE|6|0|0006|PLEURAL EFFUSION (RIGHT SIDE)|20 NOV 2022|11:00|0|N|20 DEC 2022|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
014|014-1001|AE|7|0|0007|ORTHOSTATIC HYPOTENSION|24 JUN 2021|11:00|0|N|29 JUN 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
014|014-1001|AE|8|0|0008|ONYCHOMYCOSIS|16 FEB 2022|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
014|014-1001|AE|9|0|0009|ELEVATED LFTS|28 MAR 2020|14:30|0|N|30 MAR 2020|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
014|014-1002|AE|1|0|0001|INTERMITTENT STOMACH PAIN|29 JUL 2023|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
014|014-1002|AE|2|0|0002|OEDEMA LIMBS - LEFT LEG|22 JUN 2023|22:30|0|N|28 JUN 2023|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
014|014-1002|AE|3|0|0003|NAUSEA (GRADE 1)|23 MAR 2021|08:15|0|N|19 APR 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
014|014-1002|AE|4|0|0004|SKIN RASHES|18 JUL 2022|23:00|0|N|21 JUL 2022|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
014|014-1002|AE|5|0|0005|DIABETES INSIPIDUS|23 MAY 2022|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
014|014-1002|AE|6|0|0006|HYPERTENSION|26 JAN 2021|08:15|0|N|27 JAN 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
014|014-1002|AE|7|0|0007|OBSTRUCTIVE SLEEP APNEA|06 AUG 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
014|014-1002|AE|8|0|0008|BREAST CANCER|04 APR 2023|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
014|014-1003|AE|1|0|0001|INTERMITTENT DIARRHOEA|30 MAR 2021|14:00|0|N|07 APR 2021|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
014|014-1003|AE|2|0|0002|ANAEMIA|15 FEB 2021|08:00|0|N|28 FEB 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
014|014-1004|AE|1|0|0001|CPK INCREASED|29 JAN 2021|09:00|0|N|03 FEB 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
014|014-1004|AE|2|0|0002|HYPERBILIRUBINEMIA|03 FEB 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
014|014-1004|AE|3|0|0003|NEUTROPENIA|20 APR 2021|09:00|0|N|08 MAY 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
014|014-1004|AE|4|0|0004|NEUTROPENIC FEVER|23 JAN 2021|12:00|0|N|12 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
014|014-1004|AE|5|0|0005|SYMPTOMATIC ANEMIA|11 MAY 2021|18:00|0|N|24 MAY 2021|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
014|014-1004|AE|6|0|0006|CORONARY DISEASE|01 NOV 2020|09:00|0|N|16 NOV 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
014|014-1005|AE|1|0|0001|DEGENERATIVE SPONDYLOSIS|17 DEC 2020|11:00|0|N|18 DEC 2020|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
014|014-1006|AE|1|0|0001|ATTENTION DISTURBANCE|02 AUG 2020|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
014|014-1006|AE|2|0|0002|LEG TREMORS|17 AUG 2020|12:15|0|N|23 AUG 2020|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
015|015-1001|AE|1|0|0001|PULMONARY EMBOLISM|10 DEC 2021|09:30|0|N|11 DEC 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
015|015-1001|AE|10|0|0010|GENERALIZED LYMPHADENOPATHY|30 NOV 2021|12:00|0|N|03 DEC 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
015|015-1001|AE|11|0|0011|ISCHEMIC HEART DISEASE|17 MAR 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
015|015-1001|AE|2|0|0002|HYPERCHOLESTEROLEMIA|11 JAN 2021|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
015|015-1001|AE|3|0|0003|SMALL BILATERAL INGUINAL HERNIA|26 JUL 2021|14:30|0|N|20 AUG 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
015|015-1001|AE|4|0|0004|INTERNAL HEMORRHOIDS|05 JAN 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
015|015-1001|AE|5|0|0005|HYPERCHOLESTEROEMIA|24 JAN 2022|16:00|0|N|15 FEB 2022|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
015|015-1001|AE|6|0|0006|INTESTINAL FLORA DYSREGULATION|29 APR 2021|12:00|0|N|04 MAY 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
015|015-1001|AE|7|0|0007|ACUTE MEDIAL MENISCUS TEAR OF RIGHT KNEE|29 MAY 2021|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
015|015-1001|AE|8|0|0008|HYPERTENSION (INTERMITTENT)|12 MAY 2022|16:00|0|N|17 MAY 2022|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
015|015-1001|AE|9|0|0009|AGITATION|20 JUN 2022|11:00|0|N|10 JUL 2022|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
015|015-1002|AE|1|0|0001|GLAUCOMA|23 OCT 2023|12:00|0|N|25 OCT 2023|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
015|015-1002|AE|2|0|0002|WEIGHT GAIN|01 FEB 2022|18:00|0|N|04 FEB 2022|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
015|015-1002|AE|3|0|0003|WORSENING NEUTROPENIA|12 JAN 2024|10:00|0|N|09 FEB 2024|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
015|015-1002|AE|4|0|0004|SERUM CREATININE INCREASED|02 JAN 2023|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
015|015-1002|AE|5|0|0005|INSOMNIA - INTERMITTENT|11 AUG 2021|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
015|015-1002|AE|6|0|0006|CHRONIC KNEE PAIN|04 OCT 2022|09:15|0|N|30 OCT 2022|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
015|015-1003|AE|1|0|0001|URINARY RETENTION|05 FEB 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
015|015-1003|AE|2|0|0002|POSTMENOPAUSAL|02 FEB 2021|08:00|0|N|23 FEB 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
015|015-1003|AE|3|0|0003|HISTORY OF IRON DEFICIENCY|25 JAN 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
015|015-1003|AE|4|0|0004|THRUSH|26 JAN 2021|09:00|0|N|01 FEB 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
015|015-1004|AE|1|0|0001|ALT INCREASED (INTERMITTENT)|19 MAY 2021|11:00|0|N|20 MAY 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
015|015-1004|AE|2|0|0002|ANAEMIA|15 AUG 2020|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
015|015-1004|AE|3|0|0003|DENTAL ABSCESS|04 JAN 2021|14:30|0|N|11 JAN 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
015|015-1005|AE|1|0|0001|ABDOMINAL PAIN|04 FEB 2022|22:00|0|N|02 MAR 2022|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
015|015-1005|AE|2|0|0002|RENAL INSUFFICIENCY|27 JAN 2023|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
015|015-1005|AE|3|0|0003|CALCULUS GALLBLADDER|05 NOV 2021|12:00|0|N|29 NOV 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
015|015-1006|AE|1|0|0001|MONOCLONAL B CELL LYMPHOCYTOSIS|15 JUL 2022|15:00|0|N|13 AUG 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
015|015-1006|AE|2|0|0002|SLOW TRANSIT CONSTIPATION|16 FEB 2021|17:00|0|N|20 FEB 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
015|015-1006|AE|3|0|0003|NEUROPATHY – BILATERAL LEGS AND TOES|23 JUN 2023|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
015|015-1006|AE|4|0|0004|DYSARTHRIA|02 AUG 2022|22:30|0|N|24 AUG 2022|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
015|015-1006|AE|5|0|0005|PICC LINE SITE PAIN|25 MAY 2022|08:30|0|N|25 MAY 2022|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
015|015-1006|AE|6|0|0006|HIPS PAIN (INTERMITTENT)|13 JUN 2023|12:00|0|N|02 JUL 2023|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
015|015-1006|AE|7|0|0007|LEFT AXILLARY ABSCESS|10 OCT 2020|08:00|0|N|25 OCT 2020|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
015|015-1006|AE|8|0|0008|ORAL MUCOSITIS|12 DEC 2020|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
015|015-1006|AE|9|0|0009|FUNGAL PNEUMONIA|23 JUL 2020|13:00|0|N|22 AUG 2020|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
015|015-1007|AE|1|0|0001|DIZZINESS|16 JAN 2021|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
015|015-1007|AE|2|0|0002|MUCOSITIS - ORAL|15 JAN 2021|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
015|015-1007|AE|3|0|0003|HYPERKALAEMIA|16 JAN 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
015|015-1007|AE|4|0|0004|IMPACTED CERUMEN OF RIGHT EAR|16 JAN 2021|10:00|0|N|12 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
015|015-1007|AE|5|0|0005|EDEMA CAUSING PAIN: RIGHT LATERAL CHEST WALL|15 JAN 2021|08:45|0|N|03 FEB 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
015|015-1007|AE|6|0|0006|INSOMNIA|16 JAN 2021|09:30|0|N|05 FEB 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
015|015-1008|AE|1|0|0001|HAEMATOMA RIGHT OUTER THIGH|24 DEC 2021|11:00|0|N|14 JAN 2022|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
015|015-1008|AE|2|0|0002|FLUID OVERLOAD|16 AUG 2021|20:00|0|N|26 AUG 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
015|015-1008|AE|3|0|0003|DRY EYE SYNDROME|14 JUL 2022|11:00|0|N|14 JUL 2022|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
015|015-1008|AE|4|0|0004|BLOOD LACTATE DEHYDROGENASE INCREASED|23 SEP 2020|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
015|015-1008|AE|5|0|0005|ALT INCREASED (INTERMITTENT)|20 OCT 2020|22:00|0|N|06 NOV 2020|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
015|015-1009|AE|1|0|0001|IMPACTED CERUMEN OF RIGHT EAR|25 SEP 2020|13:45|0|N|09 OCT 2020|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
015|015-1009|AE|2|0|0002|HYPERTENSION (INTERMITTENT)|01 OCT 2020|07:30|0|N|21 OCT 2020|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
015|015-1009|AE|3|0|0003|HERPES ZOSTER|29 SEP 2020|18:00|0|N|12 OCT 2020|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
015|015-1009|AE|4|0|0004|WORSENING ANEMIA|27 SEP 2020|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
016|016-1001|AE|1|0|0001|LYME DISEASE|12 JAN 2023|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
016|016-1001|AE|2|0|0002|HEMATOMA|21 SEP 2020|09:15|0|N|21 OCT 2020|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1002|AE|1|0|0001|ELEVATED WBC COUNT|15 SEP 2020|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
016|016-1003|AE|1|0|0001|HISTORY OF PROSTATE CANCER|06 AUG 2020|15:00|0|N|25 AUG 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
016|016-1004|AE|1|0|0001|BULLOUS DERMATITIS|25 SEP 2020|14:00|0|N|10 OCT 2020|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
016|016-1004|AE|2|0|0002|SMALL BILATERAL INGUINAL HERNIA|21 SEP 2020|20:00|0|N|06 OCT 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1004|AE|3|0|0003|INTERMITTENT HEADACHES|01 NOV 2020|20:00|0|N|22 NOV 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
016|016-1004|AE|4|0|0004|SICK SINUS SYNDROME|12 NOV 2020|08:00|0|N|07 DEC 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
016|016-1004|AE|5|0|0005|C-REACTIVE PROTEIN INCREASED|09 JAN 2021|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
016|016-1004|AE|6|0|0006|ALT INCREASED|04 JAN 2021|15:00|0|N|06 JAN 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
016|016-1004|AE|7|0|0007|BENIGN PROSTATIC HYPERPLASIA|08 OCT 2020|11:00|0|N|03 NOV 2020|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1005|AE|1|0|0001|LYMPHOCYTOPENIA|04 NOV 2020|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
016|016-1005|AE|10|0|0010|DIARRHEA|15 OCT 2020|15:00|0|N|14 NOV 2020|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1005|AE|11|0|0011|LARGE HIATAL HERNIA|07 OCT 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
016|016-1005|AE|2|0|0002|GASRITIS|17 OCT 2020|09:00|0|N|05 NOV 2020|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
016|016-1005|AE|3|0|0003|BLOOD LACTATE DEHYDROGENASE INCREASED|31 OCT 2020|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
016|016-1005|AE|4|0|0004|MINI CEREBROVASCULAR ACCIDENT|23 SEP 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
016|016-1005|AE|5|0|0005|CHILLS|08 NOV 2020|08:00|0|N|22 NOV 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
016|016-1005|AE|6|0|0006|LYMPHEDEMA|24 SEP 2020|10:00|0|N|05 OCT 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1005|AE|7|0|0007|ANEMIA|09 OCT 2020|12:00|0|N|03 NOV 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1005|AE|8|0|0008|VISION DECREASED|06 OCT 2020|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
016|016-1005|AE|9|0|0009|SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, RED SWOLLEN AREA ON HAND|03 NOV 2020|12:00|0|N|28 NOV 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1006|AE|1|0|0001|HIPS PAIN (INTERMITTENT)|05 OCT 2020|12:15|0|N|07 OCT 2020|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
016|016-1006|AE|2|0|0002|PALPITATIONS|05 OCT 2020|15:00|0|N|20 OCT 2020|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
016|016-1006|AE|3|0|0003|LEUKOCYTOSIS|09 SEP 2020|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
016|016-1006|AE|4|0|0004|INFECTIONS AND INFESTATIONS - OTHER: C. DIFFICILE|19 SEP 2020|12:00|0|N|12 OCT 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1006|AE|5|0|0005|ARTHRITIS|26 SEP 2020|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
016|016-1006|AE|6|0|0006|INTERMITTENT DYSURIA|03 SEP 2020|15:00|0|N|24 SEP 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
016|016-1006|AE|7|0|0007|WHITE BLOOD CELL DECREASED|01 OCT 2020|17:00|0|N|02 OCT 2020|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
016|016-1006|AE|8|0|0008|ODEMA, LOWER LIMBS|05 SEP 2020|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
016|016-1006|AE|9|0|0009|TROPONIN T INCREASED|13 SEP 2020|08:15|0|N|24 SEP 2020|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
016|016-1007|AE|1|0|0001|MUSCLE PAIN|13 JAN 2021|08:00|0|N|10 FEB 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
016|016-1007|AE|2|0|0002|OEDEMA L EYE|09 FEB 2021|09:00|0|N|19 FEB 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
016|016-1007|AE|3|0|0003|BENIGN PROSTATIC HYPERPLASIA|13 FEB 2021|15:00|0|N|06 MAR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
016|016-1007|AE|4|0|0004|RECTAL HEMMORHAGE|29 JAN 2021|11:00|0|N|24 FEB 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1007|AE|5|0|0005|CANCER PAIN|12 JAN 2021|11:00|0|N|04 FEB 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1007|AE|6|0|0006|ALLERGY TO LATEX|21 JAN 2021|23:00|0|N|10 FEB 2021|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1007|AE|7|0|0007|WORSENED ANEMIA|13 FEB 2021|22:30|0|N|19 FEB 2021|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
016|016-1008|AE|1|0|0001|PULMONARY NODULES|22 SEP 2022|12:00|0|N|30 SEP 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1008|AE|2|0|0002|PAIN IN EXTREMITY L ANKLE|08 JUL 2022|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
016|016-1008|AE|3|0|0003|OVERWEIGHT|04 DEC 2022|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
016|016-1008|AE|4|0|0004|MYELODYSPLASTIC SYNDROME|03 MAY 2021|17:00|0|N|18 MAY 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
016|016-1008|AE|5|0|0005|PAIN IN EXTREMITY - BOTH HANDS|27 AUG 2021|09:15|0|N|27 AUG 2021|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1008|AE|6|0|0006|HYPERKALAEMIA|22 AUG 2021|12:00|0|N|06 SEP 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1009|AE|1|0|0001|PANCREATIC INSUFFICIENCY|03 AUG 2020|09:00|0|N|23 AUG 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
016|016-1009|AE|2|0|0002|OEDEMA - LEFT ARM|04 SEP 2020|08:00|0|N|26 SEP 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
016|016-1009|AE|3|0|0003|HYPOKALEMIA|15 SEP 2020|15:00|0|N|06 OCT 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
016|016-1009|AE|4|0|0004|INSOMNIA|18 SEP 2020|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
016|016-1009|AE|5|0|0005|HYPOKALEMIA|17 SEP 2020|13:00|0|N|20 SEP 2020|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
016|016-1009|AE|6|0|0006|HYPOTENSION - AGGRAVATED|24 AUG 2020|12:00|0|N|29 AUG 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1009|AE|7|0|0007|DRY EYE SYNDROME|18 AUG 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
016|016-1010|AE|1|0|0001|PROSTATE ABSCESS|30 JAN 2022|15:00|0|N|14 FEB 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
016|016-1010|AE|2|0|0002|PULMONARY NODULES|23 SEP 2022|08:15|0|N|24 SEP 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
016|016-1010|AE|3|0|0003|LEG PAIN|26 SEP 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
016|016-1010|AE|4|0|0004|RECTAL PAIN|25 SEP 2021|15:00|0|N|12 OCT 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
016|016-1010|AE|5|0|0005|HARD OF HEARING|13 DEC 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
016|016-1010|AE|6|0|0006|NEUTROPHIL COUNT DECREASED|03 APR 2022|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
016|016-1010|AE|7|0|0007|FLUID OVERLOAD|13 MAR 2021|10:00|0|N|04 APR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1010|AE|8|0|0008|RIGHT LEG SKIN RASH|19 APR 2022|12:00|0|N|25 APR 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
016|016-1010|AE|9|0|0009|BRUISING|14 AUG 2021|15:00|0|N|12 SEP 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
017|017-1001|AE|1|0|0001|MENOPAUSE|21 AUG 2020|12:00|0|N|01 SEP 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
017|017-1001|AE|2|0|0002|HEPATIC CYST|01 MAY 2020|08:15|0|N|27 MAY 2020|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
017|017-1001|AE|3|0|0003|HYPERURICEMIA|18 MAR 2022|10:00|0|N|26 MAR 2022|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
017|017-1002|AE|1|0|0001|NON CARDIAC CHEST PAIN|06 OCT 2021|07:30|0|N|29 OCT 2021|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
017|017-1002|AE|2|0|0002|LOCALIZED PRURITIS|28 MAR 2021|09:00|0|N|10 APR 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
017|017-1002|AE|3|0|0003|INVESTIGATIONS OTHER: MONOCYTES ELEVATED|19 JAN 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
017|017-1003|AE|1|0|0001|HYPOTENSION|22 FEB 2022|10:00|0|N|07 MAR 2022|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
017|017-1003|AE|2|0|0002|OEDEMA L EYE|19 JUL 2022|22:30|0|N|27 JUL 2022|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
017|017-1003|AE|3|0|0003|CHEST TIGHTNESS|21 AUG 2022|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
017|017-1003|AE|4|0|0004|HEARING IMPAIRMENT|02 MAR 2021|15:00|0|N|05 MAR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
017|017-1003|AE|5|0|0005|HYDRONEPHROSIS|30 AUG 2022|14:00|0|N|20 SEP 2022|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
017|017-1003|AE|6|0|0006|COUGH|30 SEP 2021|14:30|0|N|10 OCT 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
017|017-1004|AE|1|0|0001|MUSCLE PAIN|02 FEB 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
017|017-1004|AE|2|0|0002|PLATELETS COUNT DECREASED|25 MAR 2021|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
017|017-1004|AE|3|0|0003|NODULAR GOITER|28 MAR 2021|12:00|0|N|10 APR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
017|017-1004|AE|4|0|0004|CANCER-RELATED PAIN|25 JAN 2021|14:00|0|N|10 FEB 2021|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
017|017-1004|AE|5|0|0005|GGT INCREASED|24 FEB 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
017|017-1004|AE|6|0|0006|NON-CARDIAC CHEST PAIN|25 MAR 2021|14:00|0|N|30 MAR 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
017|017-1004|AE|7|0|0007|DRY EYE SYNDROME|15 JAN 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
017|017-1004|AE|8|0|0008|OTHER PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE|16 JAN 2021|08:15|0|N|28 JAN 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
018|018-1001|AE|1|0|0001|DEHYDRATION|06 SEP 2021|11:00|0|N|06 SEP 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1001|AE|10|0|0010|BILATERAL CATARACTS|01 MAY 2023|13:45|0|N|29 MAY 2023|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
018|018-1001|AE|11|0|0011|HEART FAILURE|01 JUN 2022|20:00|0|N|23 JUN 2022|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
018|018-1001|AE|2|0|0002|INR INCREASE|08 MAY 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
018|018-1001|AE|3|0|0003|SERUM CREATININE INCREASED|30 JAN 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
018|018-1001|AE|4|0|0004|ABODOMINAL PAIN|28 NOV 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
018|018-1001|AE|5|0|0005|B12 VITAMIN DEFICIENCY ANEMIA|25 FEB 2021|12:00|0|N|24 MAR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1001|AE|6|0|0006|TACHYCARDIA|04 JUN 2023|10:30|0|N|23 JUN 2023|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
018|018-1001|AE|7|0|0007|DYSGEUSIA|16 APR 2021|20:00|1|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
018|018-1001|AE|8|0|0008|HISTORY OF PROSTATE CANCER|19 MAR 2023|10:30|0|N|31 MAR 2023|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
018|018-1001|AE|9|0|0009|OEDEMA - LEFT ARM|17 NOV 2023|09:00|0|N|30 NOV 2023|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
018|018-1002|AE|1|0|0001|SENSORY NEURAL DEAFNESS ON RIGHT|29 OCT 2020|09:00|0|N|27 NOV 2020|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
018|018-1002|AE|10|0|0010|CHOLELITHIASIS|12 NOV 2020|09:00|0|N|09 DEC 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
018|018-1002|AE|2|0|0002|VITAMIN D DEFICIENCY|17 NOV 2020|09:30|0|N|23 NOV 2020|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
018|018-1002|AE|3|0|0003|PAIN|12 NOV 2020|10:00|0|N|28 NOV 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
018|018-1002|AE|4|0|0004|CYSTOCELE|28 OCT 2020|10:00|0|N|24 NOV 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1002|AE|5|0|0005|CYSTOCELE|30 OCT 2020|11:00|0|N|27 NOV 2020|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1002|AE|6|0|0006|PAIN IN EXTREMITY L ANKLE|17 NOV 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
018|018-1002|AE|7|0|0007|INTERMITTENT VOMITING|24 OCT 2020|12:00|0|N|21 NOV 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1002|AE|8|0|0008|NERVE ROOT INJURY – DUE TO LAMINECTOMY WITH BILATERAL MEDIAL FACETECTOMY|28 OCT 2020|14:30|0|N|10 NOV 2020|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
018|018-1002|AE|9|0|0009|TOOTH DISORDER|07 NOV 2020|16:00|0|N|30 NOV 2020|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
018|018-1003|AE|1|0|0001|TREMOR|30 APR 2022|11:00|0|N|10 MAY 2022|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1003|AE|2|0|0002|SECONDARY MALIGNANT NEOPLASM OF RIGHT LUNG|07 JUN 2023|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
018|018-1003|AE|3|0|0003|MIGRAINE (INTERMITTENT)|27 APR 2023|15:00|0|N|09 MAY 2023|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
018|018-1003|AE|4|0|0004|THROMBOSIS RIGHT ARM BASILIC VEIN|29 NOV 2021|08:45|0|N|18 DEC 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1003|AE|5|0|0005|MUSCLE PAIN|08 AUG 2023|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
018|018-1003|AE|6|0|0006|ANOREXIA|10 AUG 2021|11:00|0|N|16 AUG 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1003|AE|7|0|0007|TYPE 2 DIABETES MELLITUS|21 MAR 2021|10:30|0|N|03 APR 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
018|018-1003|AE|8|0|0008|BACK PAIN (INTERMITTENT)|10 DEC 2021|15:00|0|N|15 DEC 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1004|AE|1|0|0001|INTERMITTENT VOMITING|07 DEC 2020|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
018|018-1004|AE|2|0|0002|BICORNUATE UTERUS|08 JUL 2021|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
018|018-1004|AE|3|0|0003|PRURITUS|03 DEC 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
018|018-1004|AE|4|0|0004|HYPOCALCEMIA|15 JAN 2021|10:00|0|N|06 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1004|AE|5|0|0005|EDEMA EXTREMITIES (LEG)|12 DEC 2020|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
018|018-1004|AE|6|0|0006|HYPOMAGNESEMIA|06 OCT 2020|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
018|018-1004|AE|7|0|0007|HEMOLYTIC ANEMIA|03 JUL 2021|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
018|018-1005|AE|1|0|0001|CARDIAC TROPONIN T INCREASED|30 MAY 2021|13:00|0|N|22 JUN 2021|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
018|018-1005|AE|2|0|0002|HEMORRHOID PAIN|31 JUL 2022|14:30|0|N|24 AUG 2022|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
018|018-1006|AE|1|0|0001|HEADACHE - INTERMITTENT|14 JAN 2021|18:00|0|N|29 JAN 2021|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
018|018-1006|AE|2|0|0002|HYPO MAGNESIA|09 JAN 2021|12:00|0|N|17 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1006|AE|3|0|0003|MENOPAUSE|19 JAN 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
018|018-1006|AE|4|0|0004|HYPERPHOSPHATEMIA|15 JAN 2021|14:00|0|N|28 JAN 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
018|018-1006|AE|5|0|0005|PICC LINE SITE INFECTION|29 DEC 2020|15:00|0|N|06 JAN 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1006|AE|6|0|0006|ANAEMIA|21 NOV 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
018|018-1007|AE|1|0|0001|SECONDARY MALIGNANT NEOPLASM OF THE BONE|03 JUN 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
018|018-1007|AE|10|0|0010|POSTMENOPAUSAL|14 JAN 2021|22:30|0|N|08 FEB 2021|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
018|018-1007|AE|2|0|0002|SMALL UMBILICAL HERNIA|19 MAR 2022|08:15|0|N|16 APR 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
018|018-1007|AE|3|0|0003|DYSPNOEA|15 APR 2022|22:00|0|N|10 MAY 2022|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
018|018-1007|AE|4|0|0004|LUNG INFECTION (COMMUNITY ACQUIRED)|22 JUL 2021|13:45|0|N|06 AUG 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
018|018-1007|AE|5|0|0005|NON-CARDIA CHEST PAIN|02 FEB 2022|12:00|0|N|01 MAR 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1007|AE|6|0|0006|APPETITE CHANGE|01 SEP 2022|14:00|0|N|10 SEP 2022|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
018|018-1007|AE|7|0|0007|HAEMATOMA RIGHT OUTER THIGH|25 SEP 2022|15:00|0|N|17 OCT 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
018|018-1007|AE|8|0|0008|ENCEPHALOPATHY|10 AUG 2022|10:00|0|N|03 SEP 2022|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1007|AE|9|0|0009|HEPATIC HEMANGIOMA|05 MAR 2022|08:15|0|N|04 APR 2022|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
018|018-1008|AE|1|0|0001|ALKAINE PHOSPHATASE INCREASED|30 DEC 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
018|018-1008|AE|2|0|0002|WORSENED COAGULOPATHY|31 DEC 2020|09:15|0|N|14 JAN 2021|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1008|AE|3|0|0003|SUBCONJUNCTIVAL HAEMORRAGE|29 NOV 2020|09:30|0|N|13 DEC 2020|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
018|018-1008|AE|4|0|0004|ACTIVATED PARTIAL THROMBOPLASTIN TIME|27 NOV 2020|09:15|0|N|24 DEC 2020|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1009|AE|1|0|0001|LOCALIZED PRURITIS|03 JAN 2021|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
018|018-1009|AE|10|0|0010|FATTY LIVER DISEASE|08 MAR 2021|14:30|0|N|06 APR 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
018|018-1009|AE|2|0|0002|ESSENTIAL PRIMARY HYPERTENSION|21 MAR 2021|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
018|018-1009|AE|3|0|0003|OBSESSIVE COMPULSIVE DISORDER|28 APR 2021|12:00|0|N|04 MAY 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1009|AE|4|0|0004|POSTURAL DIZZINESS|05 APR 2021|13:00|0|N|01 MAY 2021|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
018|018-1009|AE|5|0|0005|PALPITATIONS|27 JAN 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
018|018-1009|AE|6|0|0006|HYDRONEPHROSIS|16 APR 2021|10:30|0|N|09 MAY 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
018|018-1009|AE|7|0|0007|ATTENTION DISTURBANCE|18 JAN 2021|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
018|018-1009|AE|8|0|0008|BENIGN  COLON  ADENOMA|20 FEB 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
018|018-1009|AE|9|0|0009|HYPOKALEMIA|17 JAN 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
018|018-1010|AE|1|0|0001|HICCUPS|30 DEC 2020|12:00|0|N|29 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
018|018-1010|AE|2|0|0002|RASH MACULO-PAPULAR|11 JUL 2021|09:00|0|N|29 JUL 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
018|018-1010|AE|3|0|0003|SUBDURAL HEMATOMA|29 MAY 2021|16:00|0|N|08 JUN 2021|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
018|018-1011|AE|1|0|0001|BLOOD LACTATE DEHYDROGENASE INCREASED|06 MAR 2021|08:00|0|N|06 MAR 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
018|018-1011|AE|2|0|0002|INFECTION: STAPH EPIDERMIS BACTEREMIA|20 MAR 2021|15:00|0|N|10 APR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
018|018-1011|AE|3|0|0003|ORAL MUCOSITIS|24 MAR 2021|14:30|0|N|22 APR 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
019|019-1001|AE|1|0|0001|MUSCLE PAIN|08 NOV 2021|22:30|0|N|25 NOV 2021|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
019|019-1001|AE|10|0|0010|HISTORY OF IRON DEFICIENCY|24 NOV 2020|10:00|0|N|26 NOV 2020|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
019|019-1001|AE|2|0|0002|PULMONARY NODULE|20 MAY 2022|22:00|0|N|28 MAY 2022|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
019|019-1001|AE|3|0|0003|HEARING IMPAIRMENT|12 MAR 2021|07:30|0|N|24 MAR 2021|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
019|019-1001|AE|4|0|0004|CARDIAC TROPONIN T INCREASED|30 OCT 2022|08:00|0|N|20 NOV 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
019|019-1001|AE|5|0|0005|OVERWEIGHT|25 OCT 2020|09:30|0|N|06 NOV 2020|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
019|019-1001|AE|6|0|0006|SIADH (SYNDROME OF INAPPROPRIATE ADH PRODUCTION)|03 AUG 2022|10:00|0|N|28 AUG 2022|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1001|AE|7|0|0007|BULLOUS DERMATITIS|20 JUN 2022|15:00|0|N|12 JUL 2022|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
019|019-1001|AE|8|0|0008|FLUID OVERLOAD|28 APR 2022|10:30|0|N|12 MAY 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
019|019-1001|AE|9|0|0009|GENERALIZED WEAKNESS|19 AUG 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
019|019-1002|AE|1|0|0001|DOUBLE RENAL CYST|08 OCT 2020|08:00|0|N|08 OCT 2020|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
019|019-1002|AE|2|0|0002|HYPERKALAEMIA|07 FEB 2021|22:30|0|N|08 MAR 2021|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
019|019-1002|AE|3|0|0003|LOW BACK PAIN|03 DEC 2020|08:00|0|N|09 DEC 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
019|019-1002|AE|4|0|0004|NON CARDIAC CHEST PAIN|07 DEC 2020|14:00|0|N|05 JAN 2021|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
019|019-1002|AE|5|0|0005|ANEMIA, UNSPECIFIED|08 DEC 2020|09:00|0|N|18 DEC 2020|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
019|019-1002|AE|6|0|0006|SKIN AND SUBCUTANEOUS TISSUE DISORDER - SUPERFICIAL BURN RIGHT FOREARM|27 OCT 2020|15:00|0|N|13 NOV 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
019|019-1002|AE|7|0|0007|SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, RED SWOLLEN AREA ON HAND|18 JAN 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
019|019-1003|AE|1|0|0001|GGT INCREASED (GAMMA-GLUTAMYL TRANSFERASE)|24 APR 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
019|019-1003|AE|2|0|0002|NEUTROPENIA|16 MAR 2023|12:00|0|N|26 MAR 2023|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1003|AE|3|0|0003|BLOOD LACTATE DEHYDROGENASE INCREASED|02 FEB 2021|08:45|0|N|16 FEB 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1003|AE|4|0|0004|DRY MOUTH|02 JAN 2021|08:00|0|N|14 JAN 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
019|019-1003|AE|5|0|0005|PERIPHERAL NEURITIS|01 MAR 2022|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
019|019-1003|AE|6|0|0006|MEMORY LOSS|03 JUN 2022|12:00|0|N|16 JUN 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1004|AE|1|0|0001|MUSCLE SPASM OF BACK|14 FEB 2021|11:00|0|N|03 MAR 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1005|AE|1|0|0001|DIABETES MELLITUS|06 AUG 2021|15:00|0|N|03 SEP 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
019|019-1005|AE|2|0|0002|FLATULENCE|05 OCT 2020|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
019|019-1005|AE|3|0|0003|NEUTROPENIA|26 AUG 2020|14:00|0|N|08 SEP 2020|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
019|019-1005|AE|4|0|0004|ANEMIA, UNSPECIFIED|21 JUN 2020|08:30|0|N|17 JUL 2020|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
019|019-1006|AE|1|0|0001|INTERMITTENT DYSURIA|08 MAY 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
019|019-1006|AE|10|0|0010|ELEVATED URIC ACID|06 APR 2021|11:00|0|N|04 MAY 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1006|AE|2|0|0002|INTERMITTENT HEADACHES|28 AUG 2021|12:15|0|N|11 SEP 2021|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
019|019-1006|AE|3|0|0003|HYPERTENSION|30 SEP 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
019|019-1006|AE|4|0|0004|ONYCHOMYCOSIS|31 JAN 2022|09:00|0|N|06 FEB 2022|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
019|019-1006|AE|5|0|0005|MELANOMA INSITU|07 FEB 2021|15:00|0|N|09 FEB 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1006|AE|6|0|0006|PANCREATIC INSUFFICIENCY|02 OCT 2021|08:00|0|N|05 OCT 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
019|019-1006|AE|7|0|0007|DRY EYES|27 DEC 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
019|019-1006|AE|8|0|0008|PERICARDIAL EFFUSION|24 SEP 2021|14:00|0|N|03 OCT 2021|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
019|019-1006|AE|9|0|0009|AST INCREASE|29 JUN 2021|08:00|0|N|24 JUL 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
019|019-1007|AE|1|0|0001|PAIN IN EXTREMITY - BOTH FEET|30 MAY 2022|20:00|0|N|28 JUN 2022|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1007|AE|2|0|0002|FATTY LIVER DISEASE|19 MAR 2021|15:00|0|N|02 APR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
019|019-1008|AE|1|0|0001|ALANINE AMINOTRANSFERASE INCREASED|15 NOV 2020|08:30|0|N|18 NOV 2020|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
019|019-1008|AE|2|0|0002|GASTRO OESOPHAGEAL REFLUX DISEASE|03 FEB 2023|15:00|0|N|20 FEB 2023|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
019|019-1008|AE|3|0|0003|INFECTIONS AND INFESTATIONS - OTHER: C. DIFFICILE|16 AUG 2020|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
019|019-1008|AE|4|0|0004|SKIN RASHES|25 DEC 2022|15:00|0|N|18 JAN 2023|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1008|AE|5|0|0005|ISCHEMIC HEART DISEASE|14 MAY 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
019|019-1008|AE|6|0|0006|INFECTIONS AND INFESTATIONS - OTHER: C. DIFFICILE|02 OCT 2021|09:00|0|N|01 NOV 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
019|019-1008|AE|7|0|0007|FLATULENCE|08 JAN 2023|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
019|019-1008|AE|8|0|0008|INFECTION: STAPH EPIDERMIS BACTEREMIA|04 JUL 2022|12:00|0|N|13 JUL 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1008|AE|9|0|0009|PROTEINURIA|28 NOV 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
019|019-1009|AE|1|0|0001|WEAKNESS|12 MAY 2022|08:00|0|N|18 MAY 2022|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
019|019-1009|AE|2|0|0002|SINUSITIS|15 JUL 2022|09:00|0|N|23 JUL 2022|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
019|019-1009|AE|3|0|0003|ALANINE AMINOTRANSFERASE INCREASED (ALT)|10 FEB 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
019|019-1009|AE|4|0|0004|PAIN INTERMITTENT (BMAT PROCEDURE)|14 MAR 2022|09:00|0|N|10 APR 2022|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
019|019-1009|AE|5|0|0005|MUCOSITIS - ORAL|19 AUG 2020|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
019|019-1009|AE|6|0|0006|ANTIPHOSPHOLIPID SYNDROME|26 APR 2020|10:00|0|N|08 MAY 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1009|AE|7|0|0007|HYPERTENSION (INTERMITTENT)|18 JUL 2021|11:00|0|N|05 AUG 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1009|AE|8|0|0008|ABNORMAL LEFT VENTRICULAR DIASTOLIC FILLING PATTERN (STAGE I DYSFUNCTION)|08 APR 2022|09:30|0|N|13 APR 2022|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
019|019-1009|AE|9|0|0009|LOWER BACK PAIN|07 MAR 2021|09:00|0|N|28 MAR 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
019|019-1010|AE|1|0|0001|DIABETES TYPE II|20 JUN 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
019|019-1010|AE|2|0|0002|OSTEOARTHRITIS|28 JAN 2021|08:45|0|N|19 FEB 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1010|AE|3|0|0003|SINUS TACHYCARDIA INTERMITTENT|12 APR 2021|09:00|0|N|01 MAY 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
019|019-1010|AE|4|0|0004|NOVEL CORONAVIRUS INFECTION|12 MAR 2021|15:00|0|N|05 APR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
019|019-1010|AE|5|0|0005|EDEMA EXTREMITIES (LEG)|18 MAY 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
019|019-1010|AE|6|0|0006|CONFUSION|27 FEB 2021|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
019|019-1011|AE|1|0|0001|BENIGN PROSTATIC HYPERTROPHY|16 JUL 2021|10:30|0|N|24 JUL 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
019|019-1011|AE|2|0|0002|PLATELET COUNT DECREASED|12 DEC 2020|09:30|0|N|30 DEC 2020|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
019|019-1011|AE|3|0|0003|NODULAR GOITER|23 JUN 2020|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
019|019-1011|AE|4|0|0004|OCASSIONAL HYPERTENSION|23 NOV 2021|16:00|0|N|14 DEC 2021|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
019|019-1011|AE|5|0|0005|SECONDARY MALIGNANT NEOPLASM OF THE LIVER|13 NOV 2020|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
019|019-1011|AE|6|0|0006|MUSCLE SPASMS|17 DEC 2021|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
019|019-1011|AE|7|0|0007|VITAMIN D DEFICIENCY|16 APR 2022|12:00|0|N|24 APR 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
019|019-1011|AE|8|0|0008|MUCOSITIS ORAL|20 DEC 2020|08:00|0|N|20 DEC 2020|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
019|019-1011|AE|9|0|0009|ALANINE AMINOTRANSFERASE INCREASED|06 FEB 2022|10:00|0|N|10 FEB 2022|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
020|020-1001|AE|1|0|0001|CERVICAL STENOSIS|07 DEC 2020|12:00|0|N|12 DEC 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
020|020-1001|AE|10|0|0010|APPENDICITIS|31 JAN 2021|15:00|0|N|04 FEB 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
020|020-1001|AE|11|0|0011|WEAKNESS|05 MAR 2021|08:00|0|N|14 MAR 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
020|020-1001|AE|2|0|0002|LYME DISEASE|17 SEP 2020|15:00|0|N|17 SEP 2020|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
020|020-1001|AE|3|0|0003|ORTHOSTATIC HYPOTENSION|07 OCT 2020|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
020|020-1001|AE|4|0|0004|SKIN SQUAMOUS CELL CARCINOMAS|02 FEB 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
020|020-1001|AE|5|0|0005|RESTLESS LEGS|12 MAY 2021|09:00|0|N|02 JUN 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
020|020-1001|AE|6|0|0006|RIGHT ABDOMINAL WALL SQUAMOUS CELL CARCINOMA|05 DEC 2020|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
020|020-1001|AE|7|0|0007|PLEURAL EFFUSIONS|20 DEC 2020|11:00|0|N|30 DEC 2020|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
020|020-1001|AE|8|0|0008|HYPOCALCEMIA|18 OCT 2020|14:00|0|N|05 NOV 2020|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
020|020-1001|AE|9|0|0009|DENTAL ABSCESS|04 MAY 2021|14:00|0|N|25 MAY 2021|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
020|020-1002|AE|1|0|0001|FALL|24 MAR 2021|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
020|020-1002|AE|10|0|0010|INTERMITTENT NAUSEA|28 OCT 2020|14:00|0|N|21 NOV 2020|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
020|020-1002|AE|2|0|0002|UTERINE CERVICAL CYST|20 SEP 2020|09:00|0|N|21 SEP 2020|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
020|020-1002|AE|3|0|0003|GGT INCREASED (GAMMA-GLUTAMYL TRANSFERASE)|16 JAN 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
020|020-1002|AE|4|0|0004|LEFT RADIAL ARTERIAL THROMBOSIS|13 SEP 2020|13:00|0|N|28 SEP 2020|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
020|020-1002|AE|5|0|0005|HYPERTENSION R/T CKD|10 SEP 2020|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
020|020-1002|AE|6|0|0006|ALANINE AMINOTRANSFERASE INCREASED|16 AUG 2020|09:00|0|N|21 AUG 2020|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
020|020-1002|AE|7|0|0007|UTERINE CERVICAL CYST|19 AUG 2020|09:00|0|N|13 SEP 2020|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
020|020-1002|AE|8|0|0008|OSTEOPOROSIS|06 OCT 2020|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
020|020-1002|AE|9|0|0009|HEADACHE|04 DEC 2020|12:00|0|N|15 DEC 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
020|020-1003|AE|1|0|0001|B12 VITAMIN DEFICIENCY ANEMIA|04 NOV 2020|11:00|0|N|04 NOV 2020|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
020|020-1003|AE|2|0|0002|STROKE|20 FEB 2021|12:00|0|N|08 MAR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
020|020-1003|AE|3|0|0003|HYPERTENSION R/T CKD|05 NOV 2020|10:30|0|N|28 NOV 2020|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
020|020-1003|AE|4|0|0004|WORSENED PLATELET COUNT DECREASED|17 FEB 2021|15:00|0|N|01 MAR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
020|020-1003|AE|5|0|0005|BILATERAL PLEURAL EFFUSIONS|02 FEB 2021|16:00|0|N|12 FEB 2021|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
020|020-1003|AE|6|0|0006|BOWEL IRREGULARITY|27 OCT 2020|15:00|0|N|22 NOV 2020|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
020|020-1004|AE|1|0|0001|OBSTRUCTIVE SLEEP APNEA|24 SEP 2020|11:00|0|N|28 SEP 2020|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
020|020-1004|AE|2|0|0002|IV CATHETER OCCLUSION|27 JUL 2021|08:00|0|N|08 AUG 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
020|020-1005|AE|1|0|0001|SECONDARY MALIGNANT NEOPLASM OF THE LIVER|13 APR 2022|09:00|0|N|04 MAY 2022|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
020|020-1005|AE|2|0|0002|THYROID NODULE|30 JAN 2022|09:00|0|N|26 FEB 2022|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
021|021-1001|AE|1|0|0001|HYSTEROMYOMA|09 FEB 2021|10:00|0|N|24 FEB 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
021|021-1001|AE|2|0|0002|MEMORY IMPAIRMENT|27 MAR 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
021|021-1001|AE|3|0|0003|AGITATION|09 MAR 2021|08:45|0|N|17 MAR 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
021|021-1001|AE|4|0|0004|RESPIRATORY FAILURE|21 JAN 2021|15:00|0|N|21 JAN 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
021|021-1001|AE|5|0|0005|HEADACHE|02 MAR 2021|12:00|0|N|07 MAR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
021|021-1001|AE|6|0|0006|INFECTION: STAPH EPIDERMIS BACTEREMIA|20 FEB 2021|09:30|0|N|01 MAR 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
021|021-1001|AE|7|0|0007|GAIT PROBLEM|08 FEB 2021|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
021|021-1001|AE|8|0|0008|NON CARDIAC CHEST PAIN|02 FEB 2021|14:00|0|N|20 FEB 2021|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
021|021-1002|AE|1|0|0001|INSOMNIA - INTERMITTENT|19 FEB 2022|08:45|0|N|08 MAR 2022|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
021|021-1002|AE|2|0|0002|WORSENING ANEMIA|09 JAN 2021|20:00|0|N|11 JAN 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
021|021-1002|AE|3|0|0003|LYME DISEASE|18 FEB 2021|13:00|0|N|05 MAR 2021|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
021|021-1003|AE|1|0|0001|SUBCLINICAL SEIZURES|23 APR 2022|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
021|021-1003|AE|2|0|0002|SKIN RASHES|27 MAR 2022|15:00|0|N|03 APR 2022|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
021|021-1003|AE|3|0|0003|INTERMITTENT CONSTIPATION|16 APR 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
021|021-1003|AE|4|0|0004|SEASONAL ALLERGIC RHINITIS|20 MAR 2021|12:00|0|N|03 APR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
021|021-1003|AE|5|0|0005|HIPS PAIN (INTERMITTENT)|05 FEB 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
021|021-1003|AE|6|0|0006|DIARRHOEA - INTERMITTENT|06 MAR 2021|23:00|0|N|09 MAR 2021|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
021|021-1003|AE|7|0|0007|HEPATIC HEMANGIOMA|18 JUN 2021|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
021|021-1003|AE|8|0|0008|MILD AORTIC REGURGITATION|02 SEP 2020|08:15|0|N|06 SEP 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
021|021-1004|AE|1|0|0001|GLAUCOMA|23 NOV 2020|08:00|0|N|22 DEC 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
021|021-1004|AE|10|0|0010|TROPONIN T INCREASED|05 DEC 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
021|021-1004|AE|2|0|0002|PROTEINURIA|20 FEB 2021|12:00|0|N|22 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
021|021-1004|AE|3|0|0003|INFECTIONS AND INFESTATIONS - OTHER: C. DIFFICILE|11 SEP 2020|10:30|0|N|23 SEP 2020|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
021|021-1004|AE|4|0|0004|GASTROESOPHAGEAL REFLUX DISEASE|05 MAR 2021|08:00|0|N|18 MAR 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
021|021-1004|AE|5|0|0005|MACROCRYTIC ANEMIA|30 JUL 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
021|021-1004|AE|6|0|0006|HEADACHE (INTERMITTENT)|03 MAR 2022|17:00|0|N|08 MAR 2022|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
021|021-1004|AE|7|0|0007|WORSENING COLITIS|26 JUN 2021|08:00|0|N|17 JUL 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
021|021-1004|AE|8|0|0008|BILATERAL CARPEL TUNNEL SYNDROME|18 FEB 2022|12:00|0|N|19 MAR 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
021|021-1004|AE|9|0|0009|BACK PAIN (INTERMITTENT)|15 SEP 2020|13:45|0|N|27 SEP 2020|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
021|021-1005|AE|1|0|0001|MELENA|12 FEB 2022|09:00|0|N|18 FEB 2022|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
021|021-1005|AE|2|0|0002|LETHARGY|27 JUN 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
021|021-1005|AE|3|0|0003|EDEMA: BILATERAL LOWER EXTREMITIES|29 MAR 2022|20:00|0|N|23 APR 2022|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
021|021-1005|AE|4|0|0004|CHRONIC PAIN: KNEE AND HIP|24 APR 2021|15:00|0|N|03 MAY 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
021|021-1005|AE|5|0|0005|DEGENERATIVE DISEASE OF THE CERVICAL SPINE|03 JAN 2021|09:30|0|N|07 JAN 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
021|021-1005|AE|6|0|0006|CHRONIC KNEE PAIN|03 FEB 2021|12:00|0|N|06 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
021|021-1005|AE|7|0|0007|BACK PAIN (INTERMITTENT)|09 OCT 2020|15:00|0|N|27 OCT 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
021|021-1005|AE|8|0|0008|BILATERAL PLEURAL EFFUSION|10 JUN 2021|08:15|0|N|21 JUN 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
021|021-1005|AE|9|0|0009|DEGENERATIVE CHANGES LUMBAR SPINE|05 OCT 2021|12:00|0|N|03 NOV 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
021|021-1006|AE|1|0|0001|ALKALINE PHOSPHATASE INCREASED|19 JUL 2021|15:00|0|N|24 JUL 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
021|021-1006|AE|2|0|0002|WORSENING CREATININE INCREASE|14 SEP 2020|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
021|021-1006|AE|3|0|0003|INSOMNIA - INTERMITTENT|03 APR 2021|09:00|0|N|19 APR 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
021|021-1006|AE|4|0|0004|CLOSTRIDIUM DIFFICILE INFECTION|16 DEC 2020|20:00|0|N|30 DEC 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
021|021-1006|AE|5|0|0005|B12 VITAMIN DEFICIENCY ANEMIA|30 JUL 2020|13:00|0|N|18 AUG 2020|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
021|021-1006|AE|6|0|0006|MELENA|17 OCT 2020|10:00|0|N|20 OCT 2020|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
021|021-1006|AE|7|0|0007|HYPOTENSION|19 MAY 2021|14:00|0|N|29 MAY 2021|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
022|022-1001|AE|1|0|0001|WHEEZING|08 SEP 2022|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
022|022-1001|AE|2|0|0002|DIVERTICULOSIS|12 OCT 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
022|022-1001|AE|3|0|0003|SUBCLINICAL SEIZURES|06 SEP 2021|09:00|0|N|09 SEP 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
022|022-1001|AE|4|0|0004|GASTROESOPHAGEAL REFLUX DISEASE|04 MAR 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
022|022-1001|AE|5|0|0005|THROMBOCYTOPENIA|24 SEP 2021|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
022|022-1001|AE|6|0|0006|ASPARTATE AMINOTRANSFERASE INCREASED|11 JAN 2022|08:00|0|N|30 JAN 2022|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
022|022-1001|AE|7|0|0007|LOWER BACK PAIN|30 MAY 2023|12:00|0|N|02 JUN 2023|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
022|022-1002|AE|1|0|0001|CHRONIC BACK PAIN|18 AUG 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
022|022-1002|AE|2|0|0002|RASH ON SKIN NEAR PICC SITE|28 APR 2023|10:00|0|N|24 MAY 2023|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
022|022-1002|AE|3|0|0003|WOUND INFECTION|31 MAR 2021|22:00|0|N|16 APR 2021|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
022|022-1002|AE|4|0|0004|DYSARTHRIA|28 FEB 2022|08:15|0|N|14 MAR 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
022|022-1002|AE|5|0|0005|BIPOLAR DISORDER|17 JUL 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
022|022-1002|AE|6|0|0006|ARTHRALGIAS (INTERMITTENT)|04 JAN 2023|11:00|0|N|12 JAN 2023|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
022|022-1002|AE|7|0|0007|HEMATOMA|17 NOV 2022|15:00|0|N|21 NOV 2022|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
022|022-1002|AE|8|0|0008|BULLOUS DERMATITIS|12 DEC 2022|09:30|0|N|18 DEC 2022|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
022|022-1003|AE|1|0|0001|INTESTINAL FLORA DYSREGULATION|18 OCT 2020|20:00|0|N|17 NOV 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
022|022-1004|AE|1|0|0001|DEFICIENCY OF VIT. D3|15 OCT 2022|15:00|0|N|21 OCT 2022|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
022|022-1004|AE|2|0|0002|WHITE BLOOD CELL DECREASED|15 DEC 2021|08:45|0|N|15 DEC 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
022|022-1005|AE|1|0|0001|POST-MENOPAUSE|26 DEC 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
022|022-1005|AE|2|0|0002|PERIPHERAL NEURITIS|12 FEB 2022|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
022|022-1005|AE|3|0|0003|ELEVATED CARDIAC TROPONIN T|23 AUG 2022|14:00|0|N|13 SEP 2022|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
022|022-1005|AE|4|0|0004|CPK INCREASED|09 APR 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
022|022-1005|AE|5|0|0005|HETEROZYGOUS FOR HAEMOCHROMATOSIS|29 JUL 2020|12:00|0|N|16 AUG 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
022|022-1006|AE|1|0|0001|HEMATURIA|19 JAN 2022|14:00|0|N|04 FEB 2022|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
022|022-1006|AE|2|0|0002|DIABETES MELLITUS|05 SEP 2021|14:00|0|N|15 SEP 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
022|022-1006|AE|3|0|0003|BLOOD LACTATE DEHYDROGENASE INCREASED|20 DEC 2022|08:00|0|N|06 JAN 2023|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
022|022-1007|AE|1|0|0001|PROLONGED PR INTERVAL|19 FEB 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
022|022-1007|AE|2|0|0002|BILATERAL CATARACT|18 FEB 2021|15:00|0|N|24 FEB 2021|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
022|022-1007|AE|3|0|0003|LEG TREMORS|15 FEB 2021|09:00|0|N|26 FEB 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
022|022-1007|AE|4|0|0004|B12 VITAMIN DEFICIENCY ANEMIA|17 FEB 2021|15:00|0|N|14 MAR 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
022|022-1007|AE|5|0|0005|RASH MACULOPAPULAR|20 FEB 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
022|022-1007|AE|6|0|0006|HYPERCHOLESTEROLEMIA|15 FEB 2021|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
022|022-1007|AE|7|0|0007|PULMONARY EMBOLISM|16 FEB 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
022|022-1008|AE|1|0|0001|TROPONIN T INCREASED|24 SEP 2020|14:00|0|N|12 OCT 2020|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
022|022-1008|AE|2|0|0002|SLOW TRANSIT CONSTIPATION|23 JUN 2021|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
022|022-1008|AE|3|0|0003|GGT INCREASED|29 JUL 2021|15:00|0|N|29 JUL 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
022|022-1008|AE|4|0|0004|INFECTIONS AND INFESTATIONS - OTHER: C. DIFFICILE|07 MAR 2021|10:00|0|N|01 APR 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
022|022-1008|AE|5|0|0005|SECONDARY MALIGNANT NEOPLASM OF RIGHT LUNG|05 NOV 2020|08:00|0|N|22 NOV 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
022|022-1008|AE|6|0|0006|BILATERAL SUBDURAL HEMATOMA|17 APR 2021|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
022|022-1008|AE|7|0|0007|OTHER PULMONARY EMBOLISM WITHOUT ACUTE COR PULMONALE|24 JUN 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
023|023-1001|AE|1|0|0001|HEMATOMA|08 SEP 2020|12:00|0|N|03 OCT 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
023|023-1001|AE|2|0|0002|PAROXYSMAL ATRIAL FIBRILLATION|16 SEP 2020|08:15|0|N|05 OCT 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
023|023-1001|AE|3|0|0003|INTERMITTENT HIP PAIN|28 JUL 2020|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
023|023-1001|AE|4|0|0004|LIGHT FATTY LIVER|12 SEP 2020|09:00|0|N|22 SEP 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
023|023-1001|AE|5|0|0005|DRY EYES|14 AUG 2020|08:00|0|N|29 AUG 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
023|023-1002|AE|1|0|0001|PLATELET COUNT DECREASED|10 SEP 2022|14:00|0|N|02 OCT 2022|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
023|023-1002|AE|10|0|0010|FEVER|29 MAY 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
023|023-1002|AE|11|0|0011|HYPERPHOSTATAEMIA|20 SEP 2021|14:30|0|N|06 OCT 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
023|023-1002|AE|2|0|0002|ANXIETY|19 APR 2022|09:00|0|N|24 APR 2022|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
023|023-1002|AE|3|0|0003|ASCITES|23 FEB 2021|12:00|0|N|20 MAR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
023|023-1002|AE|4|0|0004|INSOMNIA - INTERMITTENT|29 SEP 2020|20:00|0|N|01 OCT 2020|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
023|023-1002|AE|5|0|0005|HISTORY OF STROKE|21 NOV 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
023|023-1002|AE|6|0|0006|BENIGN  COLON  ADENOMA|19 JAN 2021|13:45|0|N|10 FEB 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
023|023-1002|AE|7|0|0007|RHABDOMYOLYSIS|10 MAY 2022|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
023|023-1002|AE|8|0|0008|INSOMNIA DUE TO MEDICAL CONDITION|08 DEC 2021|10:00|0|N|29 DEC 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
023|023-1002|AE|9|0|0009|RIGHT ABDOMINAL WALL SQUAMOUS CELL CARCINOMA|09 JAN 2021|12:15|0|N|13 JAN 2021|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
023|023-1003|AE|1|0|0001|MYELODYSPLASTIC SYNDROME|24 NOV 2021|14:00|0|N|02 DEC 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
023|023-1003|AE|2|0|0002|ALLERGY TO PENICILLIN G BENZATHINE|26 DEC 2021|08:30|0|N|18 JAN 2022|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
023|023-1003|AE|3|0|0003|URINARY TRACT INFECTION|23 APR 2022|12:00|0|N|29 APR 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
023|023-1003|AE|4|0|0004|VITREOUS DETACHMENT LEFT EYE|20 AUG 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
023|023-1003|AE|5|0|0005|NAUSEA INTERMITTENT|24 OCT 2021|09:30|0|N|18 NOV 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
023|023-1003|AE|6|0|0006|EYE DISORDERS OTHER: BLOOD IN CONJUNCTIVA R-OUTER|22 JAN 2022|15:00|0|N|24 JAN 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
023|023-1003|AE|7|0|0007|HYPOTENSION (INTERMITTENT)|21 MAR 2022|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
023|023-1004|AE|1|0|0001|HYPERURICAEMIA|21 JAN 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
023|023-1004|AE|2|0|0002|APPENDICITIS|18 FEB 2021|15:00|0|N|22 FEB 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
023|023-1004|AE|3|0|0003|EDEMA: BILATERAL LOWER EXTREMITIES|10 SEP 2022|20:00|0|N|24 SEP 2022|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
023|023-1004|AE|4|0|0004|ESOPHAGEAL SPASM|06 MAR 2021|14:00|0|N|29 MAR 2021|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
023|023-1004|AE|5|0|0005|GENERALIZED MUSCLE WEAKNESS|15 FEB 2021|15:00|0|N|27 FEB 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
023|023-1004|AE|6|0|0006|HEARING LOSS|15 MAY 2021|22:30|0|N|13 JUN 2021|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
023|023-1004|AE|7|0|0007|HEADACHE (INTERMITTENT)|13 JAN 2021|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
023|023-1004|AE|8|0|0008|ATRIAL FIBRILLATION|16 MAR 2022|10:30|0|N|21 MAR 2022|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
023|023-1005|AE|1|0|0001|HYPOALBUMINEMIA|27 JUL 2021|12:15|0|N|20 AUG 2021|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
023|023-1005|AE|2|0|0002|PERIANAL FISSURE|14 FEB 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
023|023-1005|AE|3|0|0003|CIPROFLOXACIN HYDROCHLORIDE ALLERGY|29 AUG 2021|14:00|0|N|12 SEP 2021|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
023|023-1005|AE|4|0|0004|POST-MENOPAUSE|03 AUG 2021|12:00|0|N|19 AUG 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
023|023-1005|AE|5|0|0005|NEUTROPHIL COUNT DECREASED|17 MAY 2021|17:00|0|N|25 MAY 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
023|023-1005|AE|6|0|0006|HYPOCALCEMIA|20 JUN 2021|14:30|0|N|02 JUL 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
023|023-1005|AE|7|0|0007|CONGESTIVE HEART FAILURE|14 MAR 2021|16:00|0|N|18 MAR 2021|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
023|023-1005|AE|8|0|0008|SERUM CREATININE INCREASED|14 JUN 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
023|023-1006|AE|1|0|0001|HYPERCHOLESTEROLAEMIA|20 MAR 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
023|023-1006|AE|10|0|0010|UTERINE CERVICAL CYST|07 JUN 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
023|023-1006|AE|2|0|0002|GOUT|19 DEC 2021|15:00|0|N|18 JAN 2022|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
023|023-1006|AE|3|0|0003|INTERMITTENT CONSTIPATION|18 MAR 2021|08:00|0|N|14 APR 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
023|023-1006|AE|4|0|0004|MALIGNANT NEOPLASM RELATED FATIGUE|10 MAY 2022|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
023|023-1006|AE|5|0|0005|PROSTATE ABSCESS|25 MAY 2022|09:00|0|N|18 JUN 2022|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
023|023-1006|AE|6|0|0006|HEADACHE (INTERMITTENT)|05 OCT 2020|12:00|0|N|26 OCT 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
023|023-1006|AE|7|0|0007|SECONDARY MALIGNANT NEOPLASM OF THE LIVER|08 DEC 2021|11:00|0|N|14 DEC 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
023|023-1006|AE|8|0|0008|LEG TREMORS|12 NOV 2020|22:30|0|N|23 NOV 2020|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
023|023-1006|AE|9|0|0009|OTOMYCOSIS LEFT|24 MAR 2021|09:00|0|N|23 APR 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
023|023-1007|AE|1|0|0001|ADJUSTMENT DISORDER WITH ANXIOUS MOOD|07 JUL 2021|12:00|0|N|14 JUL 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
023|023-1007|AE|10|0|0010|COUGH|17 JAN 2021|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
023|023-1007|AE|2|0|0002|HYPERTENSION|11 AUG 2022|09:00|0|N|17 AUG 2022|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
023|023-1007|AE|3|0|0003|MUSCLE SPASM OF BACK|26 JUN 2022|17:00|0|N|26 JUN 2022|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
023|023-1007|AE|4|0|0004|HYPERBILIRUBINEMIA|28 NOV 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
023|023-1007|AE|5|0|0005|PROSTATIC OBSTRUCTION|12 MAR 2022|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
023|023-1007|AE|6|0|0006|PERIPHERAL SENSORY NEUROPATHY|12 APR 2022|16:00|0|N|06 MAY 2022|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
023|023-1007|AE|7|0|0007|CERVICAL STENOSIS|27 AUG 2020|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
023|023-1007|AE|8|0|0008|INTERMITTENT STOMACH PAIN|20 MAR 2021|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
023|023-1007|AE|9|0|0009|PLEURAL EFFUSION|28 JAN 2022|08:00|0|N|03 FEB 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
023|023-1008|AE|1|0|0001|APPENDICITIS|24 OCT 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
023|023-1008|AE|2|0|0002|GASRITIS|22 NOV 2020|10:00|0|N|06 DEC 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
023|023-1008|AE|3|0|0003|AORTIC ARTERIOSCLEROSIS|09 JUN 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
023|023-1009|AE|1|0|0001|CORONARY DISEASE|13 NOV 2021|15:00|0|N|25 NOV 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
023|023-1009|AE|2|0|0002|MEMORY LOSS|20 MAY 2021|08:00|0|N|05 JUN 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
023|023-1010|AE|1|0|0001|SECONDARY MALIGNANT NEOPLASM OF THE LIVER|27 JAN 2021|11:00|0|N|10 FEB 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
023|023-1010|AE|2|0|0002|MUCOSITIS ORAL|07 AUG 2021|15:00|0|N|15 AUG 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
023|023-1010|AE|3|0|0003|RECTAL HEMMORHAGE|12 DEC 2021|09:00|0|N|25 DEC 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
023|023-1010|AE|4|0|0004|LARGE HIATAL HERNIA|24 JAN 2022|23:00|0|N|03 FEB 2022|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
023|023-1010|AE|5|0|0005|ALOPECIA|29 MAR 2021|22:30|0|N|01 APR 2021|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
023|023-1010|AE|6|0|0006|BLOOD LACTATEDEHYDROGENASE INCREASED|08 NOV 2021|11:00|0|N|06 DEC 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
024|024-1001|AE|1|0|0001|SORE THROAT|06 NOV 2021|10:30|0|N|02 DEC 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
024|024-1002|AE|1|0|0001|OEDEMA L EYE|13 OCT 2021|14:00|0|N|24 OCT 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
024|024-1002|AE|2|0|0002|HYPERKALEMIA|05 MAR 2021|13:45|0|N|27 MAR 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
024|024-1003|AE|1|0|0001|NASAL CONGESTION|02 AUG 2021|14:30|0|N|07 AUG 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
024|024-1003|AE|2|0|0002|LOCALIZED PRURITIS|24 OCT 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
024|024-1004|AE|1|0|0001|RESTLESS LEGS|03 JUL 2021|15:00|0|N|20 JUL 2021|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
024|024-1004|AE|2|0|0002|WORSENED ANEMIA|20 DEC 2020|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
024|024-1004|AE|3|0|0003|REDNESS OF EYELID|17 APR 2021|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
024|024-1004|AE|4|0|0004|GLAUCOMA (BOTH EYES)|08 MAY 2021|15:00|0|N|12 MAY 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
024|024-1004|AE|5|0|0005|BILATERAL PLEURAL EFFUSIONS|27 MAR 2021|23:00|0|N|03 APR 2021|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
024|024-1005|AE|1|0|0001|ANTIPHOSPHOLIPID SYNDROME|24 APR 2021|09:00|0|N|08 MAY 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
024|024-1005|AE|10|0|0010|SEASONAL ALLERGIES|25 FEB 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
024|024-1005|AE|2|0|0002|PERICARDIAL EFFUSION|24 JAN 2021|17:00|0|N|10 FEB 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
024|024-1005|AE|3|0|0003|HYPOCALCEMIA|24 FEB 2021|08:00|0|N|15 MAR 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
024|024-1005|AE|4|0|0004|HEMATURIA|29 OCT 2020|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
024|024-1005|AE|5|0|0005|CHEST TIGHTNESS|14 FEB 2021|15:00|0|N|10 MAR 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
024|024-1005|AE|6|0|0006|PULMONARY NODULES|25 JAN 2021|09:00|0|N|27 JAN 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
024|024-1005|AE|7|0|0007|ENDOMETRIAL CARCINOMA|10 APR 2021|08:15|0|N|16 APR 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
024|024-1005|AE|8|0|0008|OBSTRUCTIVE SLEEP APNOEA|08 MAR 2021|09:00|0|N|11 MAR 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
024|024-1005|AE|9|0|0009|HYPOALBUMINEMIA|14 FEB 2021|09:00|0|N|24 FEB 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
024|024-1006|AE|1|0|0001|HYPOALBUMINAEMIA|04 FEB 2021|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
024|024-1007|AE|1|0|0001|SKIN AND SUBCUTANEOUS TISSUE DISORDER - SUPERFICIAL BURN RIGHT FOREARM|18 MAY 2022|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
024|024-1007|AE|2|0|0002|NEUTROPENIA|14 APR 2021|09:00|0|N|08 MAY 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
024|024-1007|AE|3|0|0003|INSOMNIA DUE TO MEDICAL CONDITION|08 MAY 2022|12:00|0|N|09 MAY 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
024|024-1007|AE|4|0|0004|PETECHIAL RASH ON LOWER EXTREMITIES|26 OCT 2021|10:00|0|N|24 NOV 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
024|024-1007|AE|5|0|0005|WORSENING NEUTROPENIA|16 SEP 2021|11:00|0|N|12 OCT 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
024|024-1007|AE|6|0|0006|RHABDOMYOLYSIS|06 JUL 2022|12:00|0|N|16 JUL 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
025|025-1001|AE|1|0|0001|PROSTATE ABSCESS|22 DEC 2021|20:00|1|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
025|025-1001|AE|2|0|0002|MENOPAUSE|29 OCT 2022|15:00|0|N|28 NOV 2022|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
025|025-1001|AE|3|0|0003|HISTORY OF STROKE|15 SEP 2021|12:00|0|N|16 SEP 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
025|025-1001|AE|4|0|0004|RASH ON SKIN NEAR PICC SITE|15 FEB 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
025|025-1001|AE|5|0|0005|RASH MACULO-PAPULAR|18 OCT 2022|08:30|0|N|11 NOV 2022|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
025|025-1001|AE|6|0|0006|GASRITIS|07 SEP 2021|12:15|0|N|11 SEP 2021|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
025|025-1001|AE|7|0|0007|SKIN AND SUBCUTANEOUS TISSUE DISORDERS -LACERATION - THUMB|29 OCT 2021|08:00|0|N|14 NOV 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
025|025-1002|AE|1|0|0001|TYPE 2 DIABETES|14 JUL 2021|09:00|0|N|25 JUL 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
025|025-1002|AE|2|0|0002|PAIN OF SKIN - AZACITIDINE SITE|12 FEB 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
025|025-1002|AE|3|0|0003|SUBCLINICAL SEIZURES|26 JUL 2020|09:00|0|N|04 AUG 2020|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
025|025-1002|AE|4|0|0004|NEUROPATHIC PAIN|14 SEP 2021|08:00|0|N|19 SEP 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
025|025-1002|AE|5|0|0005|HYPERPIGMENTATION OF THE SKIN|28 MAY 2020|08:00|0|N|25 JUN 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
025|025-1002|AE|6|0|0006|AST INCREASE|15 AUG 2021|15:00|0|N|17 AUG 2021|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
025|025-1002|AE|7|0|0007|BONE MARROW HYPOCELLULAR|11 DEC 2020|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
025|025-1003|AE|1|0|0001|MUCOSITIS|04 DEC 2021|09:00|0|N|23 DEC 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
025|025-1003|AE|2|0|0002|PANCYTOPENIA|19 MAR 2021|11:00|0|N|25 MAR 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
025|025-1003|AE|3|0|0003|ASTHMA|12 APR 2022|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
025|025-1003|AE|4|0|0004|HYPERKALEMIA|10 OCT 2020|18:00|0|N|03 NOV 2020|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
025|025-1003|AE|5|0|0005|SKIN AND SUBCUTANEOUS TISSUE DISORDER - SUPERFICIAL BURN RIGHT FOREARM|11 JAN 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
025|025-1003|AE|6|0|0006|ASPARTATE AMINOTRANSFERASE INCREASED (AST)|31 JAN 2022|11:00|0|N|17 FEB 2022|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
025|025-1004|AE|1|0|0001|NUMBNESS OF LIMBS|02 JAN 2021|11:00|0|N|08 JAN 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
025|025-1004|AE|2|0|0002|CHEST TIGHTNESS|01 JAN 2021|08:00|0|N|23 JAN 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
025|025-1004|AE|3|0|0003|PERIPHERAL NEUROPATHY|02 JAN 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
025|025-1004|AE|4|0|0004|MACROCRYTIC ANEMIA|01 JAN 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
025|025-1004|AE|5|0|0005|ANEMIA|01 JAN 2021|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
025|025-1004|AE|6|0|0006|RASH ON SKIN NEAR PICC SITE|02 JAN 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
025|025-1005|AE|1|0|0001|PAIN IN EXTREMITY L ANKLE|13 NOV 2022|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
025|025-1005|AE|2|0|0002|MACROCRYTIC ANEMIA|25 DEC 2020|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
025|025-1005|AE|3|0|0003|OSTEOARTHRITIS|05 JUN 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
025|025-1005|AE|4|0|0004|ORAL MUCOSITIS|13 OCT 2020|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
025|025-1005|AE|5|0|0005|HYPERCHOLESTEROLEMIA|21 MAY 2023|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
025|025-1005|AE|6|0|0006|ABNORMAL LEFT VENTRICULAR DIASTOLIC FILLING PATTERN (STAGE I DYSFUNCTION)|28 NOV 2021|15:00|0|N|03 DEC 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
025|025-1005|AE|7|0|0007|ORAL THRUSH|12 JUL 2021|22:30|0|N|26 JUL 2021|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
025|025-1005|AE|8|0|0008|LIGHT FATTY LIVER|16 JAN 2023|17:00|0|N|23 JAN 2023|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
025|025-1005|AE|9|0|0009|WEAKNESS|02 JUN 2022|15:00|0|N|10 JUN 2022|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
025|025-1006|AE|1|0|0001|PAIN IN EXTREMITY|26 FEB 2023|15:00|0|N|23 MAR 2023|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
025|025-1006|AE|2|0|0002|ACUTE MEDIAL MENISCUS TEAR OF RIGHT KNEE|05 FEB 2022|17:00|0|N|24 FEB 2022|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
025|025-1006|AE|3|0|0003|LOCALIZED PRURITIS|31 JAN 2021|07:30|0|N|11 FEB 2021|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
025|025-1006|AE|4|0|0004|ALT INCREASED (INTERMITTENT)|17 APR 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
025|025-1006|AE|5|0|0005|EDEMA CAUSING PAIN: RIGHT LATERAL CHEST WALL|06 MAR 2021|08:30|0|N|27 MAR 2021|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
025|025-1006|AE|6|0|0006|GERD (GASTROESOPHAGEAL REFLUX DISEASE)|04 MAY 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
025|025-1006|AE|7|0|0007|HYPOALBUMINAEMIA|02 AUG 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
026|026-1001|AE|1|0|0001|LEFT RADIAL ARTERIAL THROMBOSIS|17 JUN 2021|12:00|0|N|27 JUN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
026|026-1001|AE|2|0|0002|VASCULITIS|18 SEP 2021|12:00|0|N|24 SEP 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
026|026-1001|AE|3|0|0003|METABOLIC ALKALOSIS|05 MAR 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
026|026-1002|AE|1|0|0001|SEASONAL ALLERGIC RHINITIS|17 JAN 2021|08:45|0|N|11 FEB 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
026|026-1002|AE|2|0|0002|HYPERURICAEMIA|01 AUG 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
026|026-1002|AE|3|0|0003|GASTROESOPHAGEAL REFLUX DISEASE|05 AUG 2022|16:00|0|N|08 AUG 2022|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
026|026-1002|AE|4|0|0004|ALANINE AMINOTRANSFERASE INCREASED (ALT)|24 MAR 2022|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
026|026-1002|AE|5|0|0005|ANOREXIA|08 JAN 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
026|026-1002|AE|6|0|0006|PLEURAL EFFUSIONS|20 JUN 2023|10:30|0|N|16 JUL 2023|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
026|026-1002|AE|7|0|0007|ODEMA, LOWER LIMBS|04 JUN 2023|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
026|026-1002|AE|8|0|0008|THROMBOSIS RIGHT ARM BASILIC VEIN|15 MAY 2021|10:30|0|N|10 JUN 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
026|026-1003|AE|1|0|0001|CANCER ASSOCIATED PAIN|06 MAR 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
026|026-1003|AE|2|0|0002|DYSPNOEA|22 MAR 2022|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
026|026-1003|AE|3|0|0003|VESICULITIS|30 OCT 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
026|026-1003|AE|4|0|0004|MUCOSITIS|16 NOV 2022|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
026|026-1003|AE|5|0|0005|BLOOD AND LYMPHATIC SYSTEM OTHER: POST TRANSPLANT BLOOD MISMATCH CAUSING INCREASED TRANSFUSION REACTIONS|27 MAR 2022|12:00|0|N|23 APR 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
026|026-1003|AE|6|0|0006|DIABETES MELLITUS|04 DEC 2020|20:00|1|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
026|026-1004|AE|1|0|0001|VITAMIN B DEFICIENCY|02 MAR 2021|09:00|0|N|30 MAR 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
026|026-1005|AE|1|0|0001|FIBRINOGEN ELEVATION|16 DEC 2020|10:30|0|N|30 DEC 2020|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
026|026-1005|AE|2|0|0002|AST INCREASE|21 JAN 2021|10:00|0|N|09 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
026|026-1005|AE|3|0|0003|DIABETES MELLITUS TYPE I|22 DEC 2022|22:30|0|N|05 JAN 2023|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
026|026-1005|AE|4|0|0004|RENAL INSUFFICIENCY|31 AUG 2022|12:00|0|N|13 SEP 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
026|026-1005|AE|5|0|0005|INFUSION RELATED REACTION|25 JUL 2021|08:00|0|N|26 JUL 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
026|026-1005|AE|6|0|0006|TACHYCARDIA|28 JUN 2021|08:15|0|N|11 JUL 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
026|026-1006|AE|1|0|0001|LAMINECTOMY|08 APR 2022|14:30|0|N|02 MAY 2022|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
026|026-1006|AE|2|0|0002|METABOLIC ALKALOSIS|06 NOV 2021|17:00|0|N|30 NOV 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
026|026-1006|AE|3|0|0003|LOCALISED OEDEMA - BONE MARROW ASPIRATE TREPHINE SITE, RIGHT POSTERIOR SUPERIOR ILIAC SPINE|09 JUL 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
026|026-1006|AE|4|0|0004|OVERWEIGHT|03 DEC 2020|08:00|0|N|02 JAN 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
026|026-1006|AE|5|0|0005|FATIGUE|19 MAY 2022|09:15|0|N|14 JUN 2022|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
026|026-1006|AE|6|0|0006|DRY EYES|26 NOV 2022|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
026|026-1007|AE|1|0|0001|PERICARDIAL EFFUSION|09 FEB 2021|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
026|026-1007|AE|2|0|0002|WORSENING NEUTROPENIA|29 APR 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
026|026-1007|AE|3|0|0003|GASTRO OESOPHAGEAL REFLUX DISEASE|13 DEC 2021|10:00|0|N|06 JAN 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
026|026-1007|AE|4|0|0004|LAMINECTOMY|25 SEP 2020|20:00|1|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
026|026-1007|AE|5|0|0005|GLUCOSURIA|03 NOV 2020|08:00|0|N|02 DEC 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
027|027-1001|AE|1|0|0001|HYPERTHYROIDISM|21 APR 2021|08:45|0|N|04 MAY 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
027|027-1001|AE|2|0|0002|PAIN IN EXTREMITY|25 JUL 2021|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
027|027-1001|AE|3|0|0003|POSTMENOPAUSAL|10 SEP 2021|08:00|0|N|01 OCT 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
027|027-1001|AE|4|0|0004|BLOOD AND LYMPHATIC SYSTEM OTHER: POST TRANSPLANT BLOOD MISMATCH CAUSING INCREASED TRANSFUSION REACTIONS|29 JAN 2022|11:00|0|N|30 JAN 2022|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
027|027-1001|AE|5|0|0005|HYPERTHYROIDISM|26 FEB 2022|16:00|0|N|03 MAR 2022|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
027|027-1001|AE|6|0|0006|TROPONIN T INCREASED|15 JAN 2023|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
027|027-1001|AE|7|0|0007|NASAL CONGESTION|15 FEB 2021|10:30|0|N|09 MAR 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
027|027-1002|AE|1|0|0001|ASCITES|20 MAR 2021|12:00|0|N|12 APR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
027|027-1003|AE|1|0|0001|HYPERBILIRUBINEMIA|03 AUG 2020|11:00|0|N|01 SEP 2020|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
027|027-1003|AE|2|0|0002|FOLLICULITIS|05 DEC 2020|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
027|027-1003|AE|3|0|0003|SINUS TACHYCARDIA INTERMITTENT|05 JUN 2021|14:00|0|N|30 JUN 2021|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
027|027-1003|AE|4|0|0004|HAND TREMORS|02 SEP 2021|09:00|0|N|17 SEP 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
027|027-1003|AE|5|0|0005|GGT INCREASED (GAMMA-GLUTAMYL TRANSFERASE)|18 DEC 2020|13:00|0|N|05 JAN 2021|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
027|027-1003|AE|6|0|0006|FATTY LIVER|08 FEB 2021|09:30|0|N|21 FEB 2021|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
027|027-1003|AE|7|0|0007|HEMATOMA|10 NOV 2021|09:30|0|N|22 NOV 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
027|027-1003|AE|8|0|0008|BLOOD LACTATE DEHYDROGENASE INCREASED|06 MAR 2021|10:00|0|N|09 MAR 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
027|027-1003|AE|9|0|0009|HYPERCHOLESTEROLEMIA|24 DEC 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
027|027-1004|AE|1|0|0001|TROPONIN T INCREASED|06 APR 2021|09:30|0|N|28 APR 2021|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
027|027-1004|AE|2|0|0002|ORTHOSTATIC HYPOTENSION|29 DEC 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
027|027-1004|AE|3|0|0003|REDNESS OF EYELID|29 MAR 2021|10:00|0|N|01 APR 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
027|027-1004|AE|4|0|0004|PLEURAL EFFUSION|12 MAR 2021|11:00|0|N|28 MAR 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
027|027-1004|AE|5|0|0005|VITAMIN B12 DEFICIENCY|17 APR 2021|15:00|0|N|21 APR 2021|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
027|027-1004|AE|6|0|0006|DEGENERATIVE CHANGES LUMBAR SPINE|19 MAR 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
027|027-1005|AE|1|0|0001|SCIATICA|11 AUG 2020|15:00|0|N|03 SEP 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
027|027-1005|AE|2|0|0002|HYPERCHOLESTEROEMIA|14 MAY 2021|08:45|0|N|15 MAY 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
027|027-1005|AE|3|0|0003|PROLONGED PR INTERVAL|10 DEC 2020|11:00|0|N|11 DEC 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
027|027-1006|AE|1|0|0001|GENERALIZED WEAKNESS|22 JAN 2022|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
027|027-1006|AE|10|0|0010|SINUS BRADYCARDIA INTERMITTENT|16 MAY 2021|09:00|0|N|03 JUN 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
027|027-1006|AE|11|0|0011|PICC LINE SITE PAIN|20 OCT 2021|20:00|0|N|19 NOV 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
027|027-1006|AE|2|0|0002|HYPERURICAEMIA|15 APR 2022|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
027|027-1006|AE|3|0|0003|ABDOMINAL PAIN|04 OCT 2021|16:00|0|N|03 NOV 2021|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
027|027-1006|AE|4|0|0004|PICC LINE SITE PAIN|17 MAR 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
027|027-1006|AE|5|0|0005|OCASSIONAL HYPERTENSION|16 MAY 2022|11:00|0|N|11 JUN 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
027|027-1006|AE|6|0|0006|HYPERGLYCEMIA|12 JUL 2021|09:30|0|N|15 JUL 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
027|027-1006|AE|7|0|0007|PARAINFLUENZA VIRUS-DETAILS UNKNOWN|06 DEC 2020|15:00|0|N|21 DEC 2020|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
027|027-1006|AE|8|0|0008|ALLERGY TO LATEX|11 AUG 2021|08:00|0|N|16 AUG 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
027|027-1006|AE|9|0|0009|TROPONIN T INCREASED|20 APR 2022|08:00|0|N|29 APR 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
028|028-1001|AE|1|0|0001|LEFT BUNDLE BRANCH BLOCK|09 APR 2021|08:00|0|N|24 APR 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
028|028-1001|AE|10|0|0010|LEUKOCYTOSIS|15 JAN 2021|22:00|0|N|09 FEB 2021|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
028|028-1001|AE|11|0|0011|PARAINFLUENZA VIRUS-DETAILS UNKNOWN|01 MAR 2021|15:00|0|N|22 MAR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
028|028-1001|AE|2|0|0002|WEIGHT LOSS|01 FEB 2021|09:00|0|N|21 FEB 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
028|028-1001|AE|3|0|0003|HIPS PAIN (INTERMITTENT)|25 APR 2021|12:00|0|N|14 MAY 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
028|028-1001|AE|4|0|0004|ALANINE AMINOTRANSFERASE INCREASED (ALT)|16 APR 2021|12:15|0|N|28 APR 2021|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
028|028-1001|AE|5|0|0005|CANCER-RELATED PAIN|13 NOV 2020|12:00|0|N|24 NOV 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
028|028-1001|AE|6|0|0006|OSTEOARTHRITIS OF LEFT HIP|09 DEC 2020|09:00|0|N|26 DEC 2020|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
028|028-1001|AE|7|0|0007|WEIGHT GAIN|30 MAR 2021|08:15|0|N|02 APR 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
028|028-1001|AE|8|0|0008|HEPATIC HEMANGIOMA|18 FEB 2021|14:30|0|N|25 FEB 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
028|028-1001|AE|9|0|0009|CALCULUS GALLBLADDER|22 MAR 2021|10:00|0|N|25 MAR 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
028|028-1002|AE|1|0|0001|NAUSEA INTERMITTENT|24 NOV 2021|17:00|0|N|13 DEC 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
028|028-1002|AE|2|0|0002|MILD GENERALIZED PETECHIAL RASH|21 NOV 2020|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
028|028-1002|AE|3|0|0003|HEMORRHOID PAIN|17 MAY 2021|11:00|0|N|27 MAY 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
028|028-1002|AE|4|0|0004|PALPITATIONS|08 NOV 2021|08:00|0|N|16 NOV 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
028|028-1002|AE|5|0|0005|WORSENING CREATININE INCREASE|06 MAR 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
028|028-1002|AE|6|0|0006|PETECHIAL RASH ON LOWER EXTREMITIES|06 JUN 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
028|028-1003|AE|1|0|0001|SECONDARY MALIGNANT NEOPLASM OF RIGHT LUNG|04 JAN 2023|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
028|028-1003|AE|2|0|0002|INVESTIGATIONS OTHER: MONOCYTES ELEVATED|17 APR 2023|12:00|0|N|18 APR 2023|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
028|028-1003|AE|3|0|0003|LEFT LOWER EXTREMITY DEEP VEIN THROMBOSIS|27 JUN 2022|07:30|0|N|25 JUL 2022|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
028|028-1003|AE|4|0|0004|GASRITIS|20 OCT 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
028|028-1003|AE|5|0|0005|NODULAR GOITER|25 FEB 2021|22:00|0|N|01 MAR 2021|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
028|028-1004|AE|1|0|0001|GGT INCREASED|24 OCT 2021|14:00|0|N|05 NOV 2021|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
028|028-1004|AE|10|0|0010|URINARY TRACT INFECTION|02 MAY 2021|09:00|0|N|09 MAY 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
028|028-1004|AE|2|0|0002|CPK INCREASED|17 OCT 2021|10:30|0|N|13 NOV 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
028|028-1004|AE|3|0|0003|DYSLIPIDEMIA|07 JUN 2021|11:00|0|N|04 JUL 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
028|028-1004|AE|4|0|0004|MAJOR DEPRESSION|07 OCT 2021|09:00|0|N|06 NOV 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
028|028-1004|AE|5|0|0005|GASTRO OESOPHAGEAL REFLUX DISEASE|01 APR 2021|09:00|0|N|05 APR 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
028|028-1004|AE|6|0|0006|NEUTROPENIC FEVER|05 MAR 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
028|028-1004|AE|7|0|0007|AGITATION|12 SEP 2021|12:00|0|N|29 SEP 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
028|028-1004|AE|8|0|0008|FALL|25 AUG 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
028|028-1004|AE|9|0|0009|GASRITIS|01 AUG 2021|18:00|0|N|29 AUG 2021|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
029|029-1001|AE|1|0|0001|BONE PAIN|28 SEP 2021|20:00|0|N|24 OCT 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
029|029-1001|AE|2|0|0002|AGITATION|21 AUG 2022|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
029|029-1001|AE|3|0|0003|HEPATIC HEMANGIOMA|06 MAY 2021|16:00|0|N|10 MAY 2021|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
029|029-1002|AE|1|0|0001|MYELODYSPLASTIC SYNDROME|28 JAN 2021|08:00|0|N|13 FEB 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
029|029-1002|AE|2|0|0002|STROKE|18 MAY 2022|10:00|0|N|26 MAY 2022|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
029|029-1002|AE|3|0|0003|NEUROPATHIC PAIN|08 DEC 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
029|029-1002|AE|4|0|0004|DYSPNEA ON EXERTION|08 OCT 2020|09:00|0|N|11 OCT 2020|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
029|029-1002|AE|5|0|0005|GASTRIC ULCER|18 JUL 2020|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
029|029-1002|AE|6|0|0006|HARD OF HEARING|15 JUN 2020|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
029|029-1002|AE|7|0|0007|NEUROPATHIC PAIN|24 OCT 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
029|029-1003|AE|1|0|0001|CREATININE INCREASED|07 NOV 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
029|029-1003|AE|2|0|0002|SEASONAL ALLERGIC RHINITIS|13 JUL 2021|09:30|0|N|14 JUL 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
029|029-1003|AE|3|0|0003|LEFT BUNDLE BRANCH BLOCK|17 JUN 2021|17:00|0|N|14 JUL 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
029|029-1004|AE|1|0|0001|LAMINECTOMY|13 MAY 2021|10:00|0|N|04 JUN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
029|029-1004|AE|10|0|0010|BLOOD LACTATEDEHYDROGENASE INCREASED|16 DEC 2021|10:00|0|N|08 JAN 2022|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
029|029-1004|AE|11|0|0011|DYSGEUSIA|20 FEB 2022|09:00|0|N|09 MAR 2022|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
029|029-1004|AE|2|0|0002|HYPOXIA|25 JUL 2021|20:00|0|N|28 JUL 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
029|029-1004|AE|3|0|0003|PROSTATIC OBSTRUCTION|13 MAY 2021|12:00|0|N|26 MAY 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
029|029-1004|AE|4|0|0004|GLUCOSURIA|11 MAR 2021|08:00|0|N|25 MAR 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
029|029-1004|AE|5|0|0005|HAEMATOMA RIGHT OUTER THIGH|01 OCT 2021|15:00|0|N|06 OCT 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
029|029-1004|AE|6|0|0006|THROMBOCYTOPENIA|30 JAN 2022|07:30|0|N|21 FEB 2022|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
029|029-1004|AE|7|0|0007|INTERMITTENT DIARRHOEA|27 OCT 2020|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
029|029-1004|AE|8|0|0008|SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, RED SWOLLEN AREA ON HAND|02 NOV 2020|15:00|0|N|04 NOV 2020|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
029|029-1004|AE|9|0|0009|LARGE HIATAL HERNIA|10 OCT 2021|10:00|0|N|05 NOV 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
029|029-1005|AE|1|0|0001|ALLERGY TO PENICILLIN G BENZATHINE|17 AUG 2021|08:00|0|N|15 SEP 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
029|029-1005|AE|2|0|0002|HEMATURIA|01 FEB 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
029|029-1005|AE|3|0|0003|PAROXYSMAL SHORTNESS OF BREATH|03 OCT 2021|11:00|0|N|04 OCT 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
029|029-1005|AE|4|0|0004|WORSENING NEUTROPENIA|19 OCT 2021|08:00|0|N|19 OCT 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
030|030-1001|AE|1|0|0001|DIARRHOEA - INTERMITTENT|04 DEC 2020|09:30|0|N|18 DEC 2020|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
030|030-1001|AE|2|0|0002|MUCOSITIS - ORAL|31 JAN 2023|15:00|0|N|01 MAR 2023|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
030|030-1001|AE|3|0|0003|SWELLING OF EYELID|04 MAY 2022|08:30|0|N|15 MAY 2022|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
030|030-1001|AE|4|0|0004|SINUSITIS|19 AUG 2022|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
030|030-1001|AE|5|0|0005|HYPERTHYROIDISM|20 JUN 2022|12:00|0|N|11 JUL 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
030|030-1001|AE|6|0|0006|ANOREXIA|01 DEC 2022|10:30|0|N|03 DEC 2022|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
030|030-1001|AE|7|0|0007|HYPERPHOSTATAEMIA|14 MAY 2021|15:00|0|N|31 MAY 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
030|030-1002|AE|1|0|0001|ORAL MUCOSITIS|23 APR 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
030|030-1002|AE|2|0|0002|DRY MOUTH|11 DEC 2021|09:00|0|N|06 JAN 2022|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
030|030-1002|AE|3|0|0003|HYPERCHOLESTEROEMIA|24 JAN 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
030|030-1003|AE|1|0|0001|WORSENING CREATININE INCREASE|20 FEB 2023|17:00|0|N|25 FEB 2023|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
030|030-1003|AE|2|0|0002|PAROXYSMAL ATRIAL FIBRILLATION|16 APR 2023|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
030|030-1004|AE|1|0|0001|GERD (GASTROESOPHAGEAL REFLUX DISEASE)|08 JUN 2022|11:00|0|N|08 JUL 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
030|030-1004|AE|2|0|0002|CHRONIC VIRAL HEPATITIS B|11 MAR 2023|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
030|030-1004|AE|3|0|0003|GOUTY TOPHI|27 JUL 2023|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
030|030-1005|AE|1|0|0001|ELEVATED CARDIAC TROPONIN T|09 JAN 2021|12:00|0|N|12 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
030|030-1005|AE|2|0|0002|ISCHEMIC HEART DISEASE|10 JAN 2021|08:00|0|N|18 JAN 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
030|030-1006|AE|1|0|0001|HARD OF HEARING|27 MAR 2020|11:00|0|N|31 MAR 2020|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
030|030-1006|AE|2|0|0002|RIGHT ABDOMINAL WALL SQUAMOUS CELL CARCINOMA|30 MAR 2020|11:00|0|N|30 MAR 2020|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
030|030-1006|AE|3|0|0003|EPISTAXIS (INTERMITTENT)|13 APR 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
030|030-1006|AE|4|0|0004|OSTEO ARTHRITIS|03 APR 2020|13:00|0|N|16 APR 2020|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
030|030-1006|AE|5|0|0005|DYSPNEA|03 APR 2020|08:00|0|N|01 MAY 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
030|030-1006|AE|6|0|0006|ABNORMAL LEFT VENTRICULAR DIASTOLIC FILLING PATTERN (STAGE I DYSFUNCTION)|11 APR 2020|12:15|0|N|22 APR 2020|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
030|030-1006|AE|7|0|0007|ACTIVATED PARTIAL THROMBOPLASTIN TIME|01 APR 2020|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
031|031-1001|AE|1|0|0001|HYPOMAGNESMIA|20 MAY 2021|11:00|0|N|09 JUN 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
031|031-1001|AE|2|0|0002|BACK PAIN|03 MAR 2021|15:00|0|N|11 MAR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
031|031-1001|AE|3|0|0003|WORSENING ANEMIA|10 JUN 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
031|031-1001|AE|4|0|0004|PERICARDIAL EFFUSION|28 DEC 2020|08:00|0|N|04 JAN 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
031|031-1001|AE|5|0|0005|NEUROPATHIC PAIN|06 APR 2021|11:00|0|N|05 MAY 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
031|031-1002|AE|1|0|0001|PULMONARY NODULES|24 FEB 2022|12:00|0|N|21 MAR 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
031|031-1002|AE|2|0|0002|CARDIAC TROPONIN INCREASED|07 JUN 2021|20:00|0|N|30 JUN 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
031|031-1002|AE|3|0|0003|PERICARDIAL EFFUSION|23 AUG 2022|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
031|031-1003|AE|1|0|0001|NASAL CONGESTION|11 FEB 2021|11:00|0|N|25 FEB 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
031|031-1003|AE|2|0|0002|HICCUPS|01 MAY 2021|15:00|0|N|27 MAY 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
031|031-1003|AE|3|0|0003|HYSTEROMYOMA|17 DEC 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
031|031-1003|AE|4|0|0004|CARDIAC TROPONIN T INCREASED|27 JAN 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
031|031-1004|AE|1|0|0001|PATHOLOGICAL FRACTURE T6 VERTEBRAL BODY|23 JAN 2021|11:00|0|N|17 FEB 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
031|031-1004|AE|2|0|0002|FATIGUE (INTERMITTENT)|01 MAY 2021|20:00|1|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
031|031-1004|AE|3|0|0003|LEG PAIN|23 DEC 2020|08:15|0|N|10 JAN 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
031|031-1004|AE|4|0|0004|WHITE BLOOD CELL DECREASED|09 DEC 2022|17:00|0|N|22 DEC 2022|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
031|031-1004|AE|5|0|0005|SCIATICA|07 FEB 2023|22:30|0|N|10 FEB 2023|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
031|031-1004|AE|6|0|0006|TONGUE HAEMATOMA|17 APR 2022|09:00|0|N|01 MAY 2022|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
031|031-1005|AE|1|0|0001|EPISTAXIS|15 FEB 2022|10:00|0|N|26 FEB 2022|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
031|031-1005|AE|2|0|0002|INTRAMEDULLARY LUCENCY AT L3|02 JUN 2022|11:00|0|N|05 JUN 2022|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
031|031-1005|AE|3|0|0003|TINNITUS|20 APR 2021|15:00|0|N|02 MAY 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
031|031-1006|AE|1|0|0001|COLITIS|23 AUG 2021|10:00|0|N|25 AUG 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
031|031-1006|AE|2|0|0002|BILATERAL SUBDURAL HEMATOMA|26 MAY 2021|11:00|0|N|30 MAY 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
031|031-1006|AE|3|0|0003|HAND TREMORS|05 AUG 2021|15:00|0|N|08 AUG 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
031|031-1006|AE|4|0|0004|HYPOTHYROIDISM|18 SEP 2021|12:00|0|N|18 SEP 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
032|032-1001|AE|1|0|0001|TONGUE HAEMATOMA|13 NOV 2020|12:15|0|N|11 DEC 2020|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
032|032-1001|AE|10|0|0010|MAJOR DEPRESSION|04 JAN 2021|10:00|0|N|06 JAN 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
032|032-1001|AE|2|0|0002|PAIN HAEMATOMA R OUTER THIGH|12 FEB 2021|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
032|032-1001|AE|3|0|0003|WOUND COMPLICATION - PERIANAL ABSCESS|17 DEC 2020|18:00|0|N|21 DEC 2020|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
032|032-1001|AE|4|0|0004|INTERMITTENT DIARRHOEA|16 SEP 2020|08:00|0|N|16 SEP 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
032|032-1001|AE|5|0|0005|OEDEMA L EYE|10 OCT 2020|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
032|032-1001|AE|6|0|0006|SKIN INFECTION (RIGHT LOWER LEG CELLULITIS)|07 JAN 2021|08:00|0|N|12 JAN 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
032|032-1001|AE|7|0|0007|CEREBRAL INFARCTION|10 AUG 2020|22:30|0|N|06 SEP 2020|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
032|032-1001|AE|8|0|0008|SWELLING OF EYELID|21 AUG 2020|10:00|0|N|08 SEP 2020|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
032|032-1001|AE|9|0|0009|HEPATIC STEATOSIS|15 NOV 2020|15:00|0|N|03 DEC 2020|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
032|032-1002|AE|1|0|0001|PLEURAL EFFUSIONS|09 OCT 2020|09:00|0|N|21 OCT 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
032|032-1002|AE|10|0|0010|DYSARTHRIA|05 SEP 2021|16:00|0|N|27 SEP 2021|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
032|032-1002|AE|11|0|0011|HYPOMAGNESMIA|27 SEP 2021|09:00|0|N|04 OCT 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
032|032-1002|AE|2|0|0002|SENSORY NEURAL DEAFNESS ON RIGHT|05 MAR 2022|08:00|0|N|14 MAR 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
032|032-1002|AE|3|0|0003|NATURAL MENOPAUSE|26 NOV 2021|13:45|0|N|25 DEC 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
032|032-1002|AE|4|0|0004|DENTAL ABSCESS|24 APR 2021|15:00|0|N|14 MAY 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
032|032-1002|AE|5|0|0005|TREMOR|13 OCT 2020|13:00|0|N|27 OCT 2020|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
032|032-1002|AE|6|0|0006|POSTURAL DIZZINESS|12 MAR 2022|10:00|0|N|05 APR 2022|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
032|032-1002|AE|7|0|0007|OEDEMA L ANKLE|09 FEB 2021|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
032|032-1002|AE|8|0|0008|HYPOMAGNESMIA|24 MAY 2021|12:00|0|N|25 MAY 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
032|032-1002|AE|9|0|0009|FUNGAL PNEUMONIA|29 OCT 2020|16:00|0|N|28 NOV 2020|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
032|032-1003|AE|1|0|0001|HYDRONEPHROSIS|24 APR 2022|12:00|0|N|16 MAY 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
032|032-1004|AE|1|0|0001|POST MENOPAUSE|04 FEB 2021|08:00|0|N|25 FEB 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
032|032-1004|AE|10|0|0010|HEMORRHOIDS|22 FEB 2022|08:00|0|N|09 MAR 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
032|032-1004|AE|2|0|0002|RECTAL HEMMORHAGE|12 OCT 2021|11:00|0|N|12 OCT 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
032|032-1004|AE|3|0|0003|INCREASED GLUTAMYLTRANSFERASE|07 AUG 2022|10:00|0|N|27 AUG 2022|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
032|032-1004|AE|4|0|0004|SENSORY NEURAL DEAFNESS ON RIGHT|12 MAY 2021|10:00|0|N|20 MAY 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
032|032-1004|AE|5|0|0005|CHRONIC KIDNEY DISEASE|01 JAN 2023|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
032|032-1004|AE|6|0|0006|HEARING LOSS|23 MAR 2022|16:00|0|N|08 APR 2022|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
032|032-1004|AE|7|0|0007|WORSENING CREATININE INCREASE|01 MAY 2023|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
032|032-1004|AE|8|0|0008|TACHYCARDIA|16 NOV 2020|11:00|0|N|17 NOV 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
032|032-1004|AE|9|0|0009|ALKAINE PHOSPHATASE INCREASED|20 JAN 2022|08:45|0|N|21 JAN 2022|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
032|032-1005|AE|1|0|0001|PAROTID MASS|08 NOV 2022|10:30|0|N|27 NOV 2022|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
032|032-1005|AE|2|0|0002|VOMITING|08 OCT 2021|09:00|0|N|10 OCT 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
032|032-1005|AE|3|0|0003|SYSTEMIC LUPUS ERYTHEMATOSUS|15 SEP 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
032|032-1005|AE|4|0|0004|GGT INCREASED|07 OCT 2022|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
032|032-1005|AE|5|0|0005|PULMONARY NODULE|22 FEB 2021|09:00|0|N|06 MAR 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
032|032-1005|AE|6|0|0006|ANEMIA, UNSPECIFIED|14 DEC 2022|16:00|0|N|04 JAN 2023|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
032|032-1006|AE|1|0|0001|TYPE II DIABETES|22 JUL 2020|12:00|0|N|12 AUG 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
032|032-1006|AE|2|0|0002|INTERMITTENT NAUSEA|27 NOV 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
032|032-1006|AE|3|0|0003|DIABETES MELLITUS TYPE I|18 APR 2021|20:00|0|N|16 MAY 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
032|032-1007|AE|1|0|0001|PAIN|06 APR 2021|15:00|0|N|11 APR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
032|032-1007|AE|10|0|0010|HICCUPS|26 DEC 2022|17:00|0|N|19 JAN 2023|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
032|032-1007|AE|11|0|0011|DEFICIENCY OF VIT. D3|15 MAR 2021|15:00|0|N|10 APR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
032|032-1007|AE|2|0|0002|INTERMITTENT DYSURIA|25 SEP 2021|12:00|0|N|18 OCT 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
032|032-1007|AE|3|0|0003|CHRONIC KIDNEY DISEASE|05 JUN 2022|14:00|0|N|22 JUN 2022|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
032|032-1007|AE|4|0|0004|HYPOXIA|21 SEP 2022|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
032|032-1007|AE|5|0|0005|CPK INCREASED|27 APR 2021|08:00|0|N|15 MAY 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
032|032-1007|AE|6|0|0006|OSTEOARTHRITIS|03 MAR 2022|15:00|0|N|07 MAR 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
032|032-1007|AE|7|0|0007|NON CARDIAC CHEST PAIN|12 APR 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
032|032-1007|AE|8|0|0008|DIPLOPIA|05 NOV 2022|14:00|0|N|18 NOV 2022|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
032|032-1007|AE|9|0|0009|OSTEOARTHRITIS HIPS|16 OCT 2022|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
033|033-1001|AE|1|0|0001|LOCALIZED PRURITIS|24 AUG 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
033|033-1001|AE|2|0|0002|FEBRILE NEUTROPENIA|24 AUG 2021|09:00|0|N|07 SEP 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
033|033-1001|AE|3|0|0003|FIBROMYALGIA|01 APR 2021|12:00|0|N|19 APR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
033|033-1001|AE|4|0|0004|INSOMNIA DUE TO MEDICAL CONDITION|07 OCT 2020|22:00|0|N|13 OCT 2020|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
033|033-1001|AE|5|0|0005|FUNGAL PNEUMONIA|15 AUG 2021|11:00|0|N|11 SEP 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
033|033-1001|AE|6|0|0006|EDEMA EXTREMITIES (LEG)|08 JUL 2020|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
033|033-1002|AE|1|0|0001|DIABETES INSIPIDUS|23 AUG 2022|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
033|033-1002|AE|2|0|0002|PROSTATIC OBSTRUCTION|01 JUN 2021|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
033|033-1002|AE|3|0|0003|CHRONIC HIP PAIN|25 MAR 2022|07:30|0|N|18 APR 2022|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
033|033-1002|AE|4|0|0004|HYPERTENSION R/T CKD|23 JAN 2021|11:00|0|N|01 FEB 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
033|033-1002|AE|5|0|0005|SYMPTOMATIC ANEMIA|07 JAN 2023|09:30|0|N|25 JAN 2023|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
033|033-1002|AE|6|0|0006|NON-PRURITIC RASH (LEFT CUBICAL FOSSA)|04 SEP 2022|12:00|0|N|21 SEP 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
033|033-1002|AE|7|0|0007|PARAINFLUENZA VIRUS-DETAILS UNKNOWN|27 JUL 2021|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
033|033-1002|AE|8|0|0008|GLAUCOMA (BOTH EYES)|08 MAR 2021|15:00|0|N|13 MAR 2021|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
033|033-1003|AE|1|0|0001|MUSCLE PAIN|28 FEB 2023|08:00|0|N|23 MAR 2023|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
033|033-1003|AE|2|0|0002|DEGENERATIVE DISEASE OF THE CERVICAL SPINE|08 APR 2023|12:00|0|N|29 APR 2023|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
033|033-1003|AE|3|0|0003|CYTOKINE RELEASE SYNDROME|11 MAR 2023|09:00|0|N|06 APR 2023|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
033|033-1003|AE|4|0|0004|PATHOLOGICAL FRACTURE T6 VERTEBRAL BODY|26 OCT 2022|14:30|0|N|05 NOV 2022|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
033|033-1004|AE|1|0|0001|ABNORMAL LEFT VENTRICULAR DIASTOLIC FILLING PATTERN (STAGE I DYSFUNCTION)|04 JAN 2021|12:00|0|N|25 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
033|033-1004|AE|2|0|0002|HYPERGLYCEMIA (INTERMITTENT)|05 FEB 2021|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
033|033-1004|AE|3|0|0003|EDEMA CAUSING PAIN: RIGHT LATERAL CHEST WALL|26 DEC 2020|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
033|033-1004|AE|4|0|0004|INSOMNIA|14 JAN 2021|12:00|0|N|30 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
033|033-1004|AE|5|0|0005|AGGRAVATED ANEMIA|26 JAN 2021|10:30|0|N|03 FEB 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
033|033-1004|AE|6|0|0006|HEMOLYTIC ANEMIA|22 JAN 2021|11:00|0|N|18 FEB 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
034|034-1001|AE|1|0|0001|DENTAL ABSCESS|05 AUG 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
034|034-1001|AE|10|0|0010|PULMONARY NODULE|07 DEC 2022|08:00|0|N|10 DEC 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
034|034-1001|AE|2|0|0002|RASH ON SKIN NEAR PICC SITE|27 DEC 2022|08:00|0|N|15 JAN 2023|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
034|034-1001|AE|3|0|0003|NAUSEA - INTERMITTENT|05 JUN 2021|08:00|0|N|24 JUN 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
034|034-1001|AE|4|0|0004|EYE DISORDERS OTHER: BLOOD IN CONJUNCTIVA R-OUTER|03 JAN 2021|15:00|0|N|11 JAN 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
034|034-1001|AE|5|0|0005|ANEMIA (INTERMITTENT)|24 JAN 2022|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
034|034-1001|AE|6|0|0006|SYMPTOMATIC ANEMIA|19 OCT 2021|14:30|0|N|06 NOV 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
034|034-1001|AE|7|0|0007|INTERMITTENT NAUSEA|10 SEP 2020|12:00|0|N|08 OCT 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
034|034-1001|AE|8|0|0008|BLOOD LACTATEDEHYDROGENASE INCREASED|15 NOV 2022|10:00|0|N|24 NOV 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
034|034-1001|AE|9|0|0009|MUCOSITIS - ORAL|22 JUN 2022|11:00|0|N|21 JUL 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
034|034-1002|AE|1|0|0001|WORSENING NEUTROPENIA|04 JUL 2020|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
034|034-1002|AE|10|0|0010|OVERWEIGHT|13 JUN 2020|09:30|0|N|05 JUL 2020|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
034|034-1002|AE|11|0|0011|GENERAL ACHES/PAIN|20 JUN 2020|08:00|0|N|04 JUL 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
034|034-1002|AE|2|0|0002|LEIOMYOSARCOMA|01 JUL 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
034|034-1002|AE|3|0|0003|DYSPNEA ON EXERTION|18 JUN 2020|09:30|0|N|02 JUL 2020|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
034|034-1002|AE|4|0|0004|NUMBNESS OF LIMBS|30 JUN 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
034|034-1002|AE|5|0|0005|SKIN RASHES|10 JUN 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
034|034-1002|AE|6|0|0006|SIADH (SYNDROME OF INAPPROPRIATE ADH PRODUCTION)|18 JUN 2020|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
034|034-1002|AE|7|0|0007|WORSENED COAGULOPATHY|12 JUN 2020|08:00|0|N|12 JUN 2020|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
034|034-1002|AE|8|0|0008|SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, RED SWOLLEN AREA ON HAND|16 JUN 2020|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
034|034-1002|AE|9|0|0009|FOLATE DEFICIENCY|28 JUN 2020|14:30|0|N|05 JUL 2020|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
034|034-1003|AE|1|0|0001|VESICULITIS|04 SEP 2021|09:00|0|N|02 OCT 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
034|034-1003|AE|2|0|0002|FUNGAL PNEUMONIA|11 DEC 2021|14:30|0|N|25 DEC 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
034|034-1003|AE|3|0|0003|MUCOSITIS ORAL|31 AUG 2022|10:30|0|N|04 SEP 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
034|034-1003|AE|4|0|0004|EMPYEMA|10 FEB 2023|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
034|034-1003|AE|5|0|0005|PROTEINURIA|17 JUN 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
034|034-1003|AE|6|0|0006|TRANSAMINITIS|18 MAR 2022|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
034|034-1004|AE|1|0|0001|ASPARTATE AMINOTRANSFERASE INCREASED|30 SEP 2020|10:00|0|N|05 OCT 2020|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
034|034-1004|AE|2|0|0002|TUMOR PAIN|07 NOV 2020|09:00|0|N|15 NOV 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
034|034-1004|AE|3|0|0003|OSTEOPENIA|12 JUL 2022|15:00|0|N|01 AUG 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
034|034-1005|AE|1|0|0001|TONGUE HAEMATOMA|06 AUG 2022|10:00|0|N|22 AUG 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
034|034-1005|AE|2|0|0002|STROKE|27 DEC 2021|09:00|0|N|13 JAN 2022|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
034|034-1006|AE|1|0|0001|FLATULENCE|20 JUL 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
034|034-1006|AE|2|0|0002|BLOOD LACTATE DEHYDROGENASE INCREASED|19 JUN 2022|09:00|0|N|26 JUN 2022|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
034|034-1006|AE|3|0|0003|BUTTOCK PAIN|24 SEP 2022|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
034|034-1006|AE|4|0|0004|CHRONIC PAIN: KNEE AND HIP|21 DEC 2022|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
034|034-1006|AE|5|0|0005|DIARRHOEA - INTERMITTENT|30 MAY 2022|12:00|0|N|26 JUN 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
034|034-1006|AE|6|0|0006|ANXIETY|20 DEC 2021|22:30|0|N|30 DEC 2021|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
034|034-1006|AE|7|0|0007|HERPES ZOSTER|02 NOV 2021|11:00|0|N|18 NOV 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
034|034-1006|AE|8|0|0008|ESSENTIAL PRIMARY HYPERTENSION|18 MAR 2021|15:00|0|N|19 MAR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
034|034-1006|AE|9|0|0009|ATTENTION DISTURBANCE|21 FEB 2022|14:00|0|N|27 FEB 2022|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
034|034-1007|AE|1|0|0001|BILATERAL PLEURAL EFFUSION|28 MAY 2021|15:00|0|N|18 JUN 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
034|034-1007|AE|10|0|0010|HYPOALBUMINAEMIA|16 APR 2021|11:00|0|N|17 APR 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
034|034-1007|AE|11|0|0011|ALKAINE PHOSPHATASE INCREASED|30 APR 2021|08:00|0|N|06 MAY 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
034|034-1007|AE|2|0|0002|ESOPHAGEAL SPASM|10 MAR 2021|15:00|0|N|13 MAR 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
034|034-1007|AE|3|0|0003|GLUCOSURIA|23 JUL 2021|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
034|034-1007|AE|4|0|0004|SKIN AND SUBCUTANEOUS TISSUE DISORDERS -LACERATION - THUMB|08 JUN 2021|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
034|034-1007|AE|5|0|0005|LUNG INFECTION (COMMUNITY ACQUIRED)|04 APR 2021|15:00|0|N|24 APR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
034|034-1007|AE|6|0|0006|LYMPHOCYTOPENIA|29 JUN 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
034|034-1007|AE|7|0|0007|HYPOTHYROIDISM|01 MAR 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
034|034-1007|AE|8|0|0008|MUCOSITIS|12 MAY 2021|14:30|0|N|06 JUN 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
034|034-1007|AE|9|0|0009|PAROXYSMAL ARTERIAL FIBRILLATION|01 JUL 2021|08:00|0|N|20 JUL 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
034|034-1008|AE|1|0|0001|HEMORRHOID PAIN|20 AUG 2022|15:00|0|N|17 SEP 2022|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
034|034-1008|AE|2|0|0002|NEUTROPENIC FEVER|28 OCT 2021|08:00|0|N|03 NOV 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
034|034-1008|AE|3|0|0003|BACK PAIN (INTERMITTENT)|22 JUL 2023|18:00|0|N|13 AUG 2023|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
034|034-1008|AE|4|0|0004|HEARING LOSS|02 OCT 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
034|034-1008|AE|5|0|0005|ATYPICAL PNEUMONIA|25 MAR 2021|12:00|0|N|09 APR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
034|034-1008|AE|6|0|0006|SICK SINUS SYNDROME|16 JUL 2023|16:00|0|N|03 AUG 2023|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
034|034-1009|AE|1|0|0001|EMPYEMA|17 OCT 2021|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
034|034-1009|AE|2|0|0002|MENOPAUSE|13 MAR 2022|08:00|0|N|08 APR 2022|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
034|034-1009|AE|3|0|0003|CARDIAC TROPONIN I INCREASED|17 OCT 2022|15:00|0|N|10 NOV 2022|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
034|034-1009|AE|4|0|0004|CEREBRAL INFARCTION|19 JUL 2021|09:00|0|N|03 AUG 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
034|034-1009|AE|5|0|0005|ENCEPHALOPATHY|24 DEC 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
034|034-1009|AE|6|0|0006|HYPOTENSION|23 MAY 2022|14:30|0|N|10 JUN 2022|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
035|035-1001|AE|1|0|0001|FIBRINOGEN DECREASED|21 FEB 2021|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
035|035-1001|AE|2|0|0002|AST INCREASE|23 AUG 2022|18:00|0|N|18 SEP 2022|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
035|035-1001|AE|3|0|0003|INSOMNIA|20 APR 2022|15:00|0|N|02 MAY 2022|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
035|035-1001|AE|4|0|0004|DIABETES MELLITUS TYPE I|30 APR 2022|20:00|0|N|28 MAY 2022|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
035|035-1001|AE|5|0|0005|PERIANAL ABSCESS|11 DEC 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
035|035-1001|AE|6|0|0006|TREMOR|23 JUL 2022|22:30|0|N|07 AUG 2022|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
035|035-1001|AE|7|0|0007|HYPOMAGNESMIA|02 NOV 2022|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
035|035-1001|AE|8|0|0008|PLEURAL EFFUSION|10 JAN 2023|15:00|0|N|02 FEB 2023|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
035|035-1002|AE|1|0|0001|MEMBRANOUS NEPHROPATHY|10 FEB 2021|16:00|0|N|08 MAR 2021|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
035|035-1002|AE|2|0|0002|GLUCOSURIA|03 FEB 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
035|035-1002|AE|3|0|0003|BREAST CANCER|20 SEP 2021|13:45|0|N|05 OCT 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
035|035-1002|AE|4|0|0004|OSTEOARTHRITIS|18 AUG 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
035|035-1003|AE|1|0|0001|ALANINE AMINOTRANSFERASE INCREASED|14 DEC 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
035|035-1003|AE|2|0|0002|DIABETES MELLITUS, TYPE 2|30 MAR 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
035|035-1003|AE|3|0|0003|RESTLESS LEGS|20 JAN 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
035|035-1003|AE|4|0|0004|INTERMITTENT CONSTIPATION|19 OCT 2021|15:00|0|N|19 OCT 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
035|035-1003|AE|5|0|0005|SKIN HYPERPIGMENTATION|15 APR 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
035|035-1003|AE|6|0|0006|FUNGAL PNEUMONIA|08 AUG 2021|14:00|0|N|02 SEP 2021|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
035|035-1003|AE|7|0|0007|TUMOR PAIN|07 MAY 2022|22:30|0|N|08 MAY 2022|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
035|035-1003|AE|8|0|0008|PROTRUSION OF INTERVERTEBRAL DISC|12 JAN 2022|09:30|0|N|26 JAN 2022|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
035|035-1003|AE|9|0|0009|CEREBRAL INFARCTION|15 JUL 2022|09:00|0|N|01 AUG 2022|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
035|035-1004|AE|1|0|0001|CHRONIC BACK PAIN|06 FEB 2022|22:30|0|N|04 MAR 2022|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
035|035-1004|AE|10|0|0010|ONYCHOMYCOSIS|10 MAY 2021|10:00|0|N|12 MAY 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
035|035-1004|AE|2|0|0002|SWELLING OF EYELID|14 DEC 2021|15:00|0|N|28 DEC 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
035|035-1004|AE|3|0|0003|CONSTIPATION|19 AUG 2021|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
035|035-1004|AE|4|0|0004|ALLERGIC DERMATITIS|16 APR 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
035|035-1004|AE|5|0|0005|INSOMNIA DUE TO MEDICAL CONDITION|17 MAY 2022|20:00|0|N|28 MAY 2022|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
035|035-1004|AE|6|0|0006|PLEURAL EFFUSION|07 OCT 2021|20:00|0|N|26 OCT 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
035|035-1004|AE|7|0|0007|EMPYEMA|03 OCT 2021|15:00|0|N|17 OCT 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
035|035-1004|AE|8|0|0008|BLOOD BILIRUBIN INCREASED|20 JUL 2022|10:00|0|N|22 JUL 2022|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
035|035-1004|AE|9|0|0009|BLOOD LACTATEDEHYDROGENASE INCREASED|13 MAR 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
035|035-1005|AE|1|0|0001|EPISTAXIS|05 JAN 2021|07:30|0|N|23 JAN 2021|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
035|035-1005|AE|2|0|0002|HETEROZYGOUS FOR HAEMOCHROMATOSIS|10 JAN 2021|09:00|0|N|04 FEB 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
035|035-1005|AE|3|0|0003|BILATERAL SUBDURAL HEMATOMA|19 NOV 2020|14:00|0|N|08 DEC 2020|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
035|035-1005|AE|4|0|0004|MENOPAUSE|14 JAN 2021|15:00|0|N|27 JAN 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
035|035-1005|AE|5|0|0005|ODEMA, LOWER LIMBS|31 DEC 2020|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
035|035-1005|AE|6|0|0006|PERIPHERAL NEUROPATHY|21 JAN 2021|15:00|0|N|19 FEB 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
035|035-1005|AE|7|0|0007|SUBCLINICAL SEIZURES|25 DEC 2020|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
035|035-1006|AE|1|0|0001|SKIN AND SUBCUTANEOUS TISSUE DISORDER - SUPERFICIAL BURN RIGHT FOREARM|14 MAR 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
035|035-1006|AE|2|0|0002|MALIGNANT NEOPLASM RELATED FATIGUE|03 FEB 2021|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
036|036-1001|AE|1|0|0001|PERIPHERAL SENSORY NEUROPATHY|05 DEC 2022|22:00|0|N|17 DEC 2022|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
036|036-1001|AE|2|0|0002|WHEEZING|25 APR 2022|07:30|0|N|23 MAY 2022|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
036|036-1001|AE|3|0|0003|RIGHT UPPER EXTREMITY LYMPHEDEMA|08 AUG 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
036|036-1001|AE|4|0|0004|RESTLESS LEGS|30 MAY 2022|08:15|0|N|07 JUN 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
036|036-1001|AE|5|0|0005|ADJUSTMENT DISORDER WITH ANXIOUS MOOD|01 APR 2022|12:00|0|N|15 APR 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
036|036-1002|AE|1|0|0001|DIABETES MELLITUS TYPE I|28 DEC 2020|12:00|0|N|06 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
036|036-1003|AE|1|0|0001|INTERMITTENT DIARRHOEA|17 JAN 2022|11:00|0|N|04 FEB 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
036|036-1004|AE|1|0|0001|BLOOD BILIRUBIN INCREASED|10 JUN 2022|22:30|0|N|17 JUN 2022|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
036|036-1004|AE|2|0|0002|ATYPICAL PNEUMONIA|01 FEB 2021|11:00|0|N|18 FEB 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
036|036-1004|AE|3|0|0003|SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, RED SWOLLEN AREA ON HAND|13 SEP 2023|12:00|0|N|03 OCT 2023|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
036|036-1004|AE|4|0|0004|MELENA|29 JUL 2022|20:00|1|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
036|036-1004|AE|5|0|0005|FOLATE DEFICIENCY|03 NOV 2022|09:30|0|N|11 NOV 2022|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
036|036-1004|AE|6|0|0006|PARAINFLUENZA VIRUS-DETAILS UNKNOWN|27 MAY 2022|14:00|0|N|26 JUN 2022|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
036|036-1004|AE|7|0|0007|INR INCREASE|19 JUL 2020|15:00|0|N|12 AUG 2020|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
036|036-1004|AE|8|0|0008|DIABETES MELLITUS TYPE I|09 JUL 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
037|037-1001|AE|1|0|0001|CHOLELITHIASIS|15 NOV 2020|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
037|037-1001|AE|2|0|0002|ERECTILE DYSFUNCTION|17 AUG 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
037|037-1001|AE|3|0|0003|ABDOMINAL PAIN|26 JUL 2021|13:45|0|N|16 AUG 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
037|037-1001|AE|4|0|0004|BIPOLAR DISORDER|14 MAY 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
037|037-1001|AE|5|0|0005|SUBDURAL HEMATOMA|20 MAY 2021|09:00|0|N|30 MAY 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
037|037-1001|AE|6|0|0006|WORSENING ANEMIA|15 AUG 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
037|037-1001|AE|7|0|0007|PRURITUS|05 MAY 2021|16:00|0|N|14 MAY 2021|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
037|037-1001|AE|8|0|0008|PLATELETS COUNT DECREASED|17 JUL 2021|09:30|0|N|08 AUG 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
037|037-1001|AE|9|0|0009|TYPE 2 DIABETES MELLITUS|04 SEP 2020|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
037|037-1002|AE|1|0|0001|OTOMYCOSIS LEFT|06 AUG 2020|12:00|0|N|03 SEP 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
037|037-1002|AE|10|0|0010|MENOPAUSE|18 AUG 2020|08:00|0|N|29 AUG 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
037|037-1002|AE|11|0|0011|RIGHT ABDOMINAL WALL SQUAMOUS CELL CARCINOMA|07 AUG 2020|11:00|0|N|23 AUG 2020|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
037|037-1002|AE|2|0|0002|PULMONARY NODULES|02 SEP 2020|07:30|0|N|10 SEP 2020|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
037|037-1002|AE|3|0|0003|MENOPAUSE|27 AUG 2020|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
037|037-1002|AE|4|0|0004|NODULAR GOITER|29 AUG 2020|09:00|0|N|12 SEP 2020|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
037|037-1002|AE|5|0|0005|ALKALINE PHOSPHATASE INCREASED|23 AUG 2020|09:00|0|N|14 SEP 2020|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
037|037-1002|AE|6|0|0006|LOCALISED OEDEMA - BONE MARROW ASPIRATE TREPHINE SITE, RIGHT POSTERIOR SUPERIOR ILIAC SPINE|09 AUG 2020|14:00|0|N|04 SEP 2020|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
037|037-1002|AE|7|0|0007|SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, RED SWOLLEN AREA ON HAND|26 AUG 2020|16:00|0|N|19 SEP 2020|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
037|037-1002|AE|8|0|0008|INTERMITTENT STOMACH PAIN|30 AUG 2020|11:00|0|N|09 SEP 2020|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
037|037-1002|AE|9|0|0009|HYPERKALAEMIA|26 AUG 2020|15:00|0|N|31 AUG 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
037|037-1003|AE|1|0|0001|MILD AORTIC REGURGITATION|02 DEC 2020|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
037|037-1003|AE|2|0|0002|URINARY TRACT INFECTION|24 NOV 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
037|037-1003|AE|3|0|0003|ALLERGIC REACTION|21 NOV 2020|15:00|0|N|23 NOV 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
037|037-1003|AE|4|0|0004|OEDEMA LIMBS - LEFT LEG|04 DEC 2020|15:00|0|N|15 DEC 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
037|037-1003|AE|5|0|0005|ASCITES|04 DEC 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
037|037-1004|AE|1|0|0001|PERIPHERAL VASCULAR DISEASE|12 AUG 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
037|037-1004|AE|10|0|0010|HYPERLIPIDEMIA|11 FEB 2023|12:00|0|N|06 MAR 2023|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
037|037-1004|AE|2|0|0002|ELEVATED CARDIAC TROPONIN T|20 SEP 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
037|037-1004|AE|3|0|0003|SEASONAL ALLERGIES|17 APR 2021|08:00|0|N|29 APR 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
037|037-1004|AE|4|0|0004|MEMBRANOUS NEPHROPATHY|19 NOV 2020|22:30|0|N|25 NOV 2020|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
037|037-1004|AE|5|0|0005|ORAL MUCOSITIS|29 JAN 2022|22:00|0|N|15 FEB 2022|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
037|037-1004|AE|6|0|0006|HYPERTHYROIDISM|13 FEB 2023|08:00|0|N|14 MAR 2023|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
037|037-1004|AE|7|0|0007|HYPERTHYROIDISM|02 FEB 2021|09:00|0|N|01 MAR 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
037|037-1004|AE|8|0|0008|ENCEPHALOPATHY|11 JAN 2022|23:00|0|N|11 JAN 2022|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
037|037-1004|AE|9|0|0009|AGITATION|06 DEC 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
037|037-1005|AE|1|0|0001|ORAL THRUSH|29 SEP 2020|10:00|0|N|10 OCT 2020|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
037|037-1005|AE|2|0|0002|EDEMA CAUSING PAIN: RIGHT LATERAL CHEST WALL|08 JUN 2021|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
037|037-1005|AE|3|0|0003|LYMPHOCYTOPENIA|04 APR 2021|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
037|037-1005|AE|4|0|0004|FATIGUE|08 OCT 2020|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
037|037-1005|AE|5|0|0005|ASTHMA|26 FEB 2021|14:00|0|N|27 FEB 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
037|037-1005|AE|6|0|0006|SUBDURAL HEMATOMA|09 DEC 2020|08:00|0|N|19 DEC 2020|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
037|037-1006|AE|1|0|0001|IMPACTED CERUMEN OF RIGHT EAR|28 JUN 2021|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
037|037-1006|AE|2|0|0002|UMBILICAL HERNIA|22 JUN 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
037|037-1006|AE|3|0|0003|SKIN AND SUBCUTANEOUS TISSUE DISORDERS - OTHER, RED SWOLLEN AREA ON HAND|19 NOV 2021|17:00|0|N|13 DEC 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
037|037-1006|AE|4|0|0004|DYSPNOEA|23 JAN 2022|09:30|0|N|19 FEB 2022|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
037|037-1006|AE|5|0|0005|HYPERURICEMIA|02 JAN 2023|12:00|0|N|22 JAN 2023|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
037|037-1006|AE|6|0|0006|RASH MACULOPAPULAR|02 AUG 2022|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
037|037-1006|AE|7|0|0007|OSTEOARTHRITIS HIPS|12 DEC 2021|22:30|0|N|31 DEC 2021|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
037|037-1006|AE|8|0|0008|HYPERTHYROIDISM|31 JAN 2023|10:30|0|N|24 FEB 2023|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
037|037-1007|AE|1|0|0001|INTERMITTENT HEADACHES|19 JAN 2021|09:00|0|N|30 JAN 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
037|037-1007|AE|10|0|0010|OSTEOARTHRITIS|27 DEC 2021|09:00|0|N|15 JAN 2022|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
037|037-1007|AE|11|0|0011|HYPERPHOSPHATEMIA|21 APR 2021|09:30|0|N|21 MAY 2021|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
037|037-1007|AE|2|0|0002|CYSTOCELE|25 APR 2022|08:00|0|N|08 MAY 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE REDUCED|N|1|Patient received additional hydration.|N|N|N|N
037|037-1007|AE|3|0|0003|NON-CARDIA CHEST PAIN|01 APR 2021|08:00|0|N|28 APR 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
037|037-1007|AE|4|0|0004|MYOCARDIAL INFARCTION|01 DEC 2020|11:00|0|N|15 DEC 2020|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
037|037-1007|AE|5|0|0005|BLOOD AND LYMPHATIC SYSTEM OTHER: POST TRANSPLANT BLOOD MISMATCH CAUSING INCREASED TRANSFUSION REACTIONS|19 JAN 2021|10:00|0|N|30 JAN 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
037|037-1007|AE|6|0|0006|AST INCREASED (INTERMITTENT)|03 JUN 2020|15:00|0|N|17 JUN 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
037|037-1007|AE|7|0|0007|TROPONIN T INCREASED|27 SEP 2020|15:00|0|N|22 OCT 2020|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
037|037-1007|AE|8|0|0008|SYMPTOMATIC ANEMIA|07 OCT 2020|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
037|037-1007|AE|9|0|0009|DEFICIENCY OF VIT. D3|26 MAY 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
038|038-1001|AE|1|0|0001|MINI CEREBROVASCULAR ACCIDENT|29 AUG 2022|17:00|0|N|23 SEP 2022|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
038|038-1002|AE|1|0|0001|DRY EYE SYNDROME|06 APR 2021|08:00|0|N|02 MAY 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
038|038-1002|AE|2|0|0002|LEIOMYOSARCOMA|05 SEP 2021|07:30|0|N|16 SEP 2021|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
038|038-1003|AE|1|0|0001|PERIANAL FISSURE|02 JUN 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
038|038-1003|AE|2|0|0002|TOOTH DISORDER|26 SEP 2021|17:00|0|N|19 OCT 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
038|038-1003|AE|3|0|0003|CANCER-RELATED PAIN|11 OCT 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
038|038-1004|AE|1|0|0001|POST-MENOPAUSE|24 NOV 2022|12:00|0|N|02 DEC 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
038|038-1004|AE|2|0|0002|CIPROFLOXACIN HYDROCHLORIDE ALLERGY|20 AUG 2022|11:00|0|N|29 AUG 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
038|038-1004|AE|3|0|0003|PALPITATIONS|23 JAN 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
038|038-1004|AE|4|0|0004|WORSENING HYPERGLYCEMIA|24 MAR 2021|12:15|0|N|31 MAR 2021|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
038|038-1004|AE|5|0|0005|PROTRUSION OF INTERVERTEBRAL DISC|02 APR 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
038|038-1004|AE|6|0|0006|HETEROZYGOUS FOR HAEMOCHROMATOSIS|22 JUN 2022|09:00|0|N|24 JUN 2022|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
038|038-1005|AE|1|0|0001|FATIGUE|12 SEP 2020|08:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|UNKNOWN|N|0||N|N|N|N
038|038-1005|AE|2|0|0002|TRANSAMINITIS|24 APR 2021|20:00|0|N|18 MAY 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
038|038-1006|AE|1|0|0001|BULLOUS DERMATITIS|23 AUG 2021|12:00|0|N|07 SEP 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
038|038-1006|AE|2|0|0002|C-REACTIVE PROTEIN INCREASED|20 JAN 2022|15:00|0|N|29 JAN 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
038|038-1006|AE|3|0|0003|CORONARY DISEASE|21 MAY 2021|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
038|038-1006|AE|4|0|0004|TREMOR|15 OCT 2021|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
038|038-1006|AE|5|0|0005|FATTY LIVER|24 NOV 2021|08:00|0|N|12 DEC 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
038|038-1006|AE|6|0|0006|VITAMIN D DEFICIENCY|05 SEP 2021|09:00|0|N|13 SEP 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
038|038-1006|AE|7|0|0007|TINNITUS|16 FEB 2021|08:00|0|N|14 MAR 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
038|038-1006|AE|8|0|0008|LOW BACK PAIN|06 APR 2021|14:00|0|N|22 APR 2021|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
038|038-1006|AE|9|0|0009|NEOPLASM PAIN|27 AUG 2021|09:00|0|N|13 SEP 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
039|039-1001|AE|1|0|0001|TUMOR PAIN|10 JUN 2021|23:00|0|N|29 JUN 2021|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
039|039-1001|AE|2|0|0002|HYPOALBUMINAEMIA|23 JUL 2021|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
039|039-1001|AE|3|0|0003|POSTMENOPAUSAL|29 MAY 2022|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
039|039-1001|AE|4|0|0004|MAJOR DEPRESSION|01 OCT 2022|08:00|0|N|08 OCT 2022|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
039|039-1001|AE|5|0|0005|OEDEMA - LEFT ARM|04 FEB 2022|08:00|0|N|08 FEB 2022|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
039|039-1001|AE|6|0|0006|RIGHT UPPER EXTREMITY LYMPHEDEMA|07 SEP 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
039|039-1001|AE|7|0|0007|POST-MENOPAUSAL|22 MAY 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
039|039-1001|AE|8|0|0008|ALLERGIC REACTION|03 SEP 2022|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
039|039-1001|AE|9|0|0009|HISTORY OF PROSTATE CANCER|21 APR 2022|15:00|0|N|17 MAY 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
039|039-1002|AE|1|0|0001|LEIOMYOSARCOMA|29 DEC 2020|10:00|0|N|29 DEC 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
039|039-1003|AE|1|0|0001|TORN ROTATOR CUFF|27 OCT 2022|09:00|0|N|28 OCT 2022|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
039|039-1004|AE|1|0|0001|BLOOD BILIRUBIN INCREASED|20 AUG 2020|23:00|0|N|23 AUG 2020|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
039|039-1004|AE|2|0|0002|EMPYEMA|26 AUG 2020|14:00|0|N|20 SEP 2020|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
039|039-1004|AE|3|0|0003|ABDOMINAL DISTENSTION|19 NOV 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
039|039-1005|AE|1|0|0001|CHRONIC HIP PAIN|30 MAR 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
039|039-1005|AE|2|0|0002|HETEROZYGOUS FOR HAEMOCHROMATOSIS|30 JUN 2021|08:00|0|N|22 JUL 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
039|039-1005|AE|3|0|0003|INSOMNIA|01 JUN 2021|15:00|0|N|20 JUN 2021|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
039|039-1005|AE|4|0|0004|SLOW TRANSIT CONSTIPATION|30 MAY 2021|10:30|0|N|26 JUN 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
039|039-1005|AE|5|0|0005|PLATELETS COUNT DECREASED|24 JAN 2023|10:00|0|N|20 FEB 2023|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
039|039-1005|AE|6|0|0006|DRY MOUTH|03 DEC 2021|09:30|0|N|14 DEC 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
039|039-1005|AE|7|0|0007|METABOLIC ALKALOSIS|02 MAR 2022|22:30|0|N|09 MAR 2022|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
039|039-1005|AE|8|0|0008|ASPARTATE AMINOTRANSFERASE INCREASED (AST)|28 APR 2022|12:15|0|N|19 MAY 2022|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
039|039-1006|AE|1|0|0001|MEMBRANOUS NEPHROPATHY|16 APR 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
039|039-1006|AE|10|0|0010|CIPROFLOXACIN HYDROCHLORIDE ALLERGY|25 AUG 2021|15:00|0|N|30 AUG 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
039|039-1006|AE|11|0|0011|PROTEINURIA|15 OCT 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
039|039-1006|AE|2|0|0002|GENERALIZED LYMPHADENOPATHY|23 JUN 2021|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
039|039-1006|AE|3|0|0003|DIABETES INSIPIDUS|29 MAY 2021|08:00|0|N|24 JUN 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
039|039-1006|AE|4|0|0004|LEFT BUNDLE BRANCH BLOCK|12 SEP 2021|15:00|0|N|19 SEP 2021|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
039|039-1006|AE|5|0|0005|SECONDARY MALIGNANT NEOPLASM OF RIGHT LUNG|26 OCT 2021|16:00|0|N|19 NOV 2021|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
039|039-1006|AE|6|0|0006|RECTAL PAIN|01 NOV 2020|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
039|039-1006|AE|7|0|0007|DIVERTICULOSIS|06 MAY 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
039|039-1006|AE|8|0|0008|CHRONIC KIDNEY DISEASE STAGE II|05 APR 2021|09:00|0|N|07 APR 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
039|039-1006|AE|9|0|0009|COLITIS|26 MAR 2021|10:00|0|N|20 APR 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
040|040-1001|AE|1|0|0001|ALOPECIA|28 NOV 2021|08:30|0|N|09 DEC 2021|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
040|040-1001|AE|10|0|0010|WEAKNESS|02 OCT 2021|15:00|0|N|26 OCT 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
040|040-1001|AE|2|0|0002|GASRITIS|14 MAY 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
040|040-1001|AE|3|0|0003|FUNGAL PNEUMONIA|05 AUG 2020|16:00|0|N|09 AUG 2020|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
040|040-1001|AE|4|0|0004|EPISTAXIS|28 JUN 2020|12:00|0|N|10 JUL 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
040|040-1001|AE|5|0|0005|SEASONAL ALLERGIES|20 AUG 2020|08:30|0|N|26 AUG 2020|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
040|040-1001|AE|6|0|0006|STROKE|25 JUL 2021|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
040|040-1001|AE|7|0|0007|PERIPHERAL NEURITIS|04 JUL 2020|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
040|040-1001|AE|8|0|0008|NODULAR GOITER|08 NOV 2021|23:00|0|N|06 DEC 2021|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
040|040-1001|AE|9|0|0009|INTERMITTENT GASTROESOPHAGEAL REFLUX DISEASE|26 MAY 2021|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
040|040-1002|AE|1|0|0001|WEIGHT LOSS|04 MAR 2021|15:00|0|N|30 MAR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
040|040-1003|AE|1|0|0001|DIPLOPIA|25 FEB 2021|08:15|0|N|15 MAR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
040|040-1003|AE|10|0|0010|BULLOUS DERMATITIS|20 OCT 2021|08:15|0|N|24 OCT 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
040|040-1003|AE|11|0|0011|AST INCREASE|08 OCT 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
040|040-1003|AE|2|0|0002|ANTIPHOSPHOLIPID SYNDROME|29 MAY 2022|08:15|0|N|03 JUN 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
040|040-1003|AE|3|0|0003|ALKAINE PHOSPHATASE INCREASED|24 JAN 2021|11:00|0|N|07 FEB 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
040|040-1003|AE|4|0|0004|HYPOKALAEMIA|29 JUN 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
040|040-1003|AE|5|0|0005|TACHYCARDIA|15 AUG 2020|14:00|0|N|16 AUG 2020|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
040|040-1003|AE|6|0|0006|INTERMITTENT NEUTROPENIA|09 FEB 2021|11:00|0|N|09 FEB 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
040|040-1003|AE|7|0|0007|ANXIETY|06 JUL 2021|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
040|040-1003|AE|8|0|0008|OEDEMA LIMBS - RIGHT LEG|08 JAN 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
040|040-1003|AE|9|0|0009|COAGULOPATHY|28 MAY 2021|09:00|0|N|25 JUN 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
040|040-1004|AE|1|0|0001|SLEEP APNEA|25 MAR 2021|11:00|0|N|31 MAR 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
040|040-1004|AE|10|0|0010|MILD AORTIC REGURGITATION|21 JUL 2020|08:15|0|N|30 JUL 2020|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
040|040-1004|AE|2|0|0002|ABDOMINAL PAIN|02 FEB 2021|20:00|0|N|17 FEB 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
040|040-1004|AE|3|0|0003|MARANTIC ENDOCARDITIS|08 APR 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
040|040-1004|AE|4|0|0004|BASAL CELL CARCINOMA FROM RIGHT AND LEFT HAND PREAURICULAR REGION|07 JUN 2020|09:00|0|N|10 JUN 2020|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
040|040-1004|AE|5|0|0005|DEFICIENCY OF VIT. D3|09 MAR 2021|12:00|0|N|13 MAR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
040|040-1004|AE|6|0|0006|NASAL CONGESTION|17 JAN 2021|08:00|0|N|10 FEB 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
040|040-1004|AE|7|0|0007|PAIN OF SKIN - AZACITIDINE SITE|05 MAY 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
040|040-1004|AE|8|0|0008|INFUSION RELATED REACTION|19 OCT 2020|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
040|040-1004|AE|9|0|0009|HEADACHE|18 MAR 2020|12:00|0|N|28 MAR 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
040|040-1005|AE|1|0|0001|ABDOMINAL PAIN|14 MAR 2023|08:15|0|N|27 MAR 2023|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
040|040-1005|AE|2|0|0002|HEMORRHOIDS|10 JAN 2023|11:00|0|N|28 JAN 2023|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
040|040-1005|AE|3|0|0003|ARTHRALGIAS (INTERMITTENT)|03 DEC 2022|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
040|040-1005|AE|4|0|0004|GGT INCREASED|14 JUN 2021|13:45|0|N|18 JUN 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
040|040-1005|AE|5|0|0005|HYPERURICAEMIA|17 SEP 2023|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
040|040-1005|AE|6|0|0006|SWELLING OF EYELID|10 APR 2022|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
040|040-1005|AE|7|0|0007|INR INCREASE|16 JUL 2022|11:00|0|N|05 AUG 2022|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
040|040-1005|AE|8|0|0008|PULMONARY NODULE|19 MAY 2022|09:00|0|N|05 JUN 2022|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
040|040-1005|AE|9|0|0009|OEDEMA LIMBS - RIGHT LEG|29 JAN 2021|08:15|0|N|17 FEB 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
041|041-1001|AE|1|0|0001|POST-MENOPAUSE|29 JUL 2021|12:15|0|N|20 AUG 2021|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
041|041-1002|AE|1|0|0001|APPETITE CHANGE|05 AUG 2020|08:00|0|N|19 AUG 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
041|041-1002|AE|2|0|0002|OSTEOPENIA|12 NOV 2020|22:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|N|0||N|N|N|Y
041|041-1003|AE|1|0|0001|POST-MENOPAUSAL|02 FEB 2022|09:00|0|N|08 FEB 2022|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
041|041-1003|AE|2|0|0002|ABNORMAL GAIT|02 AUG 2020|09:00|0|N|14 AUG 2020|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
041|041-1003|AE|3|0|0003|ASPARTATE AMINOTRANSFERASE INCREASED|08 DEC 2021|09:00|0|N|19 DEC 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
041|041-1003|AE|4|0|0004|AST INCREASE|20 DEC 2020|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
041|041-1003|AE|5|0|0005|HYPO MAGNESIA|25 APR 2021|14:00|0|N|17 MAY 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
041|041-1003|AE|6|0|0006|ANXIETY|20 MAY 2021|15:00|0|N|05 JUN 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
041|041-1003|AE|7|0|0007|PROTEINURIA|06 JUL 2021|08:45|0|N|10 JUL 2021|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
041|041-1004|AE|1|0|0001|HYPOMAGNESEMIA|08 JAN 2021|22:00|0|N|30 JAN 2021|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
041|041-1004|AE|2|0|0002|DRY MOUTH|20 JAN 2021|08:00|0|N|31 JAN 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
041|041-1004|AE|3|0|0003|OSTEOARTHRITIS OF LEFT HIP|15 FEB 2021|09:15|0|N|28 FEB 2021|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
041|041-1004|AE|4|0|0004|VISION DECREASED|06 FEB 2021|10:00|0|N|14 FEB 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
041|041-1005|AE|1|0|0001|SKIN HYPERPIGMENTATION|20 FEB 2021|12:00|0|N|28 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
041|041-1005|AE|2|0|0002|WEIGHT GAIN|08 MAR 2021|08:00|0|N|21 MAR 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
041|041-1005|AE|3|0|0003|URINARY RETENTION|17 JAN 2021|13:45|0|N|03 FEB 2021|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
041|041-1005|AE|4|0|0004|DIZZINESS|21 MAR 2021|13:00|0|N|17 APR 2021|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
041|041-1005|AE|5|0|0005|HYPERCHLOLESTEROLEMIA|09 FEB 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
041|041-1005|AE|6|0|0006|HYPOMAGNESMIA|31 JAN 2021|09:30|0|N|04 FEB 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
041|041-1005|AE|7|0|0007|WOUND INFECTION|28 MAR 2021|15:00|0|N|18 APR 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
041|041-1006|AE|1|0|0001|GASTRIC ULCER|13 DEC 2020|09:30|0|N|02 JAN 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
041|041-1006|AE|2|0|0002|RESPIRATORY FAILURE|07 JAN 2021|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
041|041-1006|AE|3|0|0003|PROLONGED PR INTERVAL|07 JAN 2021|14:00|0|N|19 JAN 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
041|041-1006|AE|4|0|0004|BILATERAL CARPEL TUNNEL SYNDROME|03 JAN 2021|15:00|0|N|30 JAN 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
041|041-1006|AE|5|0|0005|ANEMIA, UNSPECIFIED|22 NOV 2020|22:30|0|N|05 DEC 2020|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
041|041-1006|AE|6|0|0006|ANEMIA|07 JAN 2021|15:00|0|N|31 JAN 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
041|041-1006|AE|7|0|0007|ALKALINE PHOSPHATASE INCREASE|13 DEC 2020|08:00|0|N|19 DEC 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
041|041-1006|AE|8|0|0008|MILD AORTIC REGURGITATION|12 JAN 2021|16:00|0|N|15 JAN 2021|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
041|041-1006|AE|9|0|0009|PERICARDIAL EFFUSION|27 JAN 2021|15:00|0|N|06 FEB 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
041|041-1007|AE|1|0|0001|HYPERKALAEMIA|03 DEC 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
041|041-1007|AE|2|0|0002|WOUND COMPLICATION - PERIANAL ABSCESS|10 MAR 2021|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
041|041-1007|AE|3|0|0003|FUNGAL PNEUMONIA|17 MAY 2022|10:00|0|N|10 JUN 2022|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
041|041-1007|AE|4|0|0004|CANCER ASSOCIATED PAIN|26 DEC 2021|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
041|041-1008|AE|1|0|0001|LIGHT FATTY LIVER|16 MAY 2021|09:00|0|N|30 MAY 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
041|041-1008|AE|2|0|0002|CARDIAC TROPONIN INCREASED|21 JUN 2021|18:00|0|N|18 JUL 2021|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
041|041-1008|AE|3|0|0003|NEUTROPHIL COUNT DECREASED|27 JUL 2020|09:30|0|N|24 AUG 2020|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
041|041-1008|AE|4|0|0004|PULMONARY NODULE|06 AUG 2021|11:00|0|N|16 AUG 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
041|041-1008|AE|5|0|0005|OSTEOARTHRITIS HIPS|03 JUN 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
041|041-1008|AE|6|0|0006|BOWEL IRREGULARITY|13 OCT 2020|22:30|0|N|04 NOV 2020|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
041|041-1008|AE|7|0|0007|HEPATIC STEATOSIS|03 JAN 2021|12:00|0|N|14 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
041|041-1008|AE|8|0|0008|ODEMA, LOWER LIMBS|03 NOV 2021|09:00|0|N|22 NOV 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
041|041-1008|AE|9|0|0009|OEDEMA LIMBS - RIGHT LEG|26 DEC 2020|14:00|0|N|27 DEC 2020|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
041|041-1009|AE|1|0|0001|FUNGAL PNEUMONIA|28 JAN 2021|13:00|0|N|02 FEB 2021|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
041|041-1009|AE|2|0|0002|PALPITATIONS|26 APR 2021|14:00|0|N|24 MAY 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
041|041-1009|AE|3|0|0003|CARDIAC TROPONIN I INCREASED|04 DEC 2021|15:00|0|N|27 DEC 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
041|041-1009|AE|4|0|0004|PERIPHERAL SENSORY NEUROPATHY|10 JAN 2021|09:00|0|N|23 JAN 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
041|041-1009|AE|5|0|0005|VITAMIN B12 DEFICIENCY|17 AUG 2021|15:00|0|N|12 SEP 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
041|041-1009|AE|6|0|0006|WORSENING HYPERGLYCEMIA|17 NOV 2021|22:00|0|N|02 DEC 2021|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
041|041-1009|AE|7|0|0007|HYPERCHOLESTEROLEMIA|17 DEC 2020|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
041|041-1010|AE|1|0|0001|SEASONAL ALLERGIC RHINITIS|13 FEB 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
041|041-1010|AE|2|0|0002|POSTURAL DIZZINESS|25 MAR 2021|22:00|0|N|22 APR 2021|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
042|042-1001|AE|1|0|0001|BILATERAL CATARACT|27 DEC 2023|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
042|042-1001|AE|10|0|0010|ESSENTIAL PRIMARY HYPERTENSION|23 SEP 2021|08:00|0|N|09 OCT 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
042|042-1001|AE|2|0|0002|ISCHEMIC HEART DISEASE|15 NOV 2020|15:00|0|N|30 NOV 2020|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
042|042-1001|AE|3|0|0003|LEG PAIN|07 MAR 2021|10:00|0|N|11 MAR 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
042|042-1001|AE|4|0|0004|PAIN IN EXTREMITY L ANKLE|20 MAY 2022|14:00|0|N|24 MAY 2022|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
042|042-1001|AE|5|0|0005|HEMATOMA|09 SEP 2021|09:00|0|N|27 SEP 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
042|042-1001|AE|6|0|0006|ASPARTATE AMINOTRANSFERASE INCREASED (AST)|06 MAY 2023|22:30|0|N|15 MAY 2023|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
042|042-1001|AE|7|0|0007|FIBRINOGEN DECREASED|23 FEB 2021|10:00|0|N|28 FEB 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
042|042-1001|AE|8|0|0008|ALT INCREASED (INTERMITTENT)|07 DEC 2020|08:00|0|N|06 JAN 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
042|042-1001|AE|9|0|0009|RESTLESS LEGS|19 JAN 2024|09:30|0|N|04 FEB 2024|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
042|042-1002|AE|1|0|0001|SKIN AND SUBCUTANEOUS TISSUE DISORDER - SUPERFICIAL BURN RIGHT FOREARM|25 JAN 2021|15:00|0|N|17 FEB 2021|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
042|042-1002|AE|2|0|0002|SEPSIS|30 DEC 2021|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
042|042-1002|AE|3|0|0003|GENERALIZED MUSCLE WEAKNESS|22 MAR 2021|11:00|0|N|24 MAR 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
042|042-1002|AE|4|0|0004|OBESITY|17 DEC 2020|15:00|0|N|17 DEC 2020|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
042|042-1002|AE|5|0|0005|ELEVATED CARDIAC TROPONIN T|21 DEC 2020|08:00|0|N|01 JAN 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
042|042-1002|AE|6|0|0006|ALANINE AMINOTRANSFERASE INCREASED (ALT)|13 SEP 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|1|Patient advised to rest more.|N|N|N|Y
042|042-1002|AE|7|0|0007|MALIGNANT PLEURAL EFFUSION|23 MAR 2021|20:00|0|N|27 MAR 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
042|042-1002|AE|8|0|0008|FUNGAL PNEUMONIA|05 OCT 2021|12:15|0|N|06 OCT 2021|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
042|042-1003|AE|1|0|0001|SUBCLINICAL SEIZURES|17 AUG 2020|09:00|0|N|06 SEP 2020|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
042|042-1003|AE|2|0|0002|HEADACHE (INTERMITTENT)|17 AUG 2020|20:00|1|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
042|042-1004|AE|1|0|0001|CHILLS|08 MAY 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
042|042-1004|AE|2|0|0002|ACTIVATED PARTIAL THROMBOPLASTIN TIME|30 MAY 2021|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
042|042-1004|AE|3|0|0003|OEDEMA - LEFT ARM|06 JUL 2021|12:15|0|N|08 JUL 2021|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
042|042-1004|AE|4|0|0004|OCASSIONAL HYPERTENSION|14 FEB 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
042|042-1004|AE|5|0|0005|BICORNUATE UTERUS|20 JAN 2021|09:00|0|N|20 JAN 2021|14:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|N
042|042-1004|AE|6|0|0006|NON-CARDIA CHEST PAIN|08 JUL 2021|15:00|0|N|28 JUL 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
042|042-1004|AE|7|0|0007|MUSCLE SPASMS|03 MAR 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
042|042-1005|AE|1|0|0001|HYPOPHOSPHATEMIA|22 APR 2021|12:00|0|N|24 APR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
042|042-1005|AE|2|0|0002|ISCHEMIC HEART DISEASE|29 SEP 2021|17:00|0|N|14 OCT 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
042|042-1005|AE|3|0|0003|GLUCOSURIA|08 JAN 2021|10:30|0|N|09 JAN 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
042|042-1005|AE|4|0|0004|ABODOMINAL PAIN|10 FEB 2021|11:00|0|N|15 FEB 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
042|042-1006|AE|1|0|0001|HEMOLYTIC ANEMIA|06 MAR 2022|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
042|042-1006|AE|2|0|0002|FIBRINOGEN DECREASED|01 JUN 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
042|042-1006|AE|3|0|0003|MENOPAUSE|19 JUN 2021|08:30|0|N|15 JUL 2021|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
042|042-1006|AE|4|0|0004|MENOPAUSE|03 OCT 2021|09:00|0|N|25 OCT 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
042|042-1006|AE|5|0|0005|DEPRESSION|29 OCT 2022|16:00|0|N|22 NOV 2022|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
042|042-1006|AE|6|0|0006|RIGHT UPPER EXTREMITY LYMPHEDEMA|25 FEB 2021|11:00|0|N|23 MAR 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
042|042-1006|AE|7|0|0007|OEDEMA L EYE|09 NOV 2020|11:00|0|N|30 NOV 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
042|042-1007|AE|1|0|0001|INTERMITTENT HEADACHES|26 DEC 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
042|042-1007|AE|2|0|0002|COUGH|01 OCT 2022|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
042|042-1007|AE|3|0|0003|CYTOKINE RELEASE SYNDROME|24 JAN 2022|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
042|042-1007|AE|4|0|0004|HYPERKALEMIA|04 DEC 2022|20:00|1|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
042|042-1007|AE|5|0|0005|MILD GENERALIZED PETECHIAL RASH|09 DEC 2021|11:00|0|N|06 JAN 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
042|042-1007|AE|6|0|0006|PULMONARY EMBOLISM|17 FEB 2021|11:00|0|N|13 MAR 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
042|042-1007|AE|7|0|0007|OBSTRUCTIVE SLEEP APNEA|18 JAN 2021|10:00|0|N|27 JAN 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
042|042-1007|AE|8|0|0008|ATRIAL FIBRILLATION|13 AUG 2022|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
042|042-1007|AE|9|0|0009|CHRONIC PAIN: KNEE AND HIP|03 SEP 2022|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
042|042-1008|AE|1|0|0001|LETHARGY|02 SEP 2021|07:30|0|N|05 SEP 2021|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
042|042-1008|AE|2|0|0002|RASH MACULO-PAPULAR|20 NOV 2020|09:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|1|Physiotherapy recommended|N|N|N|Y
042|042-1008|AE|3|0|0003|TACHYCARDIA|19 APR 2021|09:00|0|N|04 MAY 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
042|042-1008|AE|4|0|0004|GERD|29 NOV 2020|15:00|0|N|25 DEC 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
042|042-1008|AE|5|0|0005|PROLONGED PR INTERVAL|12 OCT 2020|22:30|0|N|02 NOV 2020|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
042|042-1008|AE|6|0|0006|MYELODYSPLASTIC SYNDROME|05 AUG 2021|10:00|0|N|20 AUG 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
042|042-1008|AE|7|0|0007|PAROXYSMAL ARTERIAL FIBRILLATION|19 JAN 2021|09:15|0|N|06 FEB 2021|12:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
042|042-1008|AE|8|0|0008|PERIPHERAL NEURITIS|24 AUG 2021|10:00|0|N|02 SEP 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
042|042-1008|AE|9|0|0009|RHABDOMYOLYSIS|30 NOV 2020|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
042|042-1009|AE|1|0|0001|ELEVATED CARDIAC TROPONIN T|12 AUG 2020|12:00|0|N|03 SEP 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
042|042-1009|AE|2|0|0002|OSTEOPENIA|15 AUG 2020|08:15|0|N|18 AUG 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
042|042-1009|AE|3|0|0003|OVERWEIGHT|16 AUG 2020|15:00|0|N|27 AUG 2020|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
042|042-1009|AE|4|0|0004|POST-MENOPAUSAL|14 AUG 2020|11:00|0|N|18 AUG 2020|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
042|042-1010|AE|1|0|0001|TYPE 2 DIABETES MELLITUS|05 AUG 2021|09:00|0|N|14 AUG 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
042|042-1010|AE|2|0|0002|PETECHIAL RASH ON LOWER EXTREMITIES|15 OCT 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
042|042-1010|AE|3|0|0003|POSTMENOPAUSAL|13 DEC 2023|15:00|0|N|29 DEC 2023|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
043|043-1001|AE|1|0|0001|POSTURAL DIZZINESS|14 JUN 2021|12:00|0|N|23 JUN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1001|AE|2|0|0002|INSOMNIA - INTERMITTENT|07 FEB 2021|10:00|0|N|16 FEB 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1001|AE|3|0|0003|UMBILICAL HERNIA|03 MAR 2021|15:00|0|N|18 MAR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
043|043-1001|AE|4|0|0004|OBSTRUCTIVE SLEEP APNOEA|23 MAY 2021|15:00|0|N|29 MAY 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
043|043-1001|AE|5|0|0005|SINUS BRADYCARDIA INTERMITTENT|16 MAR 2021|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
043|043-1001|AE|6|0|0006|PROLONGED PR INTERVAL|06 JAN 2021|12:00|0|N|25 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1001|AE|7|0|0007|HEPATIC HEMANGIOMA|09 DEC 2020|15:00|0|N|09 DEC 2020|16:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE REDUCED|Y|0||N|N|N|N
043|043-1001|AE|8|0|0008|LEFT LOWER EXTREMITY DEEP VEIN THROMBOSIS|09 MAR 2021|18:00|0|N|20 MAR 2021|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
043|043-1001|AE|9|0|0009|LEFT RADIAL ARTERIAL THROMBOSIS|11 DEC 2020|12:00|0|N|04 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1002|AE|1|0|0001|SUBDURAL HEMATOMA|14 SEP 2020|08:30|0|N|28 SEP 2020|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
043|043-1002|AE|10|0|0010|OEDEMA LIMBS - LEFT LEG|03 AUG 2020|09:00|0|N|21 AUG 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
043|043-1002|AE|11|0|0011|TOOTH DISORDER|07 AUG 2020|09:30|0|N|07 AUG 2020|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
043|043-1002|AE|2|0|0002|INTERMITTENT DYSURIA|13 SEP 2020|09:00|0|N|29 SEP 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
043|043-1002|AE|3|0|0003|SKIN AND SUBCUTANEOUS TISSUE DISORDERS -LACERATION - THUMB|06 JUL 2020|13:45|0|N|20 JUL 2020|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
043|043-1002|AE|4|0|0004|INTERMITTENT HIP PAIN|21 SEP 2020|09:30|0|N|15 OCT 2020|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
043|043-1002|AE|5|0|0005|GASTRIC ULCER|10 SEP 2020|11:00|0|N|06 OCT 2020|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1002|AE|6|0|0006|CHILLS|14 JUL 2020|07:30|0|N|03 AUG 2020|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
043|043-1002|AE|7|0|0007|DYSPHAGIA|01 OCT 2020|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
043|043-1002|AE|8|0|0008|INTERMITTENT STOMACH PAIN|11 JUL 2020|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
043|043-1002|AE|9|0|0009|BULLOUS DERMATITIS|08 OCT 2020|22:30|0|N|28 OCT 2020|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
043|043-1003|AE|1|0|0001|HYPERCHOLESTEROLAEMIA|21 APR 2021|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
043|043-1003|AE|10|0|0010|CHRONIC KIDNEY DISEASE|01 JUL 2021|12:00|0|Y|||||MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|Y|N|Y
043|043-1003|AE|11|0|0011|DEPRESSION|13 AUG 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
043|043-1003|AE|2|0|0002|BLOOD LACTATE DEHYDROGENASE INCREASED|23 FEB 2021|09:00|0|N|08 MAR 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
043|043-1003|AE|3|0|0003|TRANSFUSION IRON OVERLOAD|04 OCT 2021|08:15|0|N|18 OCT 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
043|043-1003|AE|4|0|0004|MUCOSITIS|14 APR 2021|07:30|0|N|24 APR 2021|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
043|043-1003|AE|5|0|0005|DIVERTICULITIS|03 SEP 2021|12:00|0|N|25 SEP 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1003|AE|6|0|0006|CONCUSSION|09 JUL 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
043|043-1003|AE|7|0|0007|TOOTHACHE|21 MAY 2021|15:00|0|N|31 MAY 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
043|043-1003|AE|8|0|0008|ADHESIVE TAPE ALLERGY|16 MAR 2021|22:30|0|N|10 APR 2021|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
043|043-1003|AE|9|0|0009|PANCYTOPENIA|13 JUN 2021|12:00|0|N|17 JUN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1004|AE|1|0|0001|CHRONIC KNEE PAIN|20 JUL 2021|17:00|0|N|04 AUG 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
043|043-1004|AE|10|0|0010|ELEVATED LFTS|24 JAN 2022|09:00|0|N|26 JAN 2022|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
043|043-1004|AE|11|0|0011|BILATERAL CATARACTS|27 MAY 2022|22:30|0|N|31 MAY 2022|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
043|043-1004|AE|2|0|0002|HEMATOCHROMATOSIS|25 JUN 2022|09:30|0|N|07 JUL 2022|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
043|043-1004|AE|3|0|0003|URINARY RETENTION|07 JUN 2023|08:30|0|N|22 JUN 2023|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
043|043-1004|AE|4|0|0004|WEAKNESS|31 AUG 2022|14:30|0|N|23 SEP 2022|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
043|043-1004|AE|5|0|0005|PANCREATIC INSUFFICIENCY|24 JUL 2021|11:00|0|N|13 AUG 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1004|AE|6|0|0006|SECONDARY MALIGNANT NEOPLASM OF RIGHT LUNG|23 JUN 2022|11:00|0|N|02 JUL 2022|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1004|AE|7|0|0007|DIABETES MELLITUS|21 APR 2022|08:15|0|N|28 APR 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
043|043-1004|AE|8|0|0008|INVESTIGATIONS OTHER: MONOCYTES ELEVATED|14 SEP 2021|11:00|0|N|26 SEP 2021|17:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1004|AE|9|0|0009|OBSTRUCTIVE SLEEP APNEA|04 JAN 2023|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
043|043-1005|AE|1|0|0001|MEMORY LOSS|12 JAN 2021|09:30|0|N|29 JAN 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
043|043-1005|AE|10|0|0010|INJECTION SITE REACTION - INTERMITTENT|04 MAR 2021|12:00|0|N|25 MAR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1005|AE|11|0|0011|HYPERPIGMENTATION OF THE SKIN|18 JAN 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
043|043-1005|AE|2|0|0002|NEUROPATHIC PAIN|17 OCT 2020|09:00|0|N|03 NOV 2020|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
043|043-1005|AE|3|0|0003|HYPERCHOLESTEROEMIA|09 SEP 2020|10:00|0|N|13 SEP 2020|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
043|043-1005|AE|4|0|0004|ENCEPHALOPATHY|24 SEP 2020|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
043|043-1005|AE|5|0|0005|FATTY LIVER|26 SEP 2020|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
043|043-1005|AE|6|0|0006|INFECTIONS AND INFESTATIONS - OTHER: C. DIFFICILE|28 MAR 2021|15:00|0|N|11 APR 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
043|043-1005|AE|7|0|0007|MUCOSITIS ORAL|28 MAR 2021|16:00|0|N|23 APR 2021|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
043|043-1005|AE|8|0|0008|ANEMIA|21 DEC 2020|08:45|0|N|27 DEC 2020|10:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1005|AE|9|0|0009|DIABETES MELLITUS|23 DEC 2020|15:00|0|N|22 JAN 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
043|043-1006|AE|1|0|0001|HEPATIC CYST|04 FEB 2022|14:00|0|N|14 FEB 2022|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
043|043-1006|AE|10|0|0010|INTERMITTENT DIARRHOEA|24 JUN 2021|12:00|0|N|11 JUL 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
043|043-1006|AE|11|0|0011|SINUS TACHYCARDIA INTERMITTENT|22 MAR 2021|15:00|0|N|19 APR 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
043|043-1006|AE|2|0|0002|BONE PAIN|02 NOV 2021|08:00|0|N|17 NOV 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
043|043-1006|AE|3|0|0003|PAIN HAEMATOMA R OUTER THIGH|02 DEC 2020|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
043|043-1006|AE|4|0|0004|GERD (GASTROESOPHAGEAL REFLUX DISEASE)|10 APR 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
043|043-1006|AE|5|0|0005|SEASONAL ALLERGIES|07 NOV 2021|08:30|0|N|08 NOV 2021|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
043|043-1006|AE|6|0|0006|ESOPHAGEAL SPASM|22 DEC 2020|14:00|0|N|23 DEC 2020|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
043|043-1006|AE|7|0|0007|PRODUCTIVE COUGH|15 JUN 2021|12:15|0|N|04 JUL 2021|09:30|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
043|043-1006|AE|8|0|0008|OBSESSIVE COMPULSIVE DISORDER|12 JUN 2021|17:00|0|N|23 JUN 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
043|043-1006|AE|9|0|0009|GGT INCREASED (GAMMA-GLUTAMYL TRANSFERASE)|07 JAN 2021|22:30|0|N|28 JAN 2021|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
044|044-1001|AE|1|0|0001|ALT INCREASED|09 JAN 2022|23:00|0|N|01 FEB 2022|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1001|AE|10|0|0010|TOOTHACHE|18 FEB 2022|09:00|0|N|02 MAR 2022|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
044|044-1001|AE|2|0|0002|RECTAL PAIN|20 NOV 2020|08:00|0|N|19 DEC 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
044|044-1001|AE|3|0|0003|ARTHRITIS|08 MAR 2021|11:00|0|N|08 MAR 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1001|AE|4|0|0004|RECTAL PAIN|14 APR 2021|23:00|0|N|01 MAY 2021|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1001|AE|5|0|0005|NEUTROPHIL COUNT DECREASED|17 AUG 2021|09:30|0|N|09 SEP 2021|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
044|044-1001|AE|6|0|0006|PERIPHERAL MOTOR NEUROPATHY|04 APR 2021|22:30|0|N|21 APR 2021|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
044|044-1001|AE|7|0|0007|NAUSEA (GRADE 1)|05 APR 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
044|044-1001|AE|8|0|0008|RHEUMATOID ARTHRITIS|27 JAN 2021|16:00|0|N|16 FEB 2021|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
044|044-1001|AE|9|0|0009|VITAMIN B12 DEFICIENCY|06 NOV 2021|08:00|0|N|10 NOV 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
044|044-1002|AE|1|0|0001|IMPACTED CERUMEN OF RIGHT EAR|28 AUG 2021|14:00|0|N|29 AUG 2021|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
044|044-1002|AE|10|0|0010|MYELODYSPLASTIC SYNDROME|17 NOV 2021|20:00|0|N|18 NOV 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
044|044-1002|AE|11|0|0011|DELIRIUM|15 JAN 2021|22:00|0|N|18 JAN 2021|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
044|044-1002|AE|2|0|0002|INTESTINAL FLORA DYSREGULATION|02 MAY 2021|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
044|044-1002|AE|3|0|0003|AGE-RELATED CATARACTS|08 JAN 2021|16:00|0|N|22 JAN 2021|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
044|044-1002|AE|4|0|0004|NASAL CONGESTION|16 JAN 2021|10:00|0|N|26 JAN 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1002|AE|5|0|0005|CORONARY DISEASE|10 APR 2021|22:30|0|N|18 APR 2021|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
044|044-1002|AE|6|0|0006|GOUTY TOPHI|15 OCT 2021|09:00|0|N|13 NOV 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
044|044-1002|AE|7|0|0007|PULMONARY NODULES|28 JUL 2021|12:00|0|N|28 JUL 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1002|AE|8|0|0008|ACUTE MEDIAL MENISCUS TEAR OF RIGHT KNEE|11 SEP 2021|08:00|0|N|15 SEP 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
044|044-1002|AE|9|0|0009|PAROTID MASS|10 AUG 2021|14:00|0|N|10 AUG 2021|08:00|0|FATAL|SEVERE|NCI CTC AE v5.0|5|RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
044|044-1003|AE|1|0|0001|BOWEL IRREGULARITY|13 AUG 2020|09:00|0|N|22 AUG 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
044|044-1003|AE|10|0|0010|FALL|13 FEB 2021|15:00|0|N|05 MAR 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
044|044-1003|AE|2|0|0002|PERIANAL FISSURE|12 NOV 2020|10:00|0|N|14 NOV 2020|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1003|AE|3|0|0003|FIBRINOGEN DECREASED|03 AUG 2020|11:00|0|N|19 AUG 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|0||N|N|N|Y
044|044-1003|AE|4|0|0004|CHILLS|14 FEB 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
044|044-1003|AE|5|0|0005|HEADACHE|18 JAN 2021|11:00|0|N|24 JAN 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1003|AE|6|0|0006|BREAST CANCER|14 MAR 2021|10:30|0|N|04 APR 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
044|044-1003|AE|7|0|0007|INJECTION SITE REACTION - INTERMITTENT|01 JAN 2021|17:00|0|N|12 JAN 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
044|044-1003|AE|8|0|0008|SECONDARY MALIGNANT NEOPLASM OF THE BONE|19 AUG 2020|09:00|0|N|01 SEP 2020|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
044|044-1003|AE|9|0|0009|ELEVATED URIC ACID|17 AUG 2020|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
044|044-1004|AE|1|0|0001|HAND TREMORS|16 SEP 2021|09:00|0|N|21 SEP 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
044|044-1004|AE|10|0|0010|REDNESS OF EYELID|03 DEC 2021|12:00|0|N|31 DEC 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1004|AE|2|0|0002|CATARACTS (MILD) BOTH EYES|21 OCT 2021|08:00|0|N|23 OCT 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
044|044-1004|AE|3|0|0003|GLAUCOMA (BOTH EYES)|31 JAN 2021|10:00|0|N|25 FEB 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1004|AE|4|0|0004|NAUSEA - INTERMITTENT|19 AUG 2021|12:00|0|N|23 AUG 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1004|AE|5|0|0005|BLAST CELL COUNT INCREASED|08 JUN 2021|10:30|0|N|04 JUL 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|UNKNOWN|N|0||N|N|N|N
044|044-1004|AE|6|0|0006|BILATERAL CATARACTS|04 FEB 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
044|044-1004|AE|7|0|0007|ANTINEOPLASTIC CHEMOTHERAPY INDUCED ANEMIA|27 DEC 2021|12:00|0|N|01 JAN 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1004|AE|8|0|0008|SLOW TRANSIT CONSTIPATION|14 FEB 2022|10:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|1|Administered oxygen therapy.|N|N|N|N
044|044-1004|AE|9|0|0009|SKIN HYPERPIGMENTATION|15 AUG 2021|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
044|044-1005|AE|1|0|0001|PLATELET COUNT DECREASED|22 MAY 2022|15:00|0|N|27 MAY 2022|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
044|044-1005|AE|2|0|0002|MYELODYSPLASTIC SYNDROME|07 JUN 2021|09:30|0|N|19 JUN 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
044|044-1005|AE|3|0|0003|METABOLIC ALKALOSIS|16 AUG 2021|11:00|0|N|27 AUG 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1005|AE|4|0|0004|MUCOSITIS - ORAL|10 JUN 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
044|044-1005|AE|5|0|0005|INTERMITTENT GASTROESOPHAGEAL REFLUX DISEASE|27 OCT 2020|12:00|0|N|06 NOV 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1005|AE|6|0|0006|BLAST CELL COUNT INCREASED|13 JUL 2021|22:30|0|N|05 AUG 2021|18:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
044|044-1005|AE|7|0|0007|DIARRHEA|21 SEP 2020|08:00|0|N|23 SEP 2020|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
044|044-1005|AE|8|0|0008|ALANINE AMINOTRANSFERASE INCREASED|21 DEC 2021|11:00|0|N|10 JAN 2022|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1006|AE|1|0|0001|OSTEOPOROSIS|15 FEB 2023|09:00|0|N|07 MAR 2023|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
044|044-1006|AE|2|0|0002|FLATULENCE|25 SEP 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
044|044-1007|AE|1|0|0001|ALKAINE PHOSPHATASE INCREASED|08 MAY 2021|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
044|044-1007|AE|2|0|0002|PAIN OF SKIN - AZACITIDINE SITE|04 FEB 2021|15:00|0|N|06 FEB 2021|10:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
044|044-1007|AE|3|0|0003|SENSORY NEURAL DEAFNESS ON RIGHT|24 APR 2021|09:00|0|N|29 APR 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|1|Antihistamines were administered.|N|N|N|N
044|044-1007|AE|4|0|0004|DIVERTICULITIS|02 OCT 2020|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
044|044-1007|AE|5|0|0005|DIPLOPIA|12 NOV 2020|09:30|0|N|12 NOV 2020|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
044|044-1008|AE|1|0|0001|PAIN HAEMATOMA R OUTER THIGH|15 OCT 2022|16:00|0|N|01 NOV 2022|18:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
044|044-1008|AE|10|0|0010|CHRONIC COUGH|22 FEB 2021|15:00|0|N|14 MAR 2021|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
044|044-1008|AE|11|0|0011|DRY EYES|05 JAN 2023|08:15|0|N|31 JAN 2023|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
044|044-1008|AE|2|0|0002|TRANSFUSION IRON OVERLOAD|01 APR 2022|10:30|0|N|12 APR 2022|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
044|044-1008|AE|3|0|0003|SLEEP APNEA|25 JUN 2022|15:00|0|N|04 JUL 2022|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1008|AE|4|0|0004|THROMBOCYTOPENIA|26 OCT 2022|15:00|0|N|17 NOV 2022|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
044|044-1008|AE|5|0|0005|INR INCREASE|11 MAY 2022|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
044|044-1008|AE|6|0|0006|HYPOXIA|02 DEC 2021|09:30|0|N|06 DEC 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
044|044-1008|AE|7|0|0007|PAROXYSMAL SHORTNESS OF BREATH|06 AUG 2022|10:00|0|N|22 AUG 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1008|AE|8|0|0008|DENTAL ABSCESS|13 OCT 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
044|044-1008|AE|9|0|0009|CREATININE INCREASED|30 OCT 2022|22:00|0|N|14 NOV 2022|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
044|044-1009|AE|1|0|0001|HYPOALBUMINEMIA|26 JUN 2021|09:00|0|N|17 JUL 2021|10:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DRUG INTERRUPTED|Y|0||N|N|N|N
044|044-1009|AE|2|0|0002|EPILEPSY|04 JUL 2021|14:30|0|N|30 JUL 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE RATE REDUCED|Y|1|Patient received antacids.|N|N|N|N
044|044-1009|AE|3|0|0003|GASTRIC ULCER|19 MAR 2021|22:30|0|N|18 APR 2021|07:45|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|NOT APPLICABLE|N|0||N|N|N|N
044|044-1010|AE|1|0|0001|HYPERCHOLESTEROLAEMIA|28 AUG 2021|10:00|0|N|19 SEP 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
044|044-1010|AE|2|0|0002|SINUSITIS|09 JAN 2021|10:00|0|N|30 JAN 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1010|AE|3|0|0003|GERD|29 MAY 2021|10:00|0|N|06 JUN 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
044|044-1011|AE|1|0|0001|ELEVATED URIC ACID|23 DEC 2022|09:00|0|N|19 JAN 2023|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
044|044-1011|AE|2|0|0002|ACTIVATED PARTIAL THROMBOPLASTIN TIME|19 JAN 2021|10:00|0|N|11 FEB 2021|14:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|N
044|044-1011|AE|3|0|0003|BONE MARROW HYPOCELLULAR|02 MAY 2021|17:00|0|N|24 MAY 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|0||Y|N|N|Y
044|044-1011|AE|4|0|0004|TREMOR|05 FEB 2023|08:00|0|N|11 FEB 2023|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
044|044-1011|AE|5|0|0005|DEGENERATIVE SPONDYLOSIS|13 FEB 2022|09:30|0|N|07 MAR 2022|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
044|044-1011|AE|6|0|0006|REDNESS OF EYELID|30 JUL 2021|09:00|0|N|09 AUG 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
044|044-1012|AE|1|0|0001|WHEEZING|23 NOV 2021|12:00|0|N|13 DEC 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1012|AE|2|0|0002|CHEST TIGHTNESS|02 AUG 2021|11:00|0|N|30 AUG 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
044|044-1012|AE|3|0|0003|SMALL BILATERAL INGUINAL HERNIA|03 DEC 2020|09:30|0|N|12 DEC 2020|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
044|044-1012|AE|4|0|0004|DEHYDRATION|20 MAY 2022|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|Y|0||N|N|N|Y
044|044-1012|AE|5|0|0005|SEASONAL ALLERGIC RHINITIS|27 FEB 2021|10:30|0|N|16 MAR 2021|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
044|044-1012|AE|6|0|0006|TUMOR PAIN|27 FEB 2021|15:00|0|N|12 MAR 2021|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
044|044-1012|AE|7|0|0007|NEOPLASM PAIN|22 MAR 2022|22:00|0|N|16 APR 2022|07:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to use relaxation techniques.|N|N|N|N
044|044-1012|AE|8|0|0008|POST-MENOPAUSE|01 AUG 2020|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
045|045-1001|AE|1|0|0001|COLITIS|17 OCT 2021|20:00|0|N|28 OCT 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
045|045-1001|AE|2|0|0002|SORE THROAT|10 APR 2022|10:00|0|N|07 MAY 2022|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
045|045-1001|AE|3|0|0003|WEIGHT LOSS|02 OCT 2022|20:00|0|N|31 OCT 2022|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
045|045-1001|AE|4|0|0004|HYPOMAGNESAEMIA|08 JAN 2022|14:00|0|N|16 JAN 2022|15:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
045|045-1001|AE|5|0|0005|POSTURAL DIZZINESS|15 MAY 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
045|045-1001|AE|6|0|0006|WHITE BLOOD CELL DECREASED|06 NOV 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
045|045-1001|AE|7|0|0007|HYPERCHOLESTEROEMIA|06 JAN 2023|20:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|UNKNOWN|N|0||N|N|N|Y
045|045-1002|AE|1|0|0001|NODULAR GOITER|06 MAY 2021|08:00|0|N|18 MAY 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
045|045-1002|AE|2|0|0002|ALANINE AMINOTRANSFERASE INCREASED|27 NOV 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
045|045-1002|AE|3|0|0003|PICC LINE SITE PAIN|19 MAY 2020|10:00|0|N|01 JUN 2020|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
045|045-1002|AE|4|0|0004|SMALL UMBILICAL HERNIA|09 DEC 2020|08:00|0|N|01 JAN 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
045|045-1002|AE|5|0|0005|NOVEL CORONAVIRUS INFECTION|07 FEB 2021|12:00|0|N|06 MAR 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
045|045-1002|AE|6|0|0006|GGT INCREASED|03 JUL 2020|15:00|0|N|10 JUL 2020|09:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|0||Y|N|N|Y
045|045-1002|AE|7|0|0007|TUBERCULOSIS EXPOSURE|05 JAN 2021|18:00|0|N|09 JAN 2021|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
045|045-1003|AE|1|0|0001|PROLONGED PR INTERVAL|04 JUL 2022|11:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
045|045-1003|AE|2|0|0002|ANEMIA (INTERMITTENT)|10 JUL 2023|23:00|0|N|29 JUL 2023|06:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
045|045-1003|AE|3|0|0003|HYPERURICAEMIA|27 MAR 2023|13:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE RATE REDUCED|Y|0||Y|N|N|N
045|045-1003|AE|4|0|0004|HERPES ZOSTER|13 AUG 2021|08:00|0|N|29 AUG 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
045|045-1003|AE|5|0|0005|WHEEZING|22 JUL 2023|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
045|045-1004|AE|1|0|0001|HYPERTHYROIDISM|28 APR 2023|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
045|045-1004|AE|2|0|0002|HYPOTENSION (INTERMITTENT)|15 FEB 2022|12:00|0|N|21 FEB 2022|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
045|045-1004|AE|3|0|0003|GLAUCOMA (BOTH EYES)|21 JUN 2023|08:30|0|N|07 JUL 2023|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
045|045-1004|AE|4|0|0004|HYPERTENSION (INTERMITTENT)|26 APR 2022|08:00|0|N|03 MAY 2022|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
045|045-1004|AE|5|0|0005|FATTY LIVER|16 SEP 2021|11:00|0|N|19 SEP 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
045|045-1004|AE|6|0|0006|CHRONIC HIP PAIN|22 DEC 2021|07:30|0|N|22 DEC 2021|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
045|045-1004|AE|7|0|0007|ANTINEOPLASTIC CHEMOTHERAPY INDUCED ANEMIA|26 JAN 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
045|045-1004|AE|8|0|0008|MUSCLE SPASMS|21 FEB 2021|09:00|0|N|01 MAR 2021|12:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|RELATED|UNKNOWN|N|0||Y|N|N|N
045|045-1005|AE|1|0|0001|ABODOMINAL PAIN|06 JUN 2021|15:00|0|N|10 JUN 2021|09:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
045|045-1005|AE|2|0|0002|ATRIAL FIBRILLATION|15 NOV 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|N|1|Increased hydration and rest advised|N|N|N|Y
045|045-1005|AE|3|0|0003|HEMATOMA|24 NOV 2021|13:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|Y|1|Patient received additional analgesics.|Y|N|N|N
045|045-1005|AE|4|0|0004|BICORNUATE UTERUS|01 DEC 2020|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
045|045-1005|AE|5|0|0005|HYPERURICEMIA|04 SEP 2021|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||N|N|N|Y
045|045-1006|AE|1|0|0001|NEOPLASM PAIN|10 JUL 2021|08:00|0|N|05 AUG 2021|10:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient was advised to rest.|N|N|N|N
045|045-1006|AE|2|0|0002|RESTLESS LEGS|01 JUN 2023|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
045|045-1006|AE|3|0|0003|BENIGN LIPOMAS|24 MAR 2021|08:15|0|N|21 APR 2021|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
045|045-1006|AE|4|0|0004|ELEVATED WBC COUNT|03 AUG 2020|13:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
045|045-1006|AE|5|0|0005|FLATULENCE|14 JUN 2021|22:00|0|Y|||||MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
045|045-1007|AE|1|0|0001|UTERINE CERVICAL CYST|28 JAN 2023|09:30|0|N|16 FEB 2023|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
045|045-1007|AE|2|0|0002|B12 VITAMIN DEFICIENCY ANEMIA|17 FEB 2022|15:00|0|N|08 MAR 2022|16:00|0|RECOVERING/RESOLVING|SEVERE|NCI CTC AE v5.0|3|RELATED|DRUG INTERRUPTED|N|0||Y|N|N|N
046|046-1001|AE|1|0|0001|INJECTION SITE REACTION - INTERMITTENT|24 JUN 2021|20:00|0|N|04 JUL 2021|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
046|046-1002|AE|1|0|0001|HYPONATREMIA|27 OCT 2021|12:00|0|N|09 NOV 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
046|046-1002|AE|2|0|0002|SMALL UMBILICAL HERNIA|07 JUL 2021|10:00|0|N|18 JUL 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
046|046-1002|AE|3|0|0003|CHRONIC KNEE PAIN|21 OCT 2020|13:00|0|N|08 NOV 2020|18:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|N|0||N|N|N|Y
046|046-1002|AE|4|0|0004|ANEMIA, UNSPECIFIED|07 FEB 2021|11:00|0|N|05 MAR 2021|13:30|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
046|046-1003|AE|1|0|0001|ANEMIA|11 AUG 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|1|Administered pain relief medication|N|N|N|Y
046|046-1003|AE|2|0|0002|PERIPHERAL NEURITIS|19 SEP 2020|13:45|0|N|16 OCT 2020|17:00|0|RECOVERING/RESOLVING|MODERATE|NCI CTC AE v5.0|2|RELATED|UNKNOWN|Y|0||N|N|N|N
046|046-1003|AE|3|0|0003|FIBRINOGEN DECREASED|30 SEP 2020|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
046|046-1004|AE|1|0|0001|TOOTHACHE|11 OCT 2020|14:00|0|Y||||UNKNOWN|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
046|046-1004|AE|2|0|0002|ALANINE AMINOTRANSFERASE INCREASED|16 AUG 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
046|046-1004|AE|3|0|0003|BREAST CANCER - RIGHT AXILLARY (ER/PR POSITIVE WITH APOCRINE FEATURES)|25 JUL 2020|10:00|0|Y||||UNKNOWN|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
046|046-1004|AE|4|0|0004|WEIGHT LOSS|13 SEP 2020|14:00|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|Y
046|046-1005|AE|1|0|0001|VITAMIN B DEFICIENCY|22 DEC 2021|07:30|0|N|31 DEC 2021|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
046|046-1005|AE|2|0|0002|HAND TREMORS|05 FEB 2022|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
046|046-1005|AE|3|0|0003|EMPYEMA|28 NOV 2021|10:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
046|046-1005|AE|4|0|0004|HYPERTENSION|16 FEB 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
046|046-1006|AE|1|0|0001|REDNESS OF EYELID|13 NOV 2020|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
046|046-1007|AE|1|0|0001|HEARING IMPAIRMENT|03 APR 2021|07:30|0|N|30 APR 2021|08:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|POSSIBLY RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
046|046-1008|AE|1|0|0001|PERIPHERAL SENSORY NEUROPATHY|16 MAY 2021|15:00|0|N|27 MAY 2021|11:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|UNLIKELY RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
046|046-1008|AE|2|0|0002|ARTHRALGIAS (INTERMITTENT)|18 MAY 2021|09:00|0|N|13 JUN 2021|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|1|Patient advised on rest and hydration.|N|N|N|N
046|046-1008|AE|3|0|0003|DELIRIUM|25 MAR 2021|09:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
046|046-1008|AE|4|0|0004|ASPARTATE AMINOTRANSFERASE INCREASED|17 AUG 2021|08:30|0|N|31 AUG 2021|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
046|046-1008|AE|5|0|0005|LOCALISED OEDEMA - BONE MARROW ASPIRATE TREPHINE SITE, RIGHT POSTERIOR SUPERIOR ILIAC SPINE|29 OCT 2021|08:30|0|N|12 NOV 2021|11:30|0|NOT RECOVERED/NOT RESOLVED|MODERATE|NCI CTC AE v5.0|2|NOT RELATED|UNKNOWN|N|0||N|N|N|Y
046|046-1009|AE|1|0|0001|WORSENING CREATININE INCREASE|09 APR 2021|10:00|0|N|04 MAY 2021|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
046|046-1009|AE|2|0|0002|CORONARY DISEASE|12 MAY 2021|16:00|0|N|18 MAY 2021|18:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|3|POSSIBLY RELATED|DOSE REDUCED|N|0||Y|N|N|N
046|046-1009|AE|3|0|0003|ACUTE KIDNEY INJURY|25 AUG 2021|11:00|0|N|16 SEP 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
046|046-1009|AE|4|0|0004|ANEMIA, UNSPECIFIED|16 JUL 2021|10:00|0|N|07 AUG 2021|16:00|0|RECOVERED/RESOLVED|MODERATE|NCI CTC AE v5.0|2|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
046|046-1009|AE|5|0|0005|FEBRILE NEUTROPENIA|27 SEP 2020|18:00|0|N|09 OCT 2020|19:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|N
046|046-1009|AE|6|0|0006|BRUISING|05 SEP 2020|15:00|0|N|14 SEP 2020|12:00|0|NOT RECOVERED/NOT RESOLVED|SEVERE|NCI CTC AE v5.0|4|UNLIKELY RELATED|DRUG INTERRUPTED|N|0||Y|N|N|Y
046|046-1010|AE|1|0|0001|HYPOKALEMIA|05 MAR 2021|08:00|0|N|30 MAR 2021|20:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|UNKNOWN|N|0||N|N|N|Y
046|046-1010|AE|10|0|0010|PNEUMONIA|23 JAN 2023|10:00|0|N|14 FEB 2023|09:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|Y|0||N|N|N|N
046|046-1010|AE|2|0|0002|SECONDARY MALIGNANT NEOPLASM OF THE BONE|27 SEP 2020|11:00|0|N|27 SEP 2020|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|NOT RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
046|046-1010|AE|3|0|0003|WORSENING HYPERGLYCEMIA|27 JUN 2021|11:00|0|N|06 JUL 2021|13:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
046|046-1010|AE|4|0|0004|EDEMA: BILATERAL LOWER EXTREMITIES|12 MAY 2020|08:15|0|N|06 JUN 2020|18:00|0|RECOVERED/RESOLVED WITH SEQUELAE|SEVERE|NCI CTC AE v5.0|3|UNLIKELY RELATED|DOSE REDUCED|N|0||Y|N|N|N
046|046-1010|AE|5|0|0005|ALLERGIC DERMATITIS|03 OCT 2021|11:30|0|Y||||UNKNOWN|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DRUG INTERRUPTED|Y|0||N|N|N|Y
046|046-1010|AE|6|0|0006|ERECTILE DYSFUNCTION|15 DEC 2020|12:00|0|N|08 JAN 2021|14:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
046|046-1010|AE|7|0|0007|HISTORY OF PROSTATE CANCER|24 JUL 2020|10:00|0|N|09 AUG 2020|16:00|0|RECOVERING/RESOLVING|MILD|NCI CTC AE v5.0|1|RELATED|DOSE RATE REDUCED|N|0||N|N|N|N
046|046-1010|AE|8|0|0008|PROLONGED PR INTERVAL|23 JUN 2023|20:00|0|N|30 JUN 2023|22:00|0|RECOVERED/RESOLVED|MILD|NCI CTC AE v5.0|1|RELATED|DOSE NOT CHANGED|N|0||N|N|N|N
046|046-1010|AE|9|0|0009|LYMPHOCYTOPENIA|17 NOV 2022|09:30|0|N|20 NOV 2022|10:30|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|Y
046|046-1011|AE|1|0|0001|COAGULOPATHY|15 FEB 2021|09:00|0|N|12 MAR 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
046|046-1011|AE|2|0|0002|INVESTIGATIONS OTHER: MONOCYTES ELEVATED|28 MAR 2021|09:00|0|N|24 APR 2021|12:00|0|RECOVERED/RESOLVED|SEVERE|NCI CTC AE v5.0|4|RELATED|DOSE RATE REDUCED|N|0||Y|N|N|N
046|046-1011|AE|3|0|0003|OSTEOARTHRITIS|08 NOV 2020|10:30|0|N|23 NOV 2020|11:00|0|RECOVERED/RESOLVED WITH SEQUELAE|MODERATE|NCI CTC AE v5.0|2|POSSIBLY RELATED|DOSE REDUCED|Y|0||N|N|N|N
046|046-1011|AE|4|0|0004|ACUTE KIDNEY INJURY|24 MAR 2021|09:30|0|N|22 APR 2021|10:30|0|FATAL|SEVERE|NCI CTC AE v5.0|5|UNLIKELY RELATED|DRUG WITHDRAWN|N|0||Y|N|N|Y
